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1SUMMARY
Studies have been undertaken to investigate the relationship 
between drug-metabolizing enzyme activity and the lipid composition of 
rat endoplasmic reticulum, particularly in respect of the fa tty  acid 
composition of liver and of microsomal preparations as well as of the 
phosphatidylcholine and phosphatidylethanolamine fractions. The study 
comprised three aspects, as follows:
1. Effect of development. During development of rats from the 
foetus to adult, in both sexes, a rapid increase of drug-metabolizing 
enzyme activity occurs that is associated with increased synthesis of 
hepatic microsomal phospholipids and fatty  acids. Both saturated and 
unsaturated fatty  acids of the phospholipids increase with age in both 
sexes. Differences in fatty  acid composition were observed between 
sexes at about 2-3 weeks of age. During development, a progressive 
decrease in the ratio of saturated to unsaturated fatty  acids and an 
increase in the phospholipid to protein ratio occur, associated with 
increased membrane flu id ity .
2. Effect of pregnancy and steroids. During pregnancy, a 
decrease in various liver microsomal enzyme activities parallels a 
decreased synthesis of phospholipids and fatty acids. The concentra­
tions of phosphatidylcholine, phosphatidylethanolamine and lysophospha- 
tidylcholine are decreased changing the composition of the phospholipids. 
The fatty  acid content is decreased with changes in the ratio of 
saturated and unsaturated fatty acids. The liver microsomal lipids 
returned to normal values 2-3 weeks post partum.
As the inhibition of drug-metabolizing activity in pregnancy has 
been attributed to reduced metabolites of progesterone, non-pregnant 
female rats were treated with 53-pregnan-3a-ol-20-one or 16a-hydroxy- 
progesterone. Whereas treatment with pregnanolone mimics the
inhibitory effects of pregnancy, 16a-hydroxyprogesterone enhances drug  
metabolism, phospholipid and fatty  acid contents.
3. Effect of microsomal enzyme inducing agents. Three aspects of 
the induction of rat liver drug-metabolizing enzymes have been observed.
2(i) Phenobarbitone and Aroclor-1254 treatments increase aminopyrine 
N-demethylase activ ity , related to cytochrome P-450, whereas 
/^roclor-1254 and 3-methylcholanthrene treatments increase 7-ethoxy- 
resorufin and 7-ethoxycoumarin O-deethylase activities related to 
cytochrome P-448. Cytochrome P-450 reductase activity is increased by 
Aroclor and phenobarbitone, and is decreased by carbon tetrachloride, 
which also decreases gIucose-6-phosphatase and aminopyrine^ N-deme­
thylase activities together with cytochrome P-450 content.
(ii) Pretreatments with phenobarbitone or Aroclor-1254 result in a 
5o% increase in the phospholipid content of the microsomes, 3-methyl­
cholanthrene causes no change, while carbon tetrachloride decreases the 
phospholipid content.
(iii) Liver microsomal cholesterol content is decreased and 
triglycerides increased by phenobarbitone or Aroclor-1254. Sphingo­
myelin content is decreased by phenobarbitone, Aroclor-1254 or 
3-methylcholanthrene. Carbon tetrachloride administration increases the 
microsomal cholesterol, triglycerides and sphingomyelin contents. The 
ratio of saturated to unsaturated fatty acids is decreased by 
phenobarbitone or Aroclor-1254, while carbon tetrachloride markedly 
increases this. The major effect of 3-methylcholanthrene was on the 
microsomal phosphatidylethanolamine fraction. All of these effects would 
result in changes in the flu idity of the phospholipid bilayer of the 
endoplasmic reticulum membrane and may thus modulate drug metabolism.
4CHAPTER 1 
HEPATIC ENDOPLASMIC RETICULUM
I .  STRUCTURAL-FUNCTIONAL RELATIONSHIP
A. Introduction
The hepatic endoplasmic reticulum exhibits great complexity in 
structure and function. Morphologically, it consists of rough- and 
smooth-surfaced channels (RER and SER respectively). The ER is an 
intracellular membrane, richly endowed with numerous enzymes required 
for glycoprotein synthesis, mixed-function oxidases, and essential 
cellular functions (Palade, 1956). These membranes are in direct 
continuity, but the SER is though to originate from the RER (Palade, 
1956). A fter cell organelles d isrupt, a large proportion of the ER gives
rise to the microsomal fraction which represents about 15% of the total
cell mass. The membranes of the RER and SER, respectively, constitute 
the rough and smooth microsomes (Claude, 1948; Porter and Kallman,
1952; DePierre and Dallner, 1975; Parodi and Le Loir, 1979;
Amar-Costesec and Beaufay, 1981; Parke, 1981). Table 1 lists the
major functions of the hepatic ER.
B. Structural Aspects
Electron micrographs of the rat hepatocyte show the ER to be
present throughout the cytoplasm as an extensive network of tubules,
vesicles, and lamellae. The cytoplasmic surface of 60% of the ER is
normally covered with ribosomes; these regions, known as RER, are
generally arranged in parallel arrays of broad flattened bags (cisternae).
The SER, which is often found in the region of Golgi apparatus, consists
of widely dispersed tubules and vesicles often associated with glycogen
deposits. The membranes of the ER as seen in the electron microscope 
o o
are 50 to 80 A thick. The lumen of RER is 200 to 300 A wide (mean
o o
width, 260 A ) , and the lumen of SER is 300 to 600 A wide (mean width,
o
430 A ) . The morphological and morphometric characteristics of the ER 
vary from region to region (peripheral, midzonal, central) of the liver
TABLE 1
Major Functions of the liver Endopiasmic Reticulum
FUNCTION
Glycoprotein synthesis 
Detoxication of 02 
Generation of 02 *
Biogenesis of cholesterol 
Biogenesis of bile acids 
Biogenesis of steroid hormones 
Deactivation of steroid hormones 
Oxidative metabolism of xenobiotics 
Reductive metabolism of xenobiotics 
Conjugation of xenobiotics 
Biogenesis of eicosanoids 
Desaturation of fatty  acids 
Vitamin D metabolism 
Oxidation of fatty acids
6lobe. A number of morphometric investigations of the rat hepatocytes 
ER have been performed (DePierre and Dallner, 1975). On the average, 
this organelle occupies 15.3% of the total cell volume; the volume of the 
ER of 756 urn3 per hepatocyte is 2.5 times that of the nucleus and 65% of 
the mitochondrial volume. The surface area of ER (approximately 63,000 
um2 per hepatocyte) is about 37.5 times the surface area of the plasma 
membrane and 8.5 times the surface area of the outer mitochondrial 
membrane (Dallner and DePierre, 1982).
C. Rough and Smooth Microsomes
Morphological studies show that the endoplasmic reticulum is 
heterogeneous regarding the distribution of ribosomes along its surface. 
Studies have compared rough and smooth microsomal fractions with initial 
attempts to subfractionate microsomes aimed at separating rough and 
smooth microsomes (DePierre and Dallner, 1975). The RNA content of 
these fractions reflects the difference in the number of ribosomes they 
contain. With rough and smooth microsomes isolated by the Cs+ 
procedure, RNA to phospholipid ratios (mg/mg) of 0.40 and 0.08, 
respectively, have been observed (Eriksson, 1973). A five-fold  
difference in the RNA to phospholipid ratios is considered as an effective  
separation of rough and smooth vesicles. On the other hand, a higher 
ratio of mannose to galactose characterize differences in the glyco­
proteins of rough vesicles (Redman and Cherial, 1972; Bergman and 
Dallner, 1974; Kreibich et a L , 1978), while the sialic acid content of 
smooth membranes (6 ug/mg protein) is approximately 6 times that of 
rough vesicles (Larsen et a l . , 1972). In  addition, glycoproteins from 
rough microsomes contain 8 monosaccharide residues per asparagine 
residue, while those of smooth microsomes contain 9-12 residues 
(Kawasaki and Yamashina, 1973). The phospholipids (Glaumann and 
Dallner, 1968) and the fatty  acids of the phospholipids (Lee and Snyder, 
1973; Ilyas et , 1978b) of rough and smooth microsomes are very  
similar in composition. I t  has been reported that smooth membranes 
contain twice as much cholesterol (Pascaud et a L , 1968) and about 1.4 
times as much vitamin K (Nyquist et a l . ,  1971) on a phospholipid basis. 
Table 2 compares rough and smooth microsomes.
7TABLE 2
Comparison of Rough and Smooth Endoplasmic Reticulum
ROUGH ER SMOOTH ER
Ribosomes are bound No ribosomes are present
Synthesis of proteins for No protein synthesis, but
secretion of intracellular contains newly synthesized
membranes occurs secretory proteins
Sugar dolichol phosphates Glycosyltransferase activity
formed, but no significant present, synthesis of glyco­
glycosyltransferase activity present proteins begins
Monooxygenase system Monooxygenase system has
elaborated higher activity
(Taken from Parke, 1981).
8D. Molecular Composition
Morphological observations suggest that ER is a major cell 
constituent (DePierre and Dallner, 1975). The ER of 1 g (wet weight) 
liver contains 40-50 mg protein and about 15 mg phospholipid. Using 
values for the recovery of enzymic markers and estimates of the purity  
of the ER, it can be calculated that ER contains 19% of the total protein, 
48% of total phospholipids, and 58% of total RNA of the rat hepatocyte 
(Claude, 1948; DePierre and Dallner, 1976). Compositional studies of 
isolated rat liver microsomes reveal that the membrane of ER is 
approximately 70% protein and 30% lipid (of which 85% is phospholipid) by 
weight. Neutral lipids, cholesterol, and carbohydrates constitute only a 
minor part. The ER membrane contains 23 molecules of phospholipid per 
protein molecule (Dallner and DePierre, 1982). Microsomal phospholipids 
have been found to consist of about 50-55% PC, 20-25% PE, 5-10% PS and 
PI and 4-5% PA, LPC and SM (Morin et a [ . , 1972). The fa tty  acid 
moieties of these phospholipids are chiefly the C l6:0 , C l6:1 , C18:0, 
C18:1, C18:2, C20:4, and C22:6 species (Lee and Snyder, 1973): the
relative amounts of the species that are present depend on the diet and 
age of the animal (Hammer and Wills, 1979; Mounie et a L , 1983). 
Microsomes also contain cholesterol (0.6 mg/g liv e r), triglycerides (0 .5  
mg/g liv e r), small amounts of cholesterol esters and free fatty  acids, 
and vitamin K (Nyquist et aiL, 1971). In addition, microsomal 
membranes contain glycoproteins (about 2% carbohydrates by weight) 
which include the neutral sugars such as mannose and galactose, the 
former in two to four-fold higher amounts than the latter. The main 
hexosamine found in ER glycoprotein is glucosamine; only minute 
quantities of galactosamine can be detected. I t  is well established that 
sialic acid is the terminal sugar of some of the oligosaccharide chains on 
these glycoproteins (Lawford and Schachter, 1966). The majority of the 
glycoproteins of the ER are not simply loosely associated with the 
surface, but represent constitutive membrane components.
E. Structural Relationship between Proteins and Lipids
Keith et aL (1973) have explored the arrangement of phospholipids 
in the lateral plane of model and biological membranes. This study
9involved electron spin resonance spectroscopy of spin label derivatives of 
lipid molecules. Under physiological conditions, most of the lipids 
diffuse rather freely in the plane of the membrane (G ulik-K rzyw icki, 
1975). These studies conclude that the bulk of the lipid in biological 
membranes is structurally independent of the membrane proteins (Singer 
and Nicolson, 1972). Vanderkooi (1974) suggests that these proteins 
may be important in structural interactions with the phospholipid 
molecules surrounding them. A distribution list of various enzymes of 
the ER is presented (Table 3 ). Stier and Sackman (1973) have sugges­
ted that cytochrome P-450 is enclosed in a phospholipid halo which is 
more rigid than the bulk of microsomal lipids, and which undergoes 
crystalline-liquid-crystalline phase change at about 32°C; approximately 
20% of the microsomal phospholipids are located in this halo, which may 
affect the diffusion of lipid-soluble substrates to and of lipid-soluble 
products away from the cytochrome P-450 molecules. However, 
cytochrome b5 is being used in many model systems to investigate the 
interaction between proteins and lipids in membranes. I t  has been 
suggested that the phospholipids exert a linking function orienting the 
proteins within the bilayer into a proper interaction state (Ruckpaul et 
a l.,  1982).
F. Functional Relationship between Lipids and Proteins
The functional properties of many proteins in d ifferent biological 
membranes are intimately related to the micro-environment provided by 
membrane lipids; the proteins of the membrane of the ER are no 
exception. The treatment of cytochrome P-450 system with specific 
agents that disrupt protein-lipid interaction, reconstitution experiments, 
and Arrhenius plots, has been shown to depend functionally on the 
nature of neighbouring phospholipid molecules (Lu and Coon, 1968; 
DePierre and Ernster, 1977; Chiang and Coon, 1979). Similar types of 
experiments have demonstrated the functional relationship of microsomal 
G6P-ase to phospholipids (Hill et a l . ,  1983). Cytochrome b5 also shows 
such a relationship (Strittm atter et a [ . , 1972, 1974; Tamburini and 
Gibson, 1983).
10
TABLE 3
Transverse Distribution of Various Enzymes of the Endoplasmic Reticulum
ENZYME LOCALIZATION CRITERIA
Cytochrome b 5
\
Cytoplasmic
surface
Release with protease 
Inhibition with antibodies 
Lack of latency
N AD PH-cytoch rome 
b5 reductase
Cytoplasmic
surface
Release with protease 
Inhibition with antibodies 
Lack of latency 
Nonpenetrating reagents
NAD PH-cytoch rome c 
reductase
Cytoplasmic
surface
Release with protease 
Inhibition with antibodies 
Lack of latency 
Localization of products
Cytochrome P-450 Cytoplasmic
surface
Denaturation with 
protease
Localization of products 
Nonpenetrating reagents
Adenosine triphosphatase Cytoplasmic
surface
Denaturation with 
protease
Localization of products
Nucleoside diphosphatase Luminal surface Lack of protease effect 
Lack of antibody 
inhibition
G lucose-6-phosphatase Luminal surface Protease denaturation 
only in presence of 
deoxycholate 
Localization of products
3-Glucuronidase Luminal surface Lack of protease effect 
Latency
Release with low concentr 
tion of deoxycholate
(Taken from Alvares, 1982).
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An increase in the high spin form of cytochrome P-450 is associated 
with a positive shift in the redox potential, thus facilitating electron 
from reductase to the terminal cytochrome (Sliger et a L , 1979; Gander 
and Mannnering, 1980). Many endogenous compounds may regulate the 
spin state of cytochrome P-450. The studies by Gibson et al. (1980) 
demonstrate that the low-spin solubilized cytochrome P-450 was 
reconverted to the high-spin form on the addition of lipid extract 
derived from the original membranes.
G. Glucose 6-Phosphatase
The classical G6P-ase is a multifunctional enzyme possessing both 
hydrolytic (phosphohydrolase) and synthetic (phosphotranslocase) 
activity (Nordlie, 1974). Functional identity has been established for 
phosphohydrolase and phosphotranserase activities based on their tissue 
distribution, kinetic measurements, and the effect of various treatments 
and inhibitors (Nordlie and Arion, 1964; Feuer et a [ . , 1965). G6P-ase 
occupies a central crossroad position in carbohydrate metabolism. Since 
it is primarily concerned with the release of free glucose, its dual nature 
(hydrolytic and synthetic activities) may be important in controlling the 
net liberation of glucose from gluconeogenic tissues.
The fact that G6P-ase is membrane-bound is also important in its 
physiological role. I t  may transport glucose between the ultracellular 
compartment (cytoplasmic matrix) and the canalicular system of the ER 
(Ernster et a L , 1962). I t  is well established that the activity of this 
enzyme in isolated liver ER changes in response to the nutritional or 
endocrine status of the animal (Nordlie, 1974). Corticosteroids increase 
the concentration or activity of the phosphotranslocase while the thyroid  
hormone influences the phosphohydrolase. However, the magnitude of 
hormonally induced changes in the enzymes of the ER is usually small 
(S iekevitz, 1972). G6P-ase is potentially an excellent model to study 
the hormonal regulation of the hepatic ER membrane.
H . Phospholipid Synthesis
I t  has been demonstrated that the final steps in the synthesis of 
many phospholipids (with the possible exception of cardiolipin) in the
12
hepatocytes are located in the microsomes (Dennis and Kennedy, 1972). 
This indicates the primary importance of ER in cellular phospholipid 
synthesis. Consequently, the structural and functional in tegrity of 
other organelles may depend on the ability of the microsomes to 
synthesize these compounds (Chiang and Coon, 1979). The hepatic ER 
has the enzymic machinery for the synthesis of both protein and 
phospholipid and hence plays a central role in its own biogenesis as well 
as of other cellular membranes (Bollen and Higgins, 1980; Higgins, 
1982). Synthesis is asymmetric, with most enzymes located at the 
cytoplasmic side of the membrane, and controlled transmembrane 
movement of phospholipid results in an asymmetric bilayer. Biosynthesis 
of key microsomal as well as mitochondrial lipids was demonstrated in 
rapidly sedimenting ER (RSER), which is known as a complex between 
ER and mitochondria; the level of synthesis of these lipids paralleled 
the level of activity of microsomal and mitochondrial marker enzymes 
(Stuhne-Sekalec and Stanacev, 1982).
Since PC and PE comprise the major phospholipids of the liver 
microsomes, this discussion will be limited to their synthesis. PC 
synthesis is known to occur through several pathways (Figure 1 ). 
However, only the pathways of Kennedy (Wilgram and Kennedy, 1963), 
and of Greenberg (Bremer and Greenberg, 1959) represent de novo
synthesis. Whereas, in the last step, the former uses, 1,2-dig lyceride  
and CDP-choline; the latter involves stepwise methylation of PE to PC 
utilizing methyl groups from S-adenosylmethionine. Ethanolamine, 
phosphorylethanolamine or CDP-ethanolamine were shown to be substrates 
for methylation (Salerno and Beeler, 1973).
I t  is known that PC species synthesized through these two 
pathways d iffer in the degree of unsaturation of the fatty  acid moiety.
The PC fraction synthesized by methylation of PE contains relatively
more polyunsaturated fatty acids than those arising from the Kennedy
pathway (R ytter et a [ . , 1968). The physiological role of the methylation 
pathway has not yet been clearly defined, but one may speculate that 
the existence of two pathways working simultaneously may provide a 
sensitive means of controlling the availability of specific PC for normal
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FIGURE 1
Pathways of phosphatidylcholine formation
C l) KENNEDY1S PATHWAY
ATP ADP ACYL-COA «^ COA
G LY C E R O L^— »  SN-GLYCEROL-3-PHOSPHATE*— PHOSPHATIDATE
ATP ADP
CHOLINE — — >  PHOSPHORYL-CHOLINE
CPC)
CTP PP
CDP-CHOLINE
PHOSPHATIDYL-CHOLINE < r
c% /
(1,2-DIACYL-GPC OR DGPC)
DIGLYCERIDE
Cdg)
CII) GREENBERGf S PATHWAY
PHOSPHATIDYL-ETHANOLAMINE
ADENOSYLMETHIONINE ADENOSYLHOMOCYSTEINE
DGPC
( I I I )  LANDS PATHWAY
ACYL-COA COA
LYSO-PHOSPHATIDYL-CHOLINE 
Cl-ACYL-GPC OR 2-ACYL GPC
1,2-DIACYL-GPC
MARINETTI*S PATHWAY
1-ACYL-GPC .GPC
1-ACYL-GPC ^ 1 ,2 -D IA C Y L -G P C
CV) HUBSCHER1S PATHWAY
CHOLINE
PHOSPHATIDYL-X PHOSPHATIDYLCHOLINE
(DGPC)
(Taken from Sakamoto, H. and Akino, T . 1972].
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function and integrity of the membranes (Young et a l . , 1971; Cooper 
and Feuer, 1972; Acheampong-Mensah and Feuer, 1974).
I .  Fatty Acid Synthesis
Fatty acid composition of the phospholipids may regulate the 
structure of the endoplasmic reticulum by influencing hydrophobic bonds 
between membrane proteins and phospholipids (Fonk et a L , 1982). The 
role of acyl chain saturation and membrane viscosity affecting the ER 
membrane functions have been studied in both model membranes and 
biological systems (Parkes and Thompson, 1973).
The ER contains the enzyme acyl CoA-synthetase which is 
responsible for removing lipids from these membranes and for initiation 
of the synthesis and transformation of fatty acids by activation of 
exogenous and endogenous acids to acyl-CoA derivatives (B renner, 
1977). Arachidonate and related long chain polyunsaturated acids may 
be esterified mainly by the l-acyl-sn-glycerol-3-phosphocholine  
acyltransferase system, whereas monoene and diene fatty  acids may be 
incorporated into the 3-position of phospholipids by the 1-acy i-sn -g ly - 
cerol-3-phosphate acyltransferase system (Hill and Lands, 1968; Lands 
et a [ . , 1982). The oxidation of fatty acids occurs primarily in the 
mitochondria, and de novo synthesis of fatty  acids occurs in the cytosol. 
By contrast the endoplasmic reticulum desaturates fatty  acids and 
converts unsaturated acyl CoA derivatives to high homologs with 
increased chain length and number of double bonds. Moreover,
microsomal cytochrome P-450 can also affect Q  -  and certain other
9
hydroxylations of fatty acids. The A -desaturation of fa tty  acids,
e .g . ,  stearic acid —  ^ stearyl CoA —> oleyl CoA, which can occur
in both animal and plant microsomes, require NADH or NADPH, a 
flovoprotein reductase, cytochrome b5, and the terminal oxidase 
(desaturase) which is a non-heme iron protein (Figure 2) (Schenkman et 
a L , 1976; Brenner, 1977).
Four families of polyunsaturated fatty acids are synthesized in the 
ER of animal hepatocyte: 1) palmitoleic, 2) oleic, 3) linoleic, and 4)
linolenic. The firs t two of these may be formed by microsomal 
desaturase from palmitic and stearic acids, but the latter two are
15
FIGURE 2
Microsomal biosynthesis of polyunsaturated fatty acids. Similar pathways 
occur for the other families of polyunsaturated acids, namely, palmitic, 
linolenic.
STEARIC ACID ■^STEARYL COA 
CC18>
A * - DESATURASE ^  o e s a t u »
>0LEYLC0A ■r ^ &- »ci8t 6’9
CCl8,A -9)
C2 2 A - 7 ' 1 0 ' 1 3 < '
ELONGATION A-DESATURASE
EUJN6ATI0N
A
CMALONYL -  COA)
C20a -5 ,8 ,H  * C20A -8,11
DESATURASE
DOCOSATETRAENOIC ACID
CC22* -4,7,10,13)
(Taken from Parke, 1981).
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6 5essentia l fa t t y  acids obta ined from p la n ts .  The A  A  and
i\
A - d e s a tu r a s e s  are microsomal enzymes (Holloway et aL , 1963), s im ilar
9
to the A  -desa tu rase  in th a t  th e y  invo lve  the cy tochrom e b5 system
(Catala et a h , 1975) and form double bonds between 6 ,7 - ;  5 ,6 - ;
64 , 5 -carbon atoms. The A  -desa tu rase  is the f i r s t  enzyme in the
sequence o f  microsomal reactions wh ich syn thes izes p o ly u n s a tu ra te d  acids
and is usua lly  fo llowed by  chain e longation to 20-carbon acids and then
5 4fu r t h e r  desa tu ra t ion  by  A  and A  -desaturases to 22-carbon acids
(B re n n e r ,  1977). The fa t t y  acid e longation process may o ccu r  in the 
m itochondria  or the microsomes; the m itochondria l reaction re q u ire s
condensation w ith  acety l CoA and reversa l o f  3 -o x id a t io n ,  wh ile  the
microsomal reaction requ ires  condensation w ith  malon y l CoA (F ig u re  3 ) .
F a tty  acids may also undergo  h y d ro x y la t io n  at t h e C d - ,  65-1 and a  
pos it ions cata lyzed by  the microsomal cytochrome P-450 monooxygenase 
system. C*> -H y d ro x y la t io n  o f  the h yd roca rbo n  chain o f  f a t t y  acids is 
followed by ox ida t ion  to a d ic a rb o x y l ic  acid wh ich invo lves  so lub le  
enzymes o f  the cytosol and NAD+ . 6<) -H y d ro x y la t io n  o f  f a t t y  acids is 
re q u ire d  to produce su cc iny l-C o A  from fa t ty  acids to regu la te  
ca rbo h yd ra te  metabolism. In  the s ta rv in g  d iabe t ic  ra ts ,  s ig n i f ic a n t  
^ -o x id a t io n  and subsequen t 3 -o x id a t io n  o f  fa t t y  acids o c cu rs ,  and the 
d ic a rb o x y l ic  acids are more re ad i ly  conve rted  in to  blood g lucose than  are  
m onocarboxy lic  acids (VVada and Usmani, 1977).
J . Prote in  Syn thes is
P r in c ip a l ly ,  ribosomes bound to the ER o f  the l iv e r  syn thes ize  th re e  
types  o f  p ro te in s .  The f i r s t  and most in tens ive  syn thes is  is devo ted to 
sec re to ry  p ro te in s ,  since the m a jo r i ty  o f  the blood p ro te in s  o r ig in a te
from  the l iv e r .  Second, all membrane p ro te in s  o f  the ER, w ith  few
excep tions , are produced by  bound ribosomes and inse rted  d i r e c t iy  in to  
the  membrane. T h i r d ,  a sizeable po r t ion  o f  the p ro te in  o f  in t ra c e l lu la r  
organelles o r ig in a te  from the ER (Campbell and B lobe l,  1976; B lobe l,  
1977). These may be t ra n s p o r te d  as so luble p ro te in  in the lumen. Such 
p ro te ins  can e i th e r  be inco rpo ra ted  in to  membrane o r  become a so lub le
FIGURE 3
Functions of the two long-chain acyl-CoA synthesis and the mechanisms 
of repression of acetyi-CoA carboxylase
FATTY ACID
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POOL I I
/
/ ^-OXIDATION /
/
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(Taken from Brenner, 1977).
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component in the luminal compartment of the organelle (Palade, 1975; 
Kreibich et .aL , 1980).
Rough ER is primarily involved with the synthesis of secretory 
proteins, which are normally discharged into the lumen of the ER and 
from there to the exterior of the cell (Blobel and Dobberstein, 1975). 
Serum albumin, a major protein synthesized in the hepatocyte, firs t 
appears in the rough ER, then in the smooth ER, and finally in the 
Golgi apparatus, to be secreted from the cell without passing into the 
cytosol. Nevertheless, this classical model of protein secretion has been 
criticized (El Hammer et a l. ,  1975). With the questionable exception of 
serum albumin, most secreted proteins are glycoproteins in which 
carbohydrate moieties are covalently bound to the polypeptide in the 
smooth ER and Golgi complex (Kornfeld and Kornfeld, 1980).
The ER of the liver contains a complete glycosylation system able to 
synthesize branching oligosaccharide chains (Daliner and Hemming,
1981). Glycosyltransferases are also present in other intracellular 
membranes. In  any case, glycosylation mostly takes place in the ER. 
The syntheses of glycoproteins is complex and occurs sequentially at 
different locations (RER, SER, Golgi) during a transport process. The 
regulation of these syntheses is largely unknown, but sugar transfer 
may be regulated by the specificity of individual polyprenyl phosphates, 
and by the specificity of the individual glycosyltransferases. There are 
two major types of amino acid-sugar linkage involved, namely aspara- 
gine-N-acetyl-glucosamine and serine (threonine)-N-acetyl-galactosamine; 
other linkages include hydroxylysine-galactose and serine-xylose  
(Schachter, 1974). The core of the carbohydrate moieties of secretory 
protein is thought to be assembled on dolichol pyrophosphate molecules; 
no sequential assembly occurs on the polypeptide itself (Figure 4 ). 
Transfer of the core portion to the protein takes place while the nascent 
chain is still attached to the ribosomes (Figure 5) (Daliner and DePierre,
1982).
Bond et ah (1969) have demonstrated the existence of microsomal 
DNA by using techniques specifically designed to exclude contamination 
by nuclear mitochondrial material. I t  is tempting to speculate that this 
particular DNA may have a role in the regulation of the synthesis of
FIGURE 4
STRUCTURE OF THE DOLICHOL PHOSPHATES
' c h 3 c h 3I I
PO£t-C H 2-C H 2-C H -C H 2-(C H  2-CH=C-CHa )n
ASSEMBLY OF CORE OLIGOSACCHARIDE ON DOLICHOL-PP
P-Dolichol
UDP-GlcNAc ------------------------------------------ » |
GlcNAc-PP-Dolichol
J«-UDP-GlcNAc
(GlcNAc)2-PP-Dolichol
U(GDP-Man) 5 
Man5-(G lcNAc) 2-PP-Dolichol
^(M an-P-DolicholK  
Marig-(GlcNAc) 2-PP-DolichoI
J*(Glc-P-Dolichol) 3 
Glc3-Mang-(GlcNAc) 2-PP-Dolichol
(Taken from Daliner and DePierre, 1982).
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FIGURE 5
Processing and completion of the protein-bound oligosaccharide 
in the ER-Golgi system. DP, dolichol-P; DPP, dolichol-PP; 
A , asparagine; GA, N-acetylglucosamine; M, mannose;
Gl, glucose; GAL, galactose; S, sialic acid.
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(Taken from Daliner and DePierre, 1982)
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glycoproteins. Williams et aL (1968) have suggested that certain 
steroids are implicated in the binding of ribosomes to the ER. Although 
this concept has not gained wide acceptance, the control of tissue 
proliferation and differentiation, mediated by regulation of the binding of 
ribosomes to the ER by steroid hormones, is an attractive hypothesis 
which accords with many physiological and biochemical observations. 
Corticosterone was found to promote rough ER formation in liver and to 
increase the ability of smooth microsomes to bind polyribosomes; 
estradiol, but not testosterone, produces the same effect with male 
smooth ER and polyribosomes, whereas the converse effect is found for 
smooth ER and ribosomes from female rat liver (Sunshine et a l . , 1971).
Short oligosaccharides chains are probably necessary to fix  enzymes 
at certain positions in the membrane and direct them into close proximity 
to neighbouring enzymes for interaction (e .g . ,  in consecutive electron 
transport) (Lenarz, 1975; Peterkofsky and Assad, 1979). I f ,  as seems 
like ly, cytochrome b5 is glycosylated on the asparagine in position 105 
(Figure 6 ) ,  the above hypothesis would gain some support (Kornfeld and 
Kornfeld, 1980).
Glycoproteins function either as secreted proteins or as components 
of the plasma membranes, other intracellular membranes, and lysosomal 
enzymes. These proteins play an essential and fundamental role in the 
structure and functions of the cell, being integral components of the ER, 
with all that implies in intermediary metabolism. They are also 
components of the plasma membrane and as such appear to determine 
cell-to-cell recognition, the immune character of the cell, and the rate of 
mitosis. Thes proteins also comprise the lysosomal enzyme which 
probably determine the rate of turnover of all cellular components. As 
secretory materials, glycoproteins comprise some plasma proteins, the 
immunoglobulins, thyroglobulins, and various mucins, which recently 
have been shown to provide many essential services to the mammalian 
organism ( Table 4) (Elstein and Parke, 1977; Yang, 1977; Kreibich et 
a L , 1978; Taniguchi et a L , 1979; Bosterling et aL , 1982).
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FIGURE 6
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TABLE H
The Nature of Some Glycoproteins
Tissue Product Role Linkage
All cells Plasma membrane 
components
Cell-cell inter­
actions
?
All cells Lysosomal enzymes Turnover of cellular 
components
7
Mucous gland Mucins Protection, lubrica­
tion, transport
Ser(Thr)-G alN A c
Cartilage cells Collagen Connective tissue 
structure
HydroxyLys-Gal
Lymphocytes and 
plasma cells
Ig A , IgG , IgM Immune surveillance Asn-GlcNAc
Liver Plasma glycoproteins Transport etc. Asn-GlcNAc
Thyroid Thyroglobulin Hormone Asn-GlcNAc
(Taken from Parke, 1981).
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I I .  CYTOCHROME P-450 and b5
A. Introduction
The microsomal oxidative drug-metabolizing enzymes are associated 
with membranes and function as a multicomponent electron transport 
system. These enzyme systems have an absolute requirement for NADPH 
and molecular oxygen, and are also known as microsomal hydroxylases. 
These enzymes consist of at least two protein components: a
hemeprotein called cytochrome P-450 and a flavoprotein called NADPH 
cytochrome P-450 reductase or cytochrome c reductase (Baskin and 
Yang, 1980; Chiang, 1981). Cytochrome P-450 is the substrate- and 
oxygen-binding site of the enzyme systen, while the reductase serves as 
an electron carrier, shuttling electrons from NADPH to the cytochrome 
P-450 substrate complex (Iyanagi et a h , 1981). Oxidative reactions 
account for most of the liver phase I transformations, largely because 
there are so many ways in which a compound can be oxidized. However, 
certain drug oxidations are mediated by soluble, cystolic enzymes, rather 
than the microsomal oxidative enzymes, such as metabolism of ethanol and 
methanol. Many drugs are metabolized to substances of little or no 
pharmacological activity by enzymes localized in the ER, while these 
enzymes are also capable of converting drugs to metabolites that do 
possess measurable activ ity . These enzymes also possess the ability to 
convert biologically inactive compounds to those of considerable 
pharmacological or toxicological activ ity . Phase I reactions generally 
convert foreign compounds to derivatives which can undergo phase I I  
reactions, consisting of conjugation or synthesis (Williams, 1959). The 
most common and important conjugation is the synthesis of glucuronic 
acid derivatives of various substrates. These may be either foreign or 
endogenous compounds, such as steroids or bilirubin. The role of these 
enzymes in animal organisms is to metabolize lipid-soluble compounds in 
such a way as to render them water soluble and thus more easily 
excreted. Table 5 lists the turnover rates of microsomal enzymes in rat 
liver.
25
TABLE 5
Turnover Rates of Microsomal Enzymes in Rat Liver
Enzymes
Half-lives
(h r)
Stearyl CoA desaturase 4
HMG-CoA reductase 4
Nucleoside diphosphatase 30
Cytochrome P-450 (protein) 40
Cytochrome P-450 (heme) 22
NADPH-cytochrome P-450 reductase 70
Arylacylamidase 100
Cytochrome b 5 (protein) 100
Cytochrome b 5 (heme) 45
NADH-cytochrome b5 reductase 140
Total microsomal membrane protein 70
(Taken from Daliner and DePierre, 1982).
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B. Cytochromes P-450
Studies during the past two decades have now firmly established 
two major roles for the cytochrome P-450 dependent mixed-function 
oxidases: (i) a physiological role in the biosynthesis and metabolism of 
cholesterol, bile acids, steroid hormones, vitamin D, prostaglandins 
(K upfer, 1980), and (ii) a detoxication role in which P-450-dependent 
mixed-function oxidases constitute a protective system against the 
accumulation and deleterious effects of xenobiotics by increasing their 
polarity and providing functional groups for subsequent conjugation and 
excretion (Parke, 1979). A further role for cytochrome P-450, namely, 
the detoxication of tissue oxygen, has also been suggested 
(Wickramsinghe and Villee, 1978), but has not been unequivocally 
established. This liver microsomal enzyme system was solubilized with 
detergent and resolved chromatographically into three components (Lu  
and Coon, 1968), which were identified as cytochrome P-450, NADPH
cytochrome P-450 (c) reductase and phosphatidylcholine. This lipid
component, essential for monooxygenase activ ity , is not an electron
carrier, but in a reconstituted system, is required for electron transport 
from NADPH to cytochrome P-450 (DePierre and Daliner, 1975).
Cytochrome P-450 gets its designation from the fact that in the 
reduced form it binds with carbon monoxide, yielding a complex with an 
absorbance maximum at 450 nm. Cytochrome P-450-dependent oxidation 
has been termed mixed function oxidation because in its reduced form, 
the hemeprotein catalyzes the consumption of a molecule of oxygen, with 
one atom of oxygen appearing in the oxidized form of the substrate and 
the other atom being reduced to form water. A general scheme for the 
cytochrome P-450 reduction-oxidation cycle is shown in Figure 7 
(Brenner, 1977; Frederick et a [ . , 1982).
While in 1964, it was thought that cytochrome P-450 existed as a 
single form (Omura and Sato, 1964), evidence has recently been
presented for the existence of eleven forms in liver microsomes from 
untreated rabbits (Aoyama et a L , 1981). Characterization of these forms 
is incomplete, consisting largely of electrophoretic and catalytic 
measurements. However, for some cytochromes P-450, N- and C-terminal 
sequencing, immunological studies, and peptide mapping have been
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FIGURE 7
Cytochrome P-450 generated oxidation reaction
R O H ^ P-450(Fe3+)^R H
(RH)P-450(Fe-0)3+ (RH)P-450(Fe3 + )
H O H ^ /  J 2 e "
(RH)P-450(Fe3+)(H02) [(RH)P-450(Fe2+)J
4
„ - \  . j r ° *
(RH)P-450(Fe3+)(0~) [(RH)P-450(Fe2+)(02) ]
(Taken from Gillette et a l . . 1972)
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carried out, providing rigorous biochemical evidence that the 
hemeproteins thus studied are different from each other. Recently, 
complementary-DNA sequence of four different forms of cytochrome P-450 
have been obtained (Nebert and Negishi, 1982).
The use of microsomal enzyme inducers, such as PB and MC, 
administered to rats, demonstrated the presence of at least two forms of 
cytochromes P-450 which differed in their spectral and catalytic 
properties. The form induced by MC is designated as cytochrome P-448 
(or cytochrome P-450c). I t  appears to possess the most widely 
contrasting substrate specificities making it relatively easy to distinguish 
(Ryan et a [ . , 1979), for although P-450 appears to insert oxygen only 
into conformationally-unhindered positions, P-448 oxygenates conforma- 
tionally-hindered or "bay-regions". The two forms also exhibit d ifferent 
stereoselectivity towards the metabolism of warfarin (Fasco et a [ . , 1978) 
and ( - )  trans-7,8-d ihydroxy-7-8-d ihydrobenzo(a)pyrene (Deutsch et a L ,
1978). In  all animal studies, cytochrome P-448 preferentially catalyzed 
the activation of benzo(a)pyrene to mutagens (Ioannides et a L , 1981); 
solubilized preparations were more efficient than P-450 in forming 
mutagenic products from this carcinogen and in converting the 
(±)-transbenzo(a)pyrene-7,8-d ihydrodiol to the 7,8-dihydrodiol-9,10-epo­
xide, the ultimate carcinogen (Levin et a l . , 1977). Paracetamol is
another substrate which is preferentially metabolized to its reactive 
intermediate(s) by P-448, possibly through N-hydroxylation, indicating 
why MC pretreatment exacerbates the toxicity of paracetamol (Ioannides 
et aL , 1983).
There are some attractive aspects of the proposition that
cytochrome P-450 is a component of the membrane binding site for 
ribosome. The synthesis of cytochrome P-450 is induced by several 
drugs, including PB (Orrenius et a L , 1965), and the turnover rate 
appears to be relatively high (Dehlinger and Schimke, 1972). These 
should be important factors if cytochrome P-450 is involved in the 
binding of ribosomes because of the highly dynamic state of liver protein 
biosynthesis which is readily affected by various agents and 
physiological changes. The native cytochrome P-450 complex is composed 
of 7 molecules (Autor et a l . ,  1973), and there is some evidence that the
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cytochrome will span the reticular membrane (DePierre and Daliner,
1975). This should be of particular interest if export proteins, which 
have to cross the reticular membrane, are synthesized on ribosomes 
attached to membranes through cytochrome P-450. A hypothetical model 
for the binding of a ribosome to heavy rough sedimentary ER through 
cytochrome P-450 is shown in Figure 8 . Ohlsson and Jergil (1977) 
proposed that six or seven cytochrome P-450 molecules participate in the 
binding site, and that they form a channel through which nascent
proteins can pass into the lumen of the ER. The presence of the
nascent protein seems to be required to bind ribosomes to the site. 
This model conforms well with the general model of Blobel and 
Dobberstein (1975).
C. Cytochrome b5
Another hemeprotein cytochrome b 5 is present in liver microsomes
and may participate in drug and endogenous substrates oxidations.
However, precise function is unclear, it is not known just how various 
components of the monooxygenase or mixed-function oxidase complex are 
arrayed in the tubular membranes of the ER (Borgese and Meldolesi,
1980). The transfer of electrons from NADPH or NADH to the terminal
cytochrome P-450, involves an acceptor which may d iffer in tissues and 
other organelles carrying out the oxidative reactions. For example, 
mitochondria of the adrenal cortex may employ the NADH-cytochrome b 5 
system, while liver microsomes may use the NADPH-cytochrome c 
reductase pathway (Mannering, 1971). In this respect, it is interesting  
that a non-heme iron containing protein, adrenodoxin, has been
identified as part of the NADPH-cytochrome P-450 reductase of adrenal
cortex mitochondria (Omura et a l . ,  1965). Recently it has been reported 
that cytochrome b 5 is present in the Golgi apparatus, but stresses its 
heterogeneous distribution, and specific shuttle between the ER and the 
Golgi apparatus (Collot et a L , 1982). A model for binding of cytochrome 
b5 to the ER is illustrated (Figure 9 ).
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FIGURE 8
Hypothetical model for the binding of ribosomes to heavy rough rapidly 
sedimenting endoplasmic reticulum via cytochrome P-450. Six or seven 
cytochrome P-450 chains form a binding unit extending through the 
membrane. They enclose a pore through which nascent export proteins 
can reach the lumen of the endoplasmic reticulum.
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(Taken from Ohlsson and Jerg il, 1977).
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FIGURE 9
A model for binding of cytochrome b5 and of NADPH-cytochrome b 5 
reductase to the endoplasmic reticulum membrane. 0 = mobile -  •  immobile 
phospholipid.
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IK . FACTORS AFFECTING THE MICROSOMAL ENZYMES SYSTEM
A. Introduction
Several factors have been shown to affect drug metabolism in the 
hepatic ER. Among these are 1) age, sex, species and genetic 
constitution of the individual; 2) nutritional and dietary agents; 3) 
ingestion of foreign chemicals including environmental chemicals; 4) 
hormonal drugs, hormonal state of the body, pregnancy; 5) changes in 
atmospheric pressure, temperature or oxygen; 6 ) and certain liver 
diseases. The interaction of these factors on the ER enzyme activity  
and function will no doubt have some pharmacological, therapeutic, and 
toxicological implications in clinical practice (Conney, 1967; Rich et a L , 
1979; Kissel et a L , 1979; Ingelman-Sundberg et a l . ,  1980; Ferrero et 
a [ . , 1980; Klinger, 1982; Walters and Konings, 1982; Mounie et aj_., 
1983; Nohmi et a L , 1983; Dhami et a [ . , 1981a,b, 1983).
The balance between activating and deactivating enzymes is often 
the determining factor in the expression of toxicity, and this may be 
altered by factors such as age, nutrition, diet (Parke and Ioannides, 
1981), and selective induction of cytochrome P-450 isoenzymes following 
exposure to chemicals. The balance between detoxication and activation 
may also be determined genetically by the predominance, or relative 
absence of certain isoenzymes of cytochrome P-450. However, when the 
amount of ingested xenobiotic is small and tissue level are low, pathways 
of detoxication generally dominate; activation to reactive intermediates is 
minimal, and even these are usually effectively deactivated by protective 
intracellular nucleophiles, such as glutathione (Hinson et a l . , 1981;
Ioannides et a L , 1983).
B. Species and Strains
Interspecies variations in hepatic microsomal drug metabolism have 
been widely reported and extensively reviewed (Williams, 1967; Parke, 
1968). These differences may be qualitative as well as quantitative. 
One investigation of the interspecies differences between the 
N-demethylation of ethylmorphine in rats, mice, guinea pigs, and rabbits 
indicated that variation in electron transport components and cytochrome 
specificity may contribute to interspecies variations in drug metabolism 
(Davies et a L , 1969). Recent studies indicate that marked species
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difference in phenacetin mutagenicity is due to the difference in 
deacetylation activity between rat and hamster liver microsomes (Nohmi et 
a L , 1983).
In terstrain  differences in drug metabolism within a species have also 
been reported in rats (Page and Vesell, 1969) and for mice (Vessel, 
1968).
C. Sex
Sex difference in drug metabolism in the rat has been extensively 
investigated (El Defrawy et a [ . , 1974; Cohen and Mannering, 1974; 
Sladek et a [ . , 1974). Hepatic microsomal monooxygenase activity has 
been reported to be higher in the male rat than in the female (Quinn et 
a L , 1958). Several factors such as a temporal decrease in drug
metabolism in the female and a temporal increase in the male rat during 
development partially account for the observed difference. Qualitative 
differences in cytochrome P-450 and hormonal status may also contribute. 
These quantitative differences include decreased cytochrome P-450 
content and NADPH cytochrome P-450 substrates, for example biphenyl, 
are metabolized equally rapidly by liver microsomes of male and female 
rats, while other substrates, such as ethoxyresorufin are metabolized 
faster by female than male rats (Burke et a L , 1978).
Sex differences in drug metabolism have also been reported in mice, 
but differences in this species are of a lower magnitude than those seen 
in the rat. Few other sex differences appear in the literature , but 
Lucier and workers (1977) observed a sex difference in p-nitrophenol 
glucuronidation in the guinea pig. Sex differences in this species do 
not appear to be as prominent as those seen in the ra t, however, 
hepatic hydroxylation (an iline), O-demethylation (p -n itropheno l), and 
cytochrome P-450 reductase activities were similar in the male and female 
guinea pig (Lu i, 1977). The sex differences in the hepatic xenobiotic 
and steroid metabolism appear at the time of puberty in the rat (Colby,
1980). Apart from the ra t, tree shrew and mouse (where the female 
generally metabolized drugs faster than the male), most species do not 
show any sex differences in drug metabolism.
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D. Pregnancy
Creaven and Parke (1965) were the firs t to report diminished drug  
metabolism in hepatic cell fractions prepared from pregnant rats or 
rabbits. Later studies have shown diminished aniline metabolism m v itro  
and diminished diphenylhydantoin metabolism jn vivo in the near-term  
pregnant rat (Gabler and Falace, 1970). The effect of pregnancy on 
hepatic drug metabolism was extensively studied by Neale and Parke
(1973). Feuer (1973) has suggested that the low levels of drug  
metabolism observed in the pregnant rat and foetus may be due to the 
inhibitory action of the maternal steroids. The effects of pregnancy on 
hepatic drug metabolism, in species other than the ra t, have not been 
extensively reported. A preliminary investigation of epoxide-metabolizing 
enzymes in the pregnant rabbit and guinea pig indicated that decreased 
drug metabolism during pregnancy may occur in these species (James et 
a l . , 1977).
A relationship between microsomal drug metabolism, phospholipids, 
and the ferric  spin state of cytochrome P-450 in the pregnant rat has 
been reported (Turcan et a L , 1981). The results of this study confirm 
earlier reports that the activity of hepatic microsomal mixed function 
oxidase system is decreased in late pregnancy (Neale and Parke, 1973; 
Dean and Stock, 1975). In  contrast, studies by Schlede and Borowski
(1974) failed to demonstrate any significant differences in drug  
metabolism in the pregnant rats.
E. Development and Aging
Liver drug-metabolizing activities are generally low at b irth  and 
reach values close to adult level in 3-4 weeks old animals (Chao and 
Chung, 1982; Dhami et a L , 1983). However, large variations in drug  
metabolizing enzyme activities relative to sex (Thomas et a L , 1981), 
animal species (Kuenzig et a l . , 1974) and substrate (Gram et a L , 1969; 
Basu et a l . ,  1971) have been reported.
I t  has long been recognized that aging is associated with alterations 
in pharmacological variables, and an age-related decline in the metabolism 
of a number of xenobiotics has been observed in elderly human subjects 
(Crooks and Stevenson, 1980), and in animals of d ifferent ages
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(Schmucker and Wang, 1980; Kato and Hudson, 1980; B irt et a l . , 
1983).
The plasma half-lives and pharmacological effects of drugs in 
elderly humans differ from those in healthy young adults, although part 
of the changes may be due to changes in renal function, plasma protein 
binding, volume of distribution, and regional blood flow. O'Malley et aL
(1971) and Vestal et a[. (1975), have provided indirect evidence for
decreased activity of the drug-metabolizing enzymes of elderly patients.
F. Diet
Under certain conditions, diet can markedly affect the hepatic 
microsomal drug-metabolizing enzyme activities and hence the pharmaco­
logical action of drugs (Hammer and Wills, 1979).
Nutritional-pharmacological interactions have gained wide attention 
in recent years (Lambert and Wills, 1977; Krishnaswamy, 1978; Mounie 
et a [ . , 1983). Drug metabolism is impaired in undernutrition and its 
effect on the microsomal enzymes varies depending on (i) the degree of 
undernutrition, and (ii) the type of substrate. The metabolism of 
aminopyrine and the levels of cytochrome P-450 were depressed
significantly in animals with weight deficits of 40%, whereas aromatic 
hydroxylation of benzo(a)pyrene was significantly impaired in only very  
severely undernourished animals with weight deficiencies of 60%
(Kalamegnam et a L , 1981).
The effects of protein- and fa t-free  diets resulted in a decrease of 
arachidonic and increase in C18 acids in the phospholipids of membranes. 
Fat-free fed rats had major proportions of eicosatrienoic acid (20:3) in 
all membranes. By contrast, rats fed on a protein-free diet had lesser 
amounts of acids with 20 and 22 carbons, and more linoleic acid (18:2) 
than rats fed a control diet (Gerson, 1974). D ietary fat deficiency 
deprives the rat of precursors, whereas, the lack of dietary protein
deprives it of the enzymes necessary for desaturation and chain
elongation. The diet may well account for a considerable portion of the
in tra - and inter-individual variability (Andersson et a [ . , 1982).
Furthermore, the liver microsomal concentration of cytochrome P-450 is
increased in animals which are fed a diet rich in polyunsaturated fatty
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acids compared with those fed a lipid-free diet. Moreover, the effects of 
PB on drug-metabolizing enzyme activities are more prominent when 
dietary fat is more unsaturated (Mounie e t a l . ,  1983).
The substitution of protein in the diet for either carbohydrate or 
lipid enhances the metabolism of many different drugs indicating that 
dietary protein may have a more generalized, rather than 
substrate-specific effect, on the mixed function oxidases system (Kappas 
et a [ . , 1976; Feldman et a L , 1980). The mechanisms of diet-induced  
changes in the rates of drug-metabolism by the cytochrome P-450-depen- 
dent mixed-function oxygenase system have not been clearly established. 
Increased protein in the diet enhances the microsomal cytochrome P-450 
content in animals, while a high carbohydrate intake produces the 
opposite effect (Campbell and Hayes, 1974; Kato, 1977). Liver weights 
and mitotic activities are also increased in animals fed high protein diets 
(A rg yris , 1971). Carbohydrate is known to inhibit the synthesis of 
delta-aminolevulinate synthase, the rate limiting enzyme in liver heme 
biosynthesis (Tschudy, 1978). Since a major portion of newly-formed 
heme in the liver is used to synthesize cytochrome P-450, it is possible 
that the "glucose effect" on delta-aminolevulinate synthase and the effect 
of carbohydrate to reduce the cytochrome P-450 content in the liver are 
in some manner closely in ter-re lated .
IV . THE ROLE OF THE HEPATIC ENDOPLASMIC RETICULUM IN
STEROID METABOLISM
The similarities between drug and steroid hydroxylases in liver 
microsomes (Table 6 ) suggest that drugs and steroids are substrates for 
the same hydroxylating enzymes (Kuntzman et a L , 1964). Analogous to 
findings with drugs undergoing oxidative demethylation (O rrenius, 
1965), NADP inhibited the rate of total hydroxylation of testosterone 
(Lisboa and Orrenius, 1969) in a competitive manner probably as it 
inhibits NADPH cytochrome c reductase (Kamin and Williams, 1962). 
Oxidized cytochrome c has also been shown to inhibit steroid 
hydroxylation and drug metabolism (Orrenius, 1965), presumably by
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TABLE 6
Similarities Between Steroid Hydroxylase and 
Hexobarbital Oxidase Systems in Liver
1. Both are localized in liver microsomes and requires NADPH and 
oxygen for activity.
2. Both are present in mammalian liver but absent in fish liver.
3. Higher activity in male Sprague-Dawley rats than in male CF2 mice.
SIM ILARITY IN SPECIES DIFFERENCE
1. Higher activity in adult male rats than in adult female rats.
2. Little or no sex difference in enzyme activity in mice.
3. Activity is higher in adult male rats than in immature rats.
4. Inhibition by the jn vitro addition of SKF 525A.
5. Activity in increased after treatment of rats with phenobarbital or 
chlordane.
6 . Activity is not increased after treatment of rats with 3-methylcholan- 
threne.
SKF 525-A = Diethylaminoethyl diphenyl propylacetate -  known inhibitor 
of drug metabolizing enzymes.
[Taken from Kuntzman et al. 1964)
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accepting electrons from the reduced flavoprotein. Tephly and 
Mannering (1968) have demonstrated that the addition of estradiol, 
testosterone, and progesterone to rat liver microsomes inhibited 
competitively the oxidation of ethylmorphine and hexobarbital, indicating 
that steroids and drugs were alternative substrates for a common enzyme 
system (Table 7 ). The low Michaelis-Menton constant for the 
hydroxylation of testosterone, progesterone, and estradiol by the 
microsomes support this concept (Kuntzman et a l . ,  1965). Identification  
of type I and type I I  spectra on the addition of progesterone, 
testosterone, and hydrocortisone to microsomes and the reduction in the 
magnitude of spectral changes upon the addition of these steroids, are 
further evidence for the direct involvement of cytochrome P-450 in the 
hydroxylation of steroids (Wada et a l . ,  1968).
In particular, progesterone and certain of its derivatives have been 
found to alter the activity of the microsomal enzyme system jn vitro  
(Soyka and Long, 1972) as well as m vivo (Jori et a [ . , 1969). The 
latter studies resulted in contradictory reports. While some studies 
showed that barbiturate metabolism was increased a fter estrogen and 
progesterone contraceptive treatment, other studies (Freudenthal et a L , 
1974) have reported a failure to show any induction of drug metabolism 
by these compounds. Conversely, the metabolism of endogenous and 
exogenous steroids is influenced by the administration of inducers of 
mixed function oxidases to animals (Bulger and Kupfer, 1983).
These contrasting findings on the regulation of drug metabolism by 
various progestins could well be related to a differential action of these 
steroids on hepatic microsomes (Feuer et a l . ,  1977). Changes in normal 
steroid balance could influence the biotransformation of drugs during 
pregnancy (Guarino et al.., 1969; Feuer and Kardish, 1975) and an 
associated delayed development of drug metabolism in the newborn may 
also result (Jondorf et a L , 1958; Kardish and Feuer, 1972). On the 
other hand, increased steroid hydroxylation brought about by the 
administration of various drugs decreased the anaesthetic action of 
progesterone and caused a decrease of this steroid in total body 
concentration and brain level of the rat (Kuntzman et a l . ,  1965).
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V * THE e f f e c t  o f  f o r e ig n  c o m p o u n d s  o n  m ic r o s o m a l  e n z y m e s
SYSTEM
A . Introduction
I t  is now established that a wide variety of environmental agents 
can induce the drug-metabolizing enzymes in the liver and in several 
extrahepatic tissues. The enhanced rate of drug biotransformation was 
often associated with a faster termination of drug action. More recently, 
however, extensive data have shown that in some instances, induction of 
microsomal monooxygenase activities can also result in the formation of 
electrophilic metabolites of drugs and chemical carcinogens, which are 
biologically more active and are often responsible for the acute or 
chronic toxicity associated with certain foreign compounds (Ioannides et 
a L , 1983). The stimulatory effect of polycyclic aromatic hydrocarbons 
on liver microsomes was firs t reported by Conney et aL (1956, 1957). 
These early studies also presented evidence of increased enzymatic 
activity by inducing the synthesis of one or more enzyme proteins. The
't
stimulating effect of barbiti^tes and other drugs was discovered by 
Remmer (1959) and by Conney and Burns (1959). Further studies on
induction by PB revealed that the enhanced rate of metabolism of drugs
)
was associated with proliferation of smooth ER in the hepatocytes (Fouts 
and Rogers, 1965) and increased concentrations of components of the 
monooxygenase enzyme system (Orrenius and Ernster, 1965). Since 
these pioneering studies, many steroid hormones, drugs, insecticides, 
and chemical carcinogens are known to stimulate drug metabolism in 
experimental animals.
On the other hand, inhibition of drug metabolism may result in 
exaggerated and prolonged response with an increased risk of toxicity. 
Many interactions of this type involve liver monooxygenase, and 
mechanisms including substrate competition and functional impairment of 
enzyme activ ity . Many compounds are toxic to the liver, causing 
structural alterations of the membrane, particularly in the ER, leading to 
functional damage. Carbon tetrachloride, coumarin, choline-deficiency or 
ethionine treatment readily cause hepatotoxicity of a similar picture, but 
perhaps by different mechanisms (Recknagel, 1967; Judah et a l . ,  1970;
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Slater and Sawyer, 1971; Cooper, 1973; Ilyas et a l. ,  1978a,b;
Fernandez et a L , 1982; Noguchi e t a L ,  1982a,b).
B. Inducers
a. Effect on the drug-metabolizing enzymes. Inducers of hepatic 
monooxygenases have been categorized into two main groups. One 
group, of which PB and the insecticide DDT are prototypes, enhances 
the metabolism of a large variety of substances by the liver enzymes. 
In rats, PB treatment resulted in an enhanced drug metabolism which 
was accompanied by an increased microsomal protein content (cytochrome 
P-450) and associated enzyme activities. Furthermore, PB treatment 
increased the incorporation of labelled amino acids into microsomal 
proteins and the incorporation was sensitive to actinomycin D, 
puromycin, cycloheximide or ethionine (Conney, 1967; Gelbion, 1972). 
In addition, repeated doses of PB caused proliferation of smooth ER as 
well as increased RNA, protein and phospholipid contents (Ernster and 
Orrenius, 1965; Remmer and M erker, 1965). The PB treatment has 
been reported to decrease the degradation of some microsomal proteins of 
rat liver (Kuriyama et a j . , 1969; Welton and Aust, 1974). Thus de 
novo synthesis and decreased degradation of microsomal proteins may 
account for the stimulation of drug-metabolizing enzymes by PB. In  the 
liver microsomes of rats treated with PB, the immunological 
characterization (Le Provost et a L , 1981), substrate specificity (Noguchi 
et a L , 1982b), selectivity of action and induction (Harada and Omura,
1981), structural and biochemical aspects (Meyer et a L , 1980) and
distribution (Gooding et a [ . , 1978) of cytochrome P-450 have been
reported extensively in the literature. More recently, however, 
extensive data have demonstrated that, in some instances, induction of 
microsomal monooxygenase activities can form electrophilic metabolites of 
chemicals and carcinogens (Ioannides et a [ . , 1981 , 1983).
Polycyclic aromatic hydrocarbons such as benzo(a)pyrene and MC, 
comprise a second major group of enzyme inducers. This group induces 
the synthesis of cytochrome P-448 or cytochrome P-450c (Kawalek et a L , 
1975; Ryan et a L , 1975; Le Provost et a [ . , 1981; Thomas et a [ . ,
1981). Aryl hydrocarbon hydroxylase activity is preferentially induced
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by these inducers, in experimental animals as well as in human tissues, 
such as skin (Kappas and Avares, 1975). Differences in substrate 
specificities of these hemeproteins are shown in Table 7.
The mechanism of induction of the drug-metabolizing enzymes by PB 
and MC involves stimulation of mRNA synthesis followed by de novo 
synthesis of new enzyme protein. MC may alter mRNA level encoding 
other polypeptides and thus effect the cellular homeostasis (Pickett et 
a l . , 1982). Induction by PB appears to stabilize enzyme protein and 
decrease the rate of degradation of mRNA, including NADPH-cyto- 
chrome-P-450 reductase (Rees, 1979). A cytosolic receptor protein is 
involved in induction by MC. However, no such receptor protein has 
yet been detected for PB (Vlasuk et a j . , 1982).
The polychlorinated biphenyl isomers have been shown to fall into 
the category of 'd rug1 or 'carcinogen' inducers according to the position 
of halogen substituents (Allen and Abrahamson, 1973). Biphenyls, 
chlorinated symmetrically at meta and para positions (3 ,4 ,4 ',4 '-te tra  and 
3,4 ,5,3 ',4 ',5 '-hexachlorophenyls) act like carcinogens and increase 
cytochrome P-448 and are the most toxic. In  contrast, biphenyl isomers, 
chlorinated at para and ortho positions (2,4,2* ,4 ',- te tra -  and 
2 ,4 ,5 ,2 ',4 ',  5 '- ,  2 ,3 ,4 ,2 ',3 ',4 '- ,  and 2 ,4 ,6 ,2 ',4 ' , 6 ' ,-hexa-chlorobiphenyls) 
act like drugs and increase cytochrome P-450. Drugs enhance the 
4-hydroxylation of biphenyl, whereas, the 2-hydroxylation is elevated by 
carcinogens (Nastainczyk et a j . , 1982).
b. Effect on phospholipids and fatty acid synthesis. In  addition 
to increasing drug-metabolizing activity and protein synthesis, the 
administration of PB jn vivo increased the content of microsomal 
phospholipids which was manifested mainly in the PC, PE, and LPC 
fractions (Cooper and Feuer, 1972). These changes were associated with 
enhanced methylation of PE to PC as evidenced by increased activ ity  of 
methyl transferase. The activity of phosphorylcholine-diglyceride 
transferase, the rate limiting enzyme in the Kennedy pathway, remained 
essentially unchanged (Young et a j . , 1971). Furthermore, PB treatment 
enhanced the incorporation of radioactivity from [ 32P] orthophosphate 
(Holtzmann and Gillette, 1966, 1968), [ llfC-Me]-L-methionine (Cooper,
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TABLE 7
Catalytic Activity of Various Purified Forms of Rat Liver Cytochrome P-450
Substrate Phenobarbital 3-Methylcholanthrene
(nmol/min/nmol nmol/mg protein
of cytochrome)
P-450 P-450. a b P-450 P-450 a c
Benzphetamine 2 . 2 216.6 2 . 6 5.0
Benzo(a)pyrene 0.04 0. 2 0.3 24.5
7-Ethoxycoumarin 0.2 13.9 1.1 67.5
Zoxazolamine 0.48 2 . 2 2 . 0 29.7
Testosterone
7 a-hydroxy 4.1 £ 0 . 10 5.4 £ 0 . 1 0
16 a-hydroxy £ 0 .0 5 1.8 £ 0 .0 5 £ 0 .0 5
6 3 -hydroxy £ 0 . 10 £ 0 . 10 £ 0 . 10 0.36
Catalytic activity is expressed as nano moles of product formed/min/nmole 
cytochrome (Taken from Ryan et a [ . , 1979).
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1973; Higgins, 1981). These observations support the conclusion that 
the methylation pathway largely accounts for the PB-induced increase in 
microsomal phospholipid content.
Actinomycin D reduced the PB-induced alteration in microsomal 
phospholipids (Cooper and Feuer, 1972). This suggested the 
involvement of gene activation perhaps to synthesize a phospholipid-syn­
thesizing enzyme. Hence j  the increased content of microsomal 
phospholipids induced by PB may involve an enhanced rate of synthesis 
(Orrenius and Ernster, 1965). However, Holtzmann and Gillette (1968) 
observed that PB increased microsomal phospholipid content by inhibiting  
phospholipid catabolism. I t  is conceivable that alterations in both 
synthesis and degradation may be of some importance in the PB-induced 
increases in microsomal phospholipid content. Pretreatment with PB 
increased the linoleic acid of PC in a manner which paralleled the 
increases in cytochrome P-450, NADPH-cytochrome P-450 reductase, and 
APDM-ase and biphenyl hydroxylases activities (Davison and Wills, 
1974a). These authors, therefore, suggest that a distinct species of PC 
or PE, containing linoleic acid at the 3 position is essential for hepatic 
microsomal oxidative demethylation.
Davison and Wills (1974b) reported that increased synthesis of 
phospholipid in the liver of PB-treated rats resulted from the stimulated 
synthesis of PC via transmethylation of PE. On the other hand, 
20 -methylcholanthrene depressed both the turnover rate of total 
phospholipids and the formation of PC. The increased content of 
membrane phospholipids by PCB administration was also due to the 
inhibition of the catabolism of phospholipids. The incorporation of [ 32P] 
orthophosphate into both whole liver and microsomal phospholipids was 
strongly inhibited by the administration of PCB (Ishidate and Nakazawa,
1976). The phospholipid composition of liver microsomes of rats given 
either PCB or PB for 2 days showed a higher content of PC, while PS 
and SM were decreased by both treatments. This fluctuation in 
composition agreed with earlier studies by Davison and Wills (1974b). 
MC and PCB inhibit the synthesis of choline-containing phospholipids at 
the site of CDP-choline formation (Ishidate et a [ . , 1978). However, 
other reports indicate that the methylation activity (PE to PC) was
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increased in the induced state and the synthesis of PC was enhanced by 
this reaction (Young et a L , 1971). I t  seems likely that the increased 
activity of the methylation pathway can compensate for decreased 
synthesis of PC via CDP-choline, so that the only net result of 
diminished CDP-choline formation is a decrease in the relative content of 
SM. Administration of trans-stilbene oxide to rats resulted in limited ER 
hypertrophy which reflected a 27% increase in phospholipid content; this 
induction also caused changes in the lipid composition of the ER (Suzuki 
et a L , 1980). Additionally the cholesterol content was decreased and 
the relative content of SM also lowered, in a manner similar to that seen 
after PB, PCB, and MC treatments. The mechanism for reduction of SM 
is not known as yet.
During induction by PB or 3-methylcholanthrene, changes in fatty  
acid derivatives of membranes and membranous phospholipids have been 
demonstrated (Ellingson et a L , 1970; Ariyoshi and Takabatake, 1971; 
Davison and Wills, 1974a; Ilyas et a [ . f 1978a,b). Several discrepancies 
in the literature exist concerning the effects of inducers on the fa tty  
acid composition of microsomes and microsomal phospholipids. Davison 
and Wills (1974a) found that PB causes a progressive increase in the 
linoleic acid content of PC and PE, and a decrease in their contents of 
arachidonic and decosahexaenoic acids. In  contrast, other researchers 
have found no increases, or constant increases in all polyunsaturated 
fatty acids after phenobarbital induction (Ellingson et a L , 1970; Ilyas 
et a [ .,  1978b; Becker et a l. ,  1978). Perhaps, these discrepancies are 
due to species variations or differences in compositions of diets.
A fter administration of 3-methylcholanthrene, the proportion of 
linoleic acid did not increase, while oleic acid increased in both PC and 
PE fractions (Davison and Wills, 1974a). I f  the 3-linoleoyl PC is 
necessary for the electron transfer from NADPH to cytochrome P-450, 
the failure to stimulate the incorporation of linoleic acid may explain why 
20-methylcholanthrene did not cause an increased rate of side chain 
oxidation, e .g . APDM-ase. However, administration of trans-stilbene  
oxide to rats raised the stearic and arachidonic acids, while oleic and 
linoleic acid were decreased (Suzuki et a l . ,  1980).
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The fatty acid composition of microsomes can also be altered by 
feeding animals a diet deficient in essential fatty acids. Kaschnitz 
(1970) reported that such a diet caused a 43% decrease in 
drug-oxydation activity of microsomes and 27% decrease in the content of 
cytochrome P-450. A marked decrease in the microsomal content of 
arachidonic acid was also observed. I t  was concluded to be at least 
partly responsible for the change in enzyme content and activ ity . Other 
observations, e .g . ,  that fatty  acid composition of microsomal 
phospholipids did not change after injection of arachis oil (Davison and 
Wills, 1974b) and that essential fatty  acids are preferentially esterified at 
position 2 of phosphoglycerides, also indicate that arachidonic acid may 
be essential to the functioning of membranes.
Polyunsaturated fatty acid composition of the diet regulates the
fatty  acid composition of the hepatic ER, and this in tu rn , is an 
important factor controlling the rate and extent of lipid peroxidation in 
vitro and possibly hi vivo (Hammer and Wills, 1978). Mounie and 
co-workers (1983) reported that the PB treatment altered the fatty  acid
composition of PC and PE fractions of the ER. Herring oil caused an
increased in oleic acid, but decreased arachidonic and docosahexaenoic 
acids in PC.
c. Effect on phosphatases. Reports on the effect of PB on 
microsomal phosphatases are contradictory. Orrenius and Eriksson 
(1966), and Stetten and Gosh (1971) observed a decrease, while 
Glaumann and Dallner (1970) showed an increase in G6 P-ase activity  
following the administration of PB to rats. However, Feuer et aL
(1972), reported no significant change in G6 P-ase and IDP-ase activities. 
Orrenius and Eriksson (1966) attributed their finding to a relative 
increase in smooth membrane proteins without concomitant increase in the 
rough membrane G6P-ase enzyme protein. Upon assaying the enzyme in 
the presence of detergents, the difference in the basal activity was 
abolished (Stetten and Ghosh, 1971). On the basis of these 
observations, the authors postulated that PB treatment resulted in either 
the conversion of active to inactive G6 P-ase or the production of a less 
active enzyme.
C. Hepatotoxins
a. Effect on the drug-metabolizing enzymes and phospholipid 
synthesis. Many compounds or treatments are toxic to the liver, causing 
structural alterations of the membranes, particularly of the ER, leading 
to functional damage. CCI4, coumarin, choline-deficiency or ethionine 
treatment readily causes hepatotoxicity of similar picture, but perhaps 
by different mechanisms (Judah et a L , 1970). The mechanism of
hepatotoxicity of CCI^ has been reviewed in greater details by these 
authors, and will not be discussed here, except to mention the features 
related to microsomal function.
The effects of CCI^ or coumarin on drug metabolism and phospho­
lipid synthesis directly contrast those of PB (Cooper and Feuer, 1972; 
Feuer et a L , 1972; Glende J r . ,  1972). Drug-metabolizing activ ity , 
protein and phospholipid content of liver microsomes were decreased by 
the administration of CCI^ rats (Cooper and Feuer, 1972), while in vitro  
lipoperoxidation by CCI^ decreased APDM-ase and NADPH-cytochrome c 
reductase activities (Glende J r . ,  1972). I t  is apparent that the nature  
of the effects of CCI^ on microsomal phospholipids and drug metabolism 
is very complex. Many toxic agents require metabolic conversion 
(activation) for the full range of their damaging actions on target tissues 
to be expressed; a number of important chemical carcinogens also have 
this requirement. The activated products can produce cell damage in 
various ways including covalent binding to nucleic acids, proteins and 
lipids (Gupta et a l . ,  1983a,b). Although CCI,* produces its major effects 
on liver in the rat and many other species, injuries to other organs such 
as kidney, lung, testis, and adrenals have also been reported (De 
Toranzo et a [ . , 1978).
Trichloromethyl radical (*C C l3) is formed during metabolism of 
carbon tetrachloride (CCI^) in rat liver microsomes (Noguchi et a L , 
1982a,b). I t  has been demonstrated that lipid peroxidation in liver 
microsomes caused by CCI^ treatment to animals results in a decreased 
cytochrome P-450 content (Imai et a h , 1966). I t  has been postulated for 
a number of years that the metabolism of CC^ by liver tissue involved a 
free radical intermediate because: (i) the lipid peroxidation in the
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microsomal membrane accompanies the metabolism of CC!^ m vitro
(Hawgen and Coon, 1976); (ii) liver damage caused by administering 
CCI^ to animals can be mitigated by prior treatment of the animals with 
free radical scavenging agents (Phillips and Langdon, 1962); and (iii) 
conjugated dienes are detected in hepatic microsomal lipid extracts after 
CCI^ treatment (Hawgen and Coon, 1976).
Two hepatic microsomal polypeptides are decreased in content 
during the early events which follow CCI^ treatment (French and Coon,
1979). I t  was firs t proposed that the cleavage of the carbon-chlorine
bond is a function of NADPH-cytochrome P-450 reductase (Slater and
Sawyer, 1971). However, the firs t polypeptide to disappear in liver 
microsomes of phenobarbital-induced rats treated with CCI^ was the
52,000 dalton P-450 cytochrome which is capable of generating the
trichloromethyl radical (*C C I3) from CCI^ (Noguchi et a l . ,  1982a). The 
formation of this highly reactive radical may have resulted in localized 
damage to the cytochrome P-450. Methanol is a well known potentiator of 
CCI^ toxicity (mechanism unknown), while chloramphenicol antagonizes 
the toxicity possibly by inhibiting cytochrome P-450 (Owens and Brabee,
1982).
b. Lipid peroxidation. Lipid peroxidation is the degradative 
oxidation of polyunsaturated fa tty  acids of intracellular lipids, often 
chemically induced, which leads to the formation of free radical 
intermediates and autocatalysis of the process. I t  also leads to the 
destruction of membrane architecture, the degradation of membrane- 
bound enzymes, and eventually to cell death. Lipid peroxidation has 
been associated with aging, atherosclerosis, liver toxic ity , and lung 
tissue in jury. The etiology and mechanism of action of lipid peroxidation 
have been well documented by Plaa and Witschi (1976) and Gryglewski et 
al. (1978).
Many toxic chemicals, including CCI^ induce the formation of lipid 
peroxides in the liver, but generally only decomposition products of lipid 
peroxides are measured, such as malondialdehyde or alkanes (Tappel,
1980). Furthermore, it has been assumed that the decomposition 
products of lipid peroxides induced by CCI^ are the toxic intermediates, 
rather than the lipid peroxides itself (Mead, 1976; G a rd n er, 1979).
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Recent reports on the increase in serum enzyme levels observed after  
CCI^ treatment confirm this hypothesis (Owens and Brabee, 1982). 
Similarly, a decrease of microsomal G6 P-ase produced by CC^ (and 
potentiated by methanol pretreatment) could be attributed to a lipid 
peroxidation pathology (Masuda, 1981).
Both cytochrome P-450 and NADPH-cytochrome c reductase seem to 
be involved in lipid peroxidation. The decoupling of cytochrome P-450 
from its flavoprotein reductase results in an electron leak from the 
flavoprotein which culminates in lipid peroxidation (Parke, 1979). 
Nonheme iron in the form of a complex Fe2+ with phosphate appears to 
be essential in peroxidation process (Kappas et a [ . , 1982).
I t  is proposed that lipid peroxides may damage the endothelial 
prostacyclin synthetase and thus contributes to the pathogenesis of an 
atherogenic lesion (Figure 10 ) (Gryglweski et a l . , 1978). An excessive 
concentration of triglycerides, cholesterol, or lipophilic chemicals would 
be expected to disturb the normal organization of the membranes, 
decoupling the monooxygenase system with non-specific hydroxylation 
and peroxidation by flavoprotein reductase. This, in tu rn , might lead 
to the pathological hydroxylation of tissue components, as has been seen 
in diabetic nephropathy, and in old age in which there is an increase in 
glycoprotein content and thickening of the glomerular basement membrane 
(De Bats, 1974). The ER would, therefore, appear to be fundamentally 
involved in the etiology of cardiovascular disease, and this multifactional 
syndrome would appear to be primarily a series of lesions arising from 
unregulated biological oxygenation (Table 8 ) (Parke, 1981).
c. Effect on fatty acid synthesis. A fter the administration of 
labelled CCIj, to rats, the label could be detected in the microsomal lipids 
of the liver (Castro and Gomez, 1972). Equally rapid is the appearance, 
in these lipids, of conjugated dienes (Reynolds and Ree, 1971), 
characteristic of peroxidized lipids (Bolland and Koch, 1945). Evidence 
obtained in various laboratories (Gordis, 1967; Gomez et a L , 1973) 
supports the view that haloalkane free radicals derived from the 
homolytic cleavage of CCI4 may covalently bind to a variety of molecular 
structures, and particularly to the lipids of the membranes of the ER in
FIGURE 10
Effects of lipid peroxidation on prostacyclin and 
thromboxane synthesis in experimental atherosclerosi
Excess l i p i d s
Phosphol 1 p i cl s
phosphol ipase
C00H
Arachidonic Acid
cyclo-oxygenase
L ip id  Peroxides
Prostag landin  Cndoperoxides
thronhoxane 
\ s y n t h e t a s e  
N .  ( p l a t e l e t s )
p ro s ta cy c l in
s y n t h e t a s e /
( a r t e r i e s )
Prostaglandins
P ro s tac y c l in
OH
Thromboxane A
[Taken from Gryglewski et al. (1978)
50
TABLE 8
Possible Role of Endoplasmic Reticulum 
in Etiology of Cardiovascular Disease
Biochemical pathology
1. Unsaturated fatty acids reduce the risk of cardiovascular 
disease; the hepatic endoplasmic reticulum contains a fatty  acid 
desaturase system.
2. Cholesterol-regulating enzyme, cholesterol 7a-hydroxylase, is a 
monooxygenase, involving cytochrome P-450.
3. Ascorbic acid deficiency predisposes to hypercholesteremia and 
cardiovascular disease, and to decreased liver monooxygenase 
activ ity .
4. Vitamin D2, associated with vascular calcification and 
experimental atherosclerosis, has a high affin ity  for cytochrome 
P-450 and decreases cholesterol 7a-hydroxylase.
5. Aorta wall contains monooxygenases which activate promutagens, 
to cause primary lesion.
6 . Blood platelets contain monooxygenases involved in synthesis of 
thromboxanes; thromboxanes and prostaglandins are involved in 
blood clotting and vasodilation.
7. High concentrations of carbon monoxide inhibit cytochrome P-450 
and are associated with increased incidence of atherosclerosis.
(Taken from Parke, 1981).
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which the metabolism of the halogenated hydrocarbon occurs (Recknagel 
and Glende, J r . ,  1973; Pencil et a L , 1982). A t the level of
unsaturated fatty  acids, the free radical attack would initiate a lipid 
peroxidation process (S later, 1966). Fatty acids of the membrane lipids 
undergo a free radical attack following CCI^ poisoning (Comporti and 
Benedetti, 1973; Benedetti et a [ . , 1977b), possibly by an addition 
reaction of the free radicals to the double bonds of unsaturated fatty  
acids, such as oleic acid and linoleic acid, but not arachidonic acid 
(Figure 11).
d. Effect on phosphatases. h'epatotoxins, mainly CCIt, and 
coumarin have been shown to decrease jn vivo hepatic microsomal 
G6P-ase and increase NDP-ase, particularly IDP-ase (Feuer and Golberg, 
1967; Feuer and Granda, 1970). Since both enzymes are membrane- 
bound (Dallner, 1963) it is not clear why fragmentation of the membrane 
by CCI4 or coumarin should have an opposite effects on these enzymes. 
However, it is unlikely that this involves the inhibition of de novo 
synthesis of the enzyme protein (Feuer and Golberg, 1967). No 
significant differences were observed when the enzymes were assayed in 
the presence of detergents. Thus, it is conceivable that the 
hepatotoxins cause these enzyme changes by affecting the environment in 
which these enzymes act.
I t  has been demonstrated that PE is required for G6 P-ase activ ity  
(Duttera et a [ . , 1968). The role of lipid peroxidation, rather than a 
direct attack of the free *CCI3 radical in the impairment of G6 P-ase 
activity has been emphasized (Recknagel et a L , 1976; Glende, J r . ,  et 
a l . ,  1976; Benedetti et a l. ,  1979).
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FIGURE 11
Chain-termination addition reaction of the free radicals 
derived from CCI^ to the fatty acid free radicals 
containing conjugated dienes
H H H
- C  = C -  C -  C = C -  C -  C = C -  C -  C = C -  
H , H H
- C  = C -  C -  C = C -  C -  C = C -  C -  C = C -  
ORGANIC FREE RADICAL*
1
-  c = c -  c -  c -  c = c -  c = c -  c -  c = c -
v- ---------V------------ >
CCL-T''” DIENE CONJUGATION
i
- C  = C -  C -  C -  C = C -  C = C -  C -  C = C -
tcL3
TERMINATION
[Taken from Benedetti et a l . ,  (1977a)].
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VARIATIONS IN DRUG METABOLISM AND LIPIDS  
DURING DEVELOPMENT IN THE LIVER OF RATS
INTRODUCTION
I t  is generally considered that the liver and other tissues of 
mammalian foetuses, except possibly human, have only a limited ability to 
metabolize drugs and other chemicals. However, most studies have been 
carried out on foetal tissues of rodents and other non-primate species. 
Rabbit foetal liver preparations were able to metabolize chlorpromazine 
only to sulphoxide, a reaction catalysed by flavoprotein oxidoreductases 
(Bhatnagar, 1971). Nevertheless, treatment of pregnant rabbits or rats 
near full-term  with inducing-agents of the liver microsomal d rug - 
metabolizing enzyme system, can result in some increases of these 
enzymes and in the metabolism of drugs, such as phenobarbital and 
meperidine (Pantuck et a L , 1968). Undoubtedly, the enzymes that
detoxicate drugs and chemicals begin to develop very late in the foetuses 
of most animals, and are present only at low levels in foetal tissue at 
fu ll-term . However, considerable evidence suggests an earlier and 
greater ability to hydroxylate steroids and to conjugate with sulphate. 
Consequently it is possible that cytochrome(s) P-448 predominate and are 
largely saturated with endogenous steroid substrates, thereby inhibiting 
the metabolism of added exogenous foreign compounds.
In  contrast to the foetuses of rodents, livers from human foetuses 
and from the foetuses of non-human primates, such as the stump-tailed 
macaque, do have relatively well developed oxidative, hydrolytic and 
conjugative detoxicating mechanisms early in gestation (Dvorchik and 
Hartman, 1982). The human foetal hepatocyte has been shown to contain 
smooth ER, indicative of the presence of the cytochrome P-450-dependent 
monooxygenase system, as early as the sixth week of gestation (Short et 
a L , 1976). The metabolism of chlorpromazine, hexobarbital,
N-methylaniline and benzo(a)pyrene in the human foetus have all been
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observed, but at much slower rates than in adults; these metabolic 
reactions all involve hydroxylations, catalysed by cytochrome P-450, the 
presence of which other workers have demonstrated in human foetal liver 
(Yaffe et a [ . , 1970; Pelkonen and Karki, 1971). Human foetal tissues 
are also able to catalyse the reduction of nitro groups in drugs, and 
this activity develops in human foetuses at around 12 weeks of gestation. 
Nitroreductase activity is present in human foetal liver, adrenal and 
lung, but the requirement of high coenzyme levels for maximal enzyme 
activity Jjn vitro indicates that the activity jn vivo may be slow (Juchau,
1971).
Considerable evidence has accumulated that drugs are metabolized 
slowly in newborn animals and that the activities of many of the 
drug-metabolizing enzymes of the neonates are considerably less than in 
the adult. The liver microsomes of newborn rats, rabbits, mice and 
guinea pigs are either lacking in certain hepatic drug metabolizing 
enzyme activities or exhibit low levels of these enzymes (Fouts and 
Adamson, 1959; Jondorf et a L , 1959; Fouts and H art, 1965). The 
drugs, hexobarbital, pentobarbital, meprobamate, carisoprodol and 
strychnine were all metabolized in the newborn rat at rates of less than 
10% of adult values, but the rates of metabolism increased rapidly with 
development of the neonates, reaching normal adult levels at 30 days 
after birth (Kato et a [ . , 1964). Basu et aL (1971) found that hepatic 
mixed-function oxidase activity developed maximally in neonatal rats at 24 
days for biphenyl 4-hydroxylase (cytochrome P-450) and at 21 days for 
biphenyl 2-hydroxylase (cytochrome P-448). However, the 4-hydroxy­
lase activ ity , like cytochrome P-450, remained at moderately high levels 
throughout the adult life, while, the 2-hydroxylase activity (P-448) 
continuously decreased and disappeared completely at 70 days after 
birth . This varying ontogenesis of the different isoenzymes of 
cytochrome P-450 and P-448 has been noted by other workers, and may 
reflect the asynchronous development of various forms of cytochrome 
P-450. In  foetal and neonatal rats, aromatic polycyclic hydrocarbons 
have been shown to be efficient inducers of monooxygenases, especially 
arylhydrocarbon hydroxylase. By contrast, the effects of phenobarbital 
are not clearcut (Pelkonen, 1980); although the mechanism responsible
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for the induction of cytochrome P-450 by phenobarbital is present but 
not very active (Cresteii et a l . ,  1982).
Quantitative electron microscopic studies of human liver indicated 
that the functional deficit of enzymes is attributable to a net reduction 
of membranes from smooth complement in the endoplasmic reticulum (De la 
Iglesia et a L , 1976). The activity lag is probably due to some maternal 
inhibitory factors (Kardish and Feuer, 1972), or associated with an 
impairment of phospholipid synthesis (Dhami et a L , 1979). Apparently, 
the event of birth initiates maturation of enzyme action, although the 
exact mechanism responsible for this process has not yet been eluci­
dated .
The hepatic endoplasmic reticulum is the major site for phosphlipid 
and glycoprotein biosynthesis, and components are transferred to other 
subcellular structures within the hepatocyte (Parkes and Thompson, 
1973). During morphogenetic and differentiation processes, several 
functions associated with subcellular organelles undergo maturation of 
metabolic functions. These stages involve the synthesis and induction of 
new enzyme systems, some of which are associated with the onset of 
drug biotransformation or metabolizing activity (Assael, 1982; Klinger, 
1982; Dhami et a L , 1983). The production of inadequate quantities and 
qualitatively different phospholipids has perhaps been responsible for
impaired microsomal enzyme activity and resulting in ’poor quality' 
endoplasmic reticulum membranes to allow for normal function. The 
relevance of hepatic phospholipid influence in membrane structure and 
function has been studied in various experimental conditions (Feuer and 
de la Iglesia, 1977; Feuer et a l . , 1977; Ilyas et a h , 1978b). An
earlier study recognized the changes of phospholipids in developing rat 
liver (Feuer, 1978).
To obtain more information on the role of phospholipids during
development, this study was designed to investigate the individual fatty  
acid derivatives in the liver and the ER of the growing ra t. These 
changes may reveal the importance of overall fa tty  acid pattern in
phospholipids relevant to the ER function.
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MATERIALS AND METHODS
Animals. Female Wistar albino rats (Woodlyn Farm, Guelph, 
Ontario, Canada) were given laboratory chow (Purina Laboratory Chow, 
Rawlston Purina C o., St. Louis, M O., USA) and tap water ad libitum. 
Animal quarters were well-aerated, air-conditioned rooms kept at 20 ± 
2 °C and at 50-60% ambient humidity.
Experimental groups included foetuses, weanling and adult animals 
of both sexes. Pregnant rats were killed on the th ird  week of gestation 
as established by the date of mating. Foetuses were removed jn utero 
on day 22 of gestation and killed by decapitation. The sex of the 
foetuses was determined by gross examination of the gonads. Additional 
experimental groups were 1 to 2 day, 2 to 3 week, 5 to 6 week, 6 to 8 
week and 11 to 12 week old male and female rats. The animals were 
starved overnight and weanling neonates were separated from the 
mothers for 8 hours before killing.
Chemicals. Fatty acid and phospholipid standards were purchased 
from Serdary Research Laboratories, London, Ontario, Canada; crude
1-amino-2-naphthol-4-sulfonic acid from Fischer Scientific C o., Toronto, 
Ontario, Canada and purified according to the method of Fiske and 
Subbarow (1925); silica gel G from Merck Co. L td ., Darmstadt, 
Germany; omnifluor (a mixture of primary and secondary scintillation 
fluors containing 98% PPO and 2% bis-MSB) from New England Nuclear 
Co. L td ., Boston, MA; cofactors for enzyme assays from Sigma Chemical 
C o., St. Louis, MO.
14Radiochemical. [ C-Me] L-methionine (specific activity 33.3 
mCi/nMol) was obtained from International Chemical and Nuclear 
Corporation, Montreal, Quebec, Canada.
Preparation of Liver Homogenate. Rats were killed under light 
anesthesia by exsanguination from the vena cava. Each liver was 
perfused with 1.15% KCI buffer to remove blood. The liver was then 
rapidly removed, rinsed with ice-cold physiological saline solution, and 
homogenized in 1.15% KCI solution in 0.1 M Tris  buffer (pH 7 .4 ) so that 
3 vol. of medium was added to each gram of tissue. Data from at least
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4 litters or from 4 animals of each sex were used as independent 
variables for each experimental group.
Preparation of Microsomes. The procedure to homogenize, separate 
and purify microsomes was carried out according to De Duve and Berthet 
(1954), as modified by Feuer et aL (1965). In  addition, the microsomal 
pellet was rinsed twice with the bu ffe r, resuspended and recentrifuged. 
The final pellet was reconstituted in 1.15% K C I-buffer, pH 7.4 equivalent 
to a preparation containing J gram of liver/m l of microsomal suspension.
Lipid Extraction. The glassware and other items used for this 
procedure were thoroughly cleaned and made fat free by washing with a 
hot chloroform-methanol mixture [2 :1 , v /v ] .  Total fatty acid content 
was determined in lyophilized homogenates. Ten ml of methanol was 
added to the lyophilized residue (0.25 gram) and left standing for 4 
hours in the dark at room temperature under N2. The content was then 
mixed with 20 ml of chloroform and allowed to stand for 2 hours at room 
temperature. The suspension was filtered through defatted Whatman 
filte r paper and the sediment was washed twice with 10 ml of 
chloroform-methanol mixture ( 2 :1 ) .  The combined filtrate  and washings 
were evaporated to dryness in a rotary evaporator at 37°C, and the dry  
residue was transferred to a screw-cap tube. The lipids were 
redissolved in 0.5 ml of hexane containing 2 ,6-d i-t-bu ty l-4 -m ethy l phenol 
(DBMP) (5 mg/100 ml) and stored in sealed tubes under N2 at -20°C . 
The samples were evaporated under N2 gas for fu rther analysis.
Separation of Phospholipids and Phosphate Determination. The 
phospholipid fraction was extracted and purified according to the method 
of Folch et al. (1957), as modified in our laboratory (Cooper and Feuer, 
1972). The extracts were evaporated to dryness and transferred  
quantitatively into 10 ml volumetric flasks. The entire extract was then 
reduced to a 0.5 ml volume and quantitatively spotted on silica gel using 
a solvent system composed of chloroform/methanol/water (25:15:2, v /v )  
according to the method of Skipski et aL (1962). For phosphate 
determination, the phospholipids were visualized with iodine vapour. For 
fa tty  acid analysis, the phospholipid bands (PC and PE) were visualized 
by spraying the plate with 0.5% 2 ,7-dichlorofluorescein in 50% methanol. 
Identification was based on standards run concomitantly. The spots
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were outlined with a pencil and wetted slightly with distilled water to 
facilitate the transfer of silica gel to a centrifuge tube using a spatula. 
Areas containing no spot were also removed as controls or blanks to 
determine phosphate content. The samples were eluted four times with 
chloroform/methanol ( 2 : 1 ) ,  the combined elutes transferred to a 
volumetric flask. The samples were evaporated under N2 and its 
phosphate content was determined according to the method of Bartlett 
(1959). The recovery of lipid phosphorus from thin layer plates was 
consistently 85-95% for samples.
Preparation of Fatty Acid Methyl Esters. To the dry residue of 
total lipid extract (liver and microsomes), 2 ml of 10% H^O,* in absolute 
methanol (w /v ) were added. Methanolysis was performed at 80°C for 4 
hours. The tube contents were cooled and diluted with distilled water. 
The fatty acid methyl esters were extracted three times with 3 ml 
portions of petroleum ether. The extracts were collected in a tube and 
evaporated to dryness under N2 gas. This residue was redissolved in
0.5 ml of hexane containing DBMP and stored at -20°C under N2 for 
fu rther gas-liquid chromatography analysis (Kuksis et a [ . , 1968).
Phosphatidylcholine and phosphatidylethanolamine fatty  acid methyl 
esters were prepared from the spots identified on the plates. These 
were scraped o ff, methylated and stored, as described above.
Gas Chromatography of Fatty Acids. Fatty acids were analyzed 
using a F and M Biochemical Gas Chromatograph Model 400, with a H 2 
flame ionization detector. The glass columns were (3 mm i.d . X 6 ft) 
packed with 10% EGSS-X on Chromosorb W, AW, 100 to 120 mesh. The 
gas chromatograph was operated isothermally at 180°C with N2 carrier 
gas at a flow rate of 60 ml/min. Peak identity and quantitative
validation of estimates of fatty acid concentration were done by 
comparison with the National Heart Institute Fatty Acid Standards 
(M ixtures, KA, KD, KF) and the Hormel Institute Fatty Acid Standards 
(Mixtures 1, 2 , and 8 ) .  The quantitative data agreed with the stated 
composition, showing a relative error of less than 5% for major
components and of less than 1% for minor components. The peak
identification was further confirmed by cod liver oil fatty  acid analysis
(Ackman and Burgher, 1965). Heptadecanoic acid ( C l7 :0 ) was used as
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an internal standard. The recovery and precision of fatty  acid analysis 
by this system of gas chromatography was observed to be 90-95% for the 
samples.
Enzyme Assays
1. Aminopyrine N-Demethylase (APDM-ase)
Aminopyrine N-demethylase activity was determined by the method 
described by Kato et al. (1964). The reaction was started by adding
1.0 ml of 25% microsomal preparation to reaction mixture preincubated at 
37°C for 5 minutes containing 0.01 M aminopyrine (0 .5 m l), 0.5 M Tris  
bu ffer, pH 7.4 (0 .3 m l), 0.01 M NADPH (0.1 m l), 0.03 M G -6-P  (1 .0  
m l), 0.05 M MgCI2 (0.5 m l), 0.1  M nicotinamide (0.5 ml) and G6 P 
dehydrogenase ( 0.1  ml or 1 u n it). A fter 30 minutes of incubation the 
reaction was stopped by adding 4.0 ml of 10% ZnSO^ with s tirrin g , 
followed by 2 .0  ml of saturated B a(O H )2. To determine formaldehyde 
content, 5.0 ml of protein-free supernatant was added to 2 .0  ml of Nash 
reagent (Nash, 1953) and heated at 60°C for 30 minutes. The colour 
was read at 415 nm against the blank (without aminopyrine).
2 . Coumarin 3-Hydroxylase (COH-ase)
For coumarin 3-hydroxylase assay (Feuer, 1970), the reaction 
mixture was similar to aminopyrine. N-demethylase assay. The reaction 
was started by adding 0.1 ml of 0.'z8wM coumarin. A fter 30 minutes of 
incubation at 37°C, the reaction was stopped by shaking with 10 ml 
purified diethyl ether and the metabolites extracted into the organic 
phase. The extract was evaporated at 37°C and dry  residue was 
dissolved in 0.5 ml alcohol. The colour reaction was developed by 
adding to the extract a mixture of 0.1  ml of Gibbs reagent ( 0 . 1% w /v  in 
alcohol), 1.9 ml ethanol and 1.5 ml of saturated sodium bicarbonate 
solution and shaking this for 10 minutes. The mixture was then 
centrifuged at 3000 rpm for 10 min and the absorbance read at 595 nm. 
Replicate incubations were stopped after various times (10-20 min) and 
the initial enzyme reaction rate determined.
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3. S-Adenosyl-L-methionine: microsoma l-phosphatidylethanolamine
methyl transferase (Methyl Transferase)
Methyl transferase was determined using the method described by 
Feuer et al. (1972). The reaction was started by adding 0.5 ml
of C-methionine ( 1 .6  ^C i/m l) to a preincubated reaction mixture at 
37°C containing 0.5 M Tris  bu ffer, pH 8.0 (0.5 m l), 0.04 M ATP-ase 
( 0 .2  m l), 0.1  M MgCI2 (0 .2  ml) and 0 .6  ml of 105,000 X g supernatant. 
At 0 , 10 and 20 minutes, 0.5 ml samples were taken and added to 9.5 ml 
of a mixture of CHCI3: CH3OH (2 :1 /v /v ) .  The extraction procedure was 
followed as described by Feuer et aL (1972). One ml of organic phase 
was pipetted into a counting v ia l, evaporated to dryness and counted in 
10 ml Buhler scintillation counting solution (Buhler, 1962).
Protein Determination. Protein was measured by the method 
described by Miller (1959).
Statistical analysis of data was carried out using Student's t-te s t 
(Snedecor and Cochran, 1967). Each result represents the means ±
S .E .M . of four measurements. The percentage recovery from gas 
chromatograph was computed by a rapid method (Fross, 1968). 
Significant differences were accepted at P<C0.05 or P <0.005 level.
The detailed results of fatty acid contents are given in Appendix 
Tables for Chapters 2 , 3 and 4 at the end of the dissertation. The 
fa tty  acid content has been rounded off for simplicity. The per cent 
composition is based on absolute values.
RESULTS
Drug-Metabolizing Enzymes
As seen in Table I ,  APDM-ase and COH-ase enzyme activities were 
low in the foetus and showed a gradual increase, reaching adult level at 
about 6 to 8 weeks after birth in both male and female rats. The 
activities of these enzymes were significantly lower in female rats than 
male rats at about 2 to 3 weeks after b irth  and onwards. These 
observations agree with previously reported data (Kardish and Feuer, 
1972).
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Methyl Transferase
Methyl transferase is required to synthesize PC from PE by 
stepwise methylation. This activity did not change immediately after 
birth . I t  increased significantly at about 2 to 3 weeks and reached 
adult level at about 6 to 8 weeks after b irth . No sex difference was 
observed in this activity in the foetus or immediately after b irth . 
However male rats showed significantly higher activity than females at
11-12 weeks of age (Table 1 ).
Microsomal Phospholipid and Protein Content
Phospholipids increased immediately after birth and a two-fold  
increase was observed between foetus and 1-2  days old rats of both 
sexes (Table 2 ). Sex difference was obvious in 2 to 3 weeks old rats 
and male rats had 3<\% or more phospholipids than female rats at 6 to 8 
or 11 to 12 weeks. Phospholipids continue to rise with the age in the 
microsomes and confirm the increase in the methyl transferase activity  
(Table 1 ).
Similarly, protein content increased sharply after b irth and reached 
to adult level at about 6 to 8 weeks after b irth . No sex difference was 
observed in protein concentrations of microsomal preparations at any age 
(Table 2 ) .
Phospholipid: Enzyme and Protein Ratio
The phospholipid: enzyme activity (APDM-ase) ratio increased
slowly after birth with a prompt elevation between 5 to 6 weeks in both 
male and female rats. The ratios were slightly higher in male rats than 
female rats (Table 3 ).
The phospholipid: protein ratio increased gradually after b irth ,
reaching maximum at about 2 to 3 weeks after birth and then decreased 
to adult level at about 6 to 8 weeks. This ratio demonstrated sex
difference from 1 to 2 days and onwards (Table 3 ).
Liver Acyl Components of Phospholipids During Development
Total hepatic fatty acid content increased progressively from the
foetus to 6 to 8 weeks in male rat (Table 4 ), and there were slight
changes in the saturated/unsaturated fatty  acid ratios among the groups.
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Palmitic acid increased gradually. Stearic acid increased sharply from 1 
to 2 days to 2 to 3 weeks old group. Among unsaturated acyl compo­
nents, palmitoleic, and docosahexaenoic acids increased gradually. 
Linoleic, arachidonic and docosapentaenoic acid contents increased 
sharply between 1 to 2 days and 2 to 3 weeks. In  contrast, oleic,
eicosatrienoic and docosahexaenoic acids were decreased in 6 to 8 week 
old group.
In female rats, total and saturated fatty  acids exhibited a similar 
trend as seen in males, except for palmitic acid that remained constant 
from birth to 11 to 12 weeks of age (Table 4 ). Among unsaturated 
components, eicosatrienoic acid concentration was variable; linoleic, 
arachidonic, docosapentaenoic and ddcosahexaenoic acid levels were 
raised sharply after b irth . The ratios between saturated and
unsaturated fatty  acids did not change in both male and female rats.
The total fatty  acid content of PC fractions increased about 70% in 
both sexes after 2 to 3 week period. While saturated and unsaturated 
fa tty  acid increased significantly, the saturated acyl components did not 
increase as much as the unsaturated derivatives (Table 4 ). The ratio of 
saturated/unsaturated fatty  acids altered in 1 to 2 day to 2 to 3 weeks 
of age from 47/53 to 45/55 in males and from 49/51 to 46/54 in females. 
A lower ratio of saturated to unsaturated was observed in male than in 
female rats at about 2 to 3 weeks of age.
Fatty acid moieties from PE fractions were also raised in the liver of 
rats of both sexes during development (Table 4 ), resulting in lower 
saturated /unsaturated ratios from 1 to 2 days to 2 to 3 weeks. The 
ratios were modified from 1 to 2 days old of 52/48 to 49/51 and 51/49 to
49/51 in 2 to 3 weeks old group in both male and female rats,
respectively. Increases in palmitic, stearic, oleic, linoleic, arachidonic 
and docosahexaenoic acids in both sexes of rats contributed to the 
changes in ratios.
Microsomal Acyl Components of Phospholipids During Development
In  the developing male ra t, total fatty  acid content of hepatic 
microsomes increased overall (Table 5 ). With increasing age, more 
unsaturated fatty acids were incorporated into the endoplasmic reticulum
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as indicated by the decreased trend in the ratio of saturated to 
unsaturated fatty  acids. The ratio changed from 48/52 of foetus to 
45/55 at 1 to 2 days after b irth , decreasing to 44/56 at 2 to 3 weeks and 
43/57 at 6 to 8 weeks after b irth . Some unsaturated components showed 
a gradual increase from foetus to 6 to 8 weeks old, such as palmitoieic, 
oleic, arachidonic, docosapentaenoic and docosahexaenoic acids. Palmitic 
and stearic acids also increased during the development from foetal age.
During development in the female ra t, the total amount of acyl 
components in microsomal preparation were enhanced (Table 5 ). There  
was an age related increase in unsaturated constituents, resulting in
decreased saturated/unsaturated fatty acid ratios. The trend in the 
reduction of ratios of 48/52 from foetus to 47/53 at 1 to 2 days and 
further reaching to 43/57 at 6 to 8 weeks was similar to male rats. The 
ratio was relatively higher in 1 to 2 days age group of female rats as 
compared to male rats of the same group. The content of eicosatrienoic 
acid concentration increased two fold immediately after b irth  and 
decreased at 2 to 3 weeks. The content returned to adult level between 
6 to 8 weeks.
In the PC fractions of microsomes in male rats, the ratio of
saturated to unsaturated fatty acid was modified to 45/55 at 2 to 3 week 
old rats from 47/53 in 1 to 2 days group. Both the saturated and
unsaturated fatty  acids were increased significantly from 1 to 2 days of 
age to 2 to 3 weeks (Table 5 ). In female rats, both saturated and
unsaturated fatty acid moieties increased with increase in age. Among 
the saturated acyl components, palmitic and stearic acids increased 
sharply from 1 to 2 days of age to 2 to 3 weeks in both sexes. The 
increases in unsaturated components were also comparable in both sexes. 
However, the saturated/unsaturated ratio was lower in male (44/56) than 
in female (45/55) rats at 2-3 weeks of age.
In  the PE fractions of male rats, both saturated and unsaturated 
acyl derivatives increased during development (Table 5 ). Among the 
unsaturated fatty  acids, eicosatrienoic acid did not change from 1 to 2
days to 2 to 3 weeks old rats. The ratio of saturated to unsaturated
fatty  acid was modified to 50/50 in 2 to 3 weeks old age group from
52/48 in 1 to 2 days old group. Similar increases were also observed in
70
female rats. However, eicosatrienoic acid content was reduced from 1 to 
2 days to 2 to 3 weeks old female rats. The saturated and unsaturated 
ratio was altered from 52/48 in 1 to 2 days to 51/49 in 2 to 3 weeks old 
rats. Similar to PC fraction, a sex difference was also observed In this 
fraction at 2 to 3 weeks old group between saturated and unsaturated 
acidU>(50/50 in male and 51/49 in female ra ts ).
Sex Difference in Individual Fatty Acids
Total fatty  acid content of liver microsomes in male foetuses is 
higher than in the female foetuses which was due to higher contents of 
all the individual acyl components including both saturated and 
unsaturated components (Table 5 ). This difference continued from 1 to 
2 days to 2 to 3 weeks after b irth . The difference disappeared at 6 to 
8 weeks of age. In  the hepatic microsomal PC fraction, the acyl 
components of 1 to 2 days old male and female rats were similar in 
contents. Total fatty acid content did not change at 2 to 3 weeks of age 
between the sexes; however, stearic and arachidonic acids slightly  
increased while palmitic acid decreased in male rats. In  the hepatic 
microsomal PE fraction, palmitic and eicosatrienoic acids increased in 
female neonates. However, palmitic, oleic and linoleic acids decreased 
while stearic and arachidonic acids slightly increased in 2 to 3 weeks old 
female rats.
DISCUSSION
Hepatic Metabolism During Development
Most biostransformation reactions with xenobiotics can be localized 
in the liver parenchymal cells, predominantly in the ER, including both 
the SER and RER types. However, in the case of some enzymes, the 
cytosol or the nuclear membranes, are active compartments. Finally the 
whole cell is required to provide the necessary co-factors.
During a well-defined period of foetal life in the rat liver a number 
of enzymes of the ER including the drug-metabolizing enzymes possess 
only a low activity (Jondorf et a [ . , 1959). The concentration of
essential coenzymes in the liver of the foetus is also low (Dallner et a l . ,
71
1965). In  the ra t, differentiation and development of biotransformations 
occur mainly after birth (Klinger et a L , 1979, 1980). However,
immediately after birth these enzymes increase rapidly and during  
puberty a different level of activity develops according to sex (Kato and 
Gillette, 1965; Schenkman et a [ . , 1967). Metabolic adaptation to the 
extrauterine life has been suggested as the main reason for the rapid 
rise (Knox et a h , 1956). Various factors such as glycogen (Bashan et 
a L , 1979) may be connected with the in utero inhibition. Extensive data 
in the literature indicate that probably progesterone derivatives comprise 
the inhibitory factors (Feuer and Liscio, 1970; Kardish and Feuer, 
1972) and are responsible for the delayed development of drug 
metabolizing activity of the foetus and neonate. Glucocorticoids trigger 
the development of cytochrome P-450, and precocious development of 
cytochrome P-450 in neonatal rat liver may be induced by glucocorticoid 
treatment (Leakey and Fouts, 1979). In contrast to foetal liver of 
various laboratory animal species, human foetal liver is able to metabolize 
drugs through cytochrome P-450 dependent enzymes but unable to 
perform glucuronidation of most substrates (Juchau et a l . ,  1980).
Development of the Endoplasmic Reticulum
The growth pattern of rat hepatocyte during postnatal development 
regarding ploidity, mitosis rate (hyperplasia) and/or hypertrophy was 
investigated by James et aL (1979). Volume, surface and number of 
microvilli of liver cells as well as the volume of nuclei increase 
postnatally (David, 1979). In  foetal liver cells, nuclei are bigger, but 
few mitochondria are seen (Vergonet et a L , 1970). In  weanling rats 2.6  
times more nuclei appear, but smaller mitochondria are observed in 
comparison to newborn rats (Lang and Herbener, 1972).
In  the firs t two weeks of life, less endoplasmic reticulum is formed 
per unit liver weight as established by electron microscopic data 
(Vergonet et a L , 1970), quantitative serology (Rohr et a L , 1971; De la 
Iglesia et a [ . , 1976) and the yield of microsomal protein (McLeod et a L ,
1972), all of which may be the reason for lower enzyme activ ity . 
Furthermore, it has been suggested that in the rat during foetal and 
early neonatal life, the lower level of drug metabolizing enzymes in the
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liver may be associated with the presence of hematopoitic ceils 
(Henderson, 1971), These cells consist of approximately half the total 
iiver tissue three days prior to b irth (Dallner e t a l . ,  1966). However, 
three days after birth they are reduced to a minimum, comparable to 
that of the liver in adult animals. The influence of the low number of 
postnatal blood cells still present cannot, therefore, provide a reasonable 
explanation for the sharply increasing pattern of enzyme activity after 
birth .
Development of Sex Differences in Rats
In rats after weanling and at the beginning of sexual maturation, 
males exhibit distinctly higher drug metabolizing enzyme activities than 
females (Chung, 1977). In  rats, this sexual differentiation was found to 
be due to a neonatal androgen-induced imprinting whereby the hypothal- 
mic-hypophyseal axis plays an obligatory role (Custafsson and Stenberg, 
1976). Therefore, the postnatal age courses of sexual maturation were 
investigated. The results in Tables 1 and 2 confirm the higher enzyme 
activities and phospholipid content during development in male rats than 
in female rats. The ratios between saturated and unsaturated fa tty  
acids were higher in female than in male rats in the microsomal 
phospholipids (Table 5 ). Palmitic and stearic acids varied throughout 
the postnatal age course. During the development more unsaturated 
fatty acids were incorporated in the membranes of male than in female 
rats. Unfortunately, only the results but not the mechanisms of sexual 
dfferentiation in mice were investigated (van den Berg et a l . ,  1978).
Phospholipid Changes During Development
The lipids of the ER undergo important quantitative and qualitative  
changes during development, especially in their fatty  acid pattern. 
They strongly influence the flu idity of membranes, diffusion velocity of 
xenobiotics and the electron transfer from NADPH to cytochrome P-450 
and, moreover, they are essential for binding xenobiotics to cytochrome 
P-450 binding sites (Ingelman-Sundberg, 1977). Microsomal lipids 
themselves bind to cytochrome P-450 and inhibit monooxygenase reactions 
depending on age (Iba et a [ ., 1975). Lipid peroxidation is evidently not
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only influenced by age-dependent differences in lipid composition, but 
also by age-dependent inhibitory and enhancing factors (Player and 
Horton, 1978).
These experiments have shown that the development of the 
endoplasmic reticulum function in the rat is paralleled by rapid
changes in the production of membrane phospholipids. The phospholipid 
level of the growing rat is increased in the total liver tissue as well as 
in the microsomal fraction. Most importantly, the phosphatidylcholine 
component is raised with the enhanced activity of methyl transferase 
(Kardish, 1971).
Fatty Acid Composition of Phospholipids During Development
Fatty acid moieties of the hepatic phospholipids are also enhanced in 
both sexes during development. Both saturated and unsaturated fatty  
acids increased during development; in PC and PE fractions unsaturated 
acyl components increased proportionally as accounted for by increase in 
linoleic, arachidonic and docosahexaenoic acids. This age-related  
increase in acyl derivative content and composition is likely due to 
increased requirements in the assembly of membranous phospholipids and 
of subcellular organelles. Furthermore, this study suggests that during  
ontogenesis, proportionally more arachidonic and docosahexaenoic acids 
were incorporated into total liver phospholipids regardless of sex 
influences. The trend to higher concentrations of unsaturated fatty  
acids was more marked in males than in females during development and 
the reason for this effect is not clear. I t  seems that the maturation 
process of hepatic structures is not connected with the formation and 
availability of sufficient amounts of specific PC. This specificity is 
gradually strengthened by the modification of the fatty acid chains 
during development, particularly with the replacement of saturated 
components by polyunsaturated ones, probably as a reflection of a 
significant shift in the synthesis or metabolism of these moieties. This 
observation is similar to the data on mouse liver lipid fractions where 
unsaturated fatty  acids increase with age, a process that influences the 
level of many enzymes (Hawcroft and M artin, 1974).
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The enzymic activity of ER membranes depends on the presence of 
phospholipids, and in particular, the degree of adequate function 
correlates with the acyl side chains of these molecules. Treating isolated 
microsomes with phospholipase C reduces both phospholipid content and 
specific activity of several microsomal enzymes. Reactivation can be 
achieved by the addition of various PC fractions (B erry  et a L , 1976; 
Gallenkamp, 1977).
Fatty acids components of the microsomal membrane are low in the
foetus and show a gradual increase with age. However, not all the acyl
components are raised in a parallel fashion; during development, 
relatively greater amounts of unsaturated fatty acids are incorporated 
into membranes with a subsequent shift to lower saturated/unsaturated  
ratio (Tables 4 and 5 ). Individual fatty acids involved in this trend are 
palmitic and stearic acids with low concentrations. In  contrast,
arachidonic, docosatrienoic, docosapentaenoic and docosahexaenoic acids 
are consistently elevated in the total phospholipid complement and in 
particular, in the PC fractions. The significance of the increasing
amounts of the polyunsaturated fatty  acid components of phospholipids in 
the development of the endoplasmic reticulum has not yet been
established. However, phospholipids play an important role in the 
efficient (or adequate) functions of these membranes and in the physical 
state of lipids, perhaps serving as modulators of these activities
(Holloway and Garfield, 1981; Higgins, 1982). Whether or not the 
replacement of the acyl components occurs by synthesis or by
exchange-transfer of the constituents from available pools is not yet 
known. Selectivity for the type of phospholipid for metabolic activity  
seems to be essential in some hepatic mitochondrial and microsomal
enzymes (Dockter and Magnusson, 1975).
A significant rise in the activity of hepatic drug-metabolizing 
enzymes occurs promptly after b irth in premature and full-term  animals 
(Manchester and Neims, 1977; Ecobichon et a L , 1978). The maturation 
of these enzyme systems represent protective mechanisms or adaptation 
of the newborn to foreign compounds. I t  appears from this work 
(Tables 4 and 5) that during the course of these events there are  
prerequisites for the normal development of enzyme activ ity . These
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include (a) increased synthesis of arachidonic and docosahexaenoic acids 
from linoleic and linolenic acids, and possibly from other precursors 
(Sprecher, 1975), and (b) the enhanced incorporation of these 
unsaturated fatty acids into phospholipids. In these processes the 
production of PC fractions containing polyunsaturated acyl side chains 
seems to be essential. Thus, the presence of unsaturated fatty  acids in 
phospholipids may enhance the flu idity of membranes as well as 
constitute an initial step in the ontogenesis of the biochemical function of 
the hepatic endoplasmic reticulum. The formation of arachidonic acid in 
tissue lipids gives support for the importance of dietary linoleic acid as 
a precursor. During ontogenesis there is a relative increase of polyun­
saturated fatty  acids as well as of linoleic acid. I t  seems, therefore, 
that the availability of these fatty  acids in the diet would invariably  
facilitate the normal maturation of the hepatic endoplasmic reticulum 
membranes. The presence of adequate unsaturated fatty  acids may be 
essential to the integrity of the detoxifying apparatus which may 
eliminate drug-induced reactions or environmental in jury by xenobiotics 
in infants (Short et £ [ . ,  1976).
Variations in the fatty acid pattern of the maternal diet were 
observed to influence the fatty  acid composition of microsomal 
phospholipid without affecting the enzyme activities in the newborn 
animals (Dallner et a [ . , 1966; Palade and Porter, 1967). These authors 
suggested a minor role of fatty acid composition of microsomal 
phospholipids in hepatic biotransformations. However, it has been 
established that cytochrome P-450 is firmly bound to the membrane of 
hepatic ER and exists substantially in the high-spin configuration in 
contrast with the soluble membrane-free hemeprotein (from the same 
biological source) that exists primarily in the low-spin configuration 
(Cinti et a [ . , 1979). Recent evidence has shown that this
low-spin/high-spin equilibrium is in part modulated by the lipids of the 
membrane and in particular, by nonesterified fatty acids (Gibson et a l . ,
1980), indicating the importance of the fatty acid pattern of the ER 
membrane. I t  has been shown that high-spin cytochrome P-450 controls 
the redox potential of the hemeprotein (Sligar et a [ . , 1979). These 
observations further suggested that unsaturated fatty  acids in the ER
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membrane may function as effectors in modulating the hemeprotein 
spin-state equilibrium, thereby influencing the drug-metabolizing enzyme 
activities in the ER.
Phospholipid-Enzyme-Protein Ratio Changes During Development
The ratio between phospholipid and protein in microsomes increases 
with age (Dallner et a l . , 1966). The present investigation confirms 
these increases in the ratio (Table 3 ). Neither in rats nor in guinea 
pigs of any ages are NADP/NADPH2 and NAD/NADH2 concentrations 
limiting for the capacity of microsomal electron transport chain (Schenker 
and O’Connel, 1965). During developmental growth, faster synthesis 
and slower degradation of proteins can be observed (Conde and Scornik,
^ 1977), whereas in senescent rats, microsomal proteins as well as protein
9 - —
synthesis (amino acid incorporation) decreases (Hrachovec, 1969).
The degree of postnatal expression of drug-metabolizing activ ity  
appears to be directly associated with the concentration of microsomal 
phospholipids at a given age. Rapid changes occurring during late 
foetal period and after b irth  in these enzymes are accompanied by a 
sudden rise of phospholipids at b irth . The continuing enhancement of 
activities further shows a close parallelism with the increased synthesis 
of the phospholipid components. I t  is probable that in the evolution of 
the hepatic endoplasmic reticulum the synthesis of membrane phospho­
lipids is one of the essential prerequisites. The most significant feature 
of these results is, therefore, that the maturational increase of membrane 
phospholipids in microsomes is possibly one of the major determinants of 
the pattern in the development of hepatic drug-metabolizing enzymes. In  
other conditions associated with modifications of the endoplasmic 
reticulum function, a similar parallelism occurs between drug-metabolizing 
enzyme activity and microsomal phospholipid synthesis; for example, the 
induction by PB (Feuer et a [ . , 1972; Ilyas et a [ . , 1978b), effect of 
hepatotoxins (Cooper and Feuer, 1972), effect of development (Basu et 
a L , 1971; Kapitulnik et a L , 1979)), excess dietary methionine
(Acheampong-Mensah and Feuer, 1974), and pregnancy (Dhami et a L , 
1981a,b). Phospholipid changes are manifested mainly in the production 
of phosphatidylcholine as catalysed by methyl transferase. Since
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phospholipids, and in particular phosphatidylcholine, are required for 
the action of membrane enzymes (Zakim and Vessey, 1975), this study 
may support the concept that phospholipids are not only essential to the 
membrane structure but may also act as organizers to increase enzyme 
activities during development.
i
CHAPTER
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THE EFFECTS OF PREGNANCY AND PROGESTERONE METABOLITES 
ON DRUG-METABOLIZING ENZYMES AND 
LIPIDS IN THE LIVER OF RATS
INTRODUCTION
I t  has been well documented that hepatic microsomal drug 
hydroxylation is decreased in pregnant animals (Neal and Parke, 1973; 
Feuer and Kardish, 1975). These decreases of enzyme activities are 
related to decreased synthesis of the membrane phospholipids which are 
an integral part of the enzyme system (Kardish, 1977; Feuer, 1979; 
Dhami et aL , 1979; Turcan et £ [ . ,  1981).
Pregnancy elicits a wide spectrum of actions on the endoplasmic 
reticulum and as the microsomal mixed-function oxidase system is
responsible for the oxidation of foreign chemicals as well as steroid 
biogenesis and metabolism (Feller and Gerald, 1971), it would be
expected that pregnancy might affect the activities of steroid hormones 
and drugs. Furthermore, high levels of oestrogens and progesterones 
during pregnancy, especially metabolites of endogenous progestogens, 
might be the cause of changes in the enzymic activities and lipid 
composition of the hepatic endoplasmic reticulum (Feuer, 1979).
Both endogenous and exogenous steroids are metabolized in the 
hepatic endoplasmic reticulum by the same enzyme system responsible for 
the metabolism of drugs and foreign compounds (Kuntzman et a L , 1964).
Steroids alter microsomal enzyme activity and interfere with the
metabolism of drugs (Feuer, 1984). In  particular, progesterone and 
certain of its derivatives have been reported to alter the activity of 
hepatic microsomal enzyme systems both m vitro  (Soyka and Deckert, 
1974; Johnston et a L , 1983) and in vivo (Feuer, 1979). Moreover, the 
foetus is also exposed to the elevated amounts of maternal steroids. 
Consequently, the delayed development of the drug-metabolizing
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capability may be associated with the effect of these compounds (Kardish  
and Feuer, 1972).
A correlation has been established between the activity of d rug - 
metabolizing enzymes and phospholipid content of hepatic microsomes in 
rats treated with several progesterone derivatives (Kardish, 1977; 
Feuer, 1979; Dhami et a L , 1979). These changes were similar to the 
inductive action of PB on the one hand, associated with increased 
enzyme activity and phospholipids, and the inhibitory effect of CCI^, on 
the other hand, associated with decreases, respectively (Ilyas et a [ . , 
1978a,b; Feuer, 1979; Bulger and Kupfer, 1983).
Thus, it became important to establish four factors (a) if the 
reduced activity of microsomal enzymes were directly associated with 
discrete fatty acid moieties of phospholipids during pregnancy; (b) if  
the inducing effect on drug metabolism by progesterone metabolites were 
related to structural microsomal phospholipid changes; (c) if increases 
in fatty  acids of the microsomal membrane brought about by progesterone 
metabolites which raise drug metabolites are similar to those seen with 
PB; and (d) if  decreases of fatty  acids brought about by progesterone 
metabolites which reduced drug metabolism and phospholipid in 
microsomes are similar to those produced with CCI4. Accordingly, 
studies have been undertaken to examine the influence of pregnancy on 
the structure and function of the hepatic endoplasmic reticulum and to 
relate these effects to the action of progesterone metabolites.
MATERIALS AND METHODS
Animals
Wistar albino rats (High Oak Ranch, Richmond H ill, Ontario, 
Canada) were housed in individual cages and maintained on laboratory 
chow (Purina Laboratory Chow, Ralston Purina C o ., St. Louis, M O ., 
U .S .A .)  and water ad libitium. All animals were kept at an 
environmental temperature of 20 ± 2°C. Housing, husbandry, and 
experimental handling of animals were within accepted guidelines of the 
Animals for Research Act of Ontario, 1971. V irgin female rats weighing
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200-250 g and pregnant rats of the same age were used. Pregnant 
animals were killed on the third week of gestation as estimated by the 
date of mating. The remaining groups were killed in the immediate 
postpartum period as well as during the second and third week of 
weanling. In another study animals weighing 180 to 190 g were treated  
with test compounds.
Experimental Compounds
Animals received progesterone derivatives including 3-pregnan-3a-
ol-20-one (pregnanolone), Sigma Chemical C o ., Kalamazoo, Michigan, 
U .S .A .) ,  and 16a-hydroxyprogesterone, synthesized in our laboratory 
(Cole and Julian, 1954). [ 1IfC-Me)-L-Methionine (sp. activity 33 mCi/m
mole was purchased from International Chemical and Nuclear Corporation, 
Montreal, Quebec. Test compounds were injected s .c . daily for 7 days 
in doses of 10 mg/kg B.Wt. dissolved in arachis oil. Control groups 
received the vehicle only. The final dose was given 24 hours before
killing . Arachis oil was of edible quality.
Tissue Preparation and Analysis
Rats were sacrificed under light anaesthesia by exsanguination from 
the inferior vena cava. Preparation of liver homogenates and microsomal 
fractions; extraction and quantitation of microsomal phospholipids; 
fa tty  acid analysis were carried out following the methods described in 
Chapter 2 .
Cytochrome P-450 Determination
Cytochrome P-450 was measured using the method described earlier 
(Omura and Sato, 1964). Tw enty-five per cent microsomal suspension (2 
ml) was diluted three fold with 0.1 M Na-K phosphate bu ffer, pH 7 .4 . 
Three ml of diluted microsomal suspension was added to two cuvettes.
In one cuvette 0.1 ml of NADPH (1 mg/ml) was added and a difference
in spectrum was recorded between the wavelength of 390 mm and 450 mm 
with Unicam Scanning Spectrophotometer Model SP-800. A couple of 
granules of sodium dithionate were added to both cuvettes and CO was 
bubbled to both cuvettes for approximately 30 seconds. A difference
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spectrum was obtained between wavelengths of 390 mm and 500 mm. 
Cytochrome P-450 was expressed as the difference in optical density 
between the wavelengths of 450 mm and 490 mm.
Enzyme Assays
NADPH Cytochrome c Reductase
1. NADPH -  cytochrome c reductase activity was measured 
according to method described (Phillips and Langdon, 1962). The 
reaction was started by adding 0.1 ml of NADPH (0.03 M) to 1.7 ml of
-3
0.05 M potassium-phosphate bu ffer, pH 7.6 containing 10 M KCN, 1 ml 
of cytochrome c (0.1 mM) and 0.2 ml of microsomal suspension (25%). 
The initial velocity was taken as the measure of cytochrome c reduction. 
The scanning was recorded at wavelength of 550 vim with Unicam 
Scanning Spectrophotometer Model SP-800. A blank mixture was scanned 
without the addition of NADPH and an equivalent volume of the buffer 
was added.
2. Aminopyrine N-Demethylase (APDM-ase), Coumarin 3-Hydro­
xylase, (COH-ase) and S-Adenosyl-L-Methionine: Microsomal Phospha-
tidylethanolamine Methyl Transferase assays were carried out according 
to methods described in Chapter 2.
Phosphatases
1. Glucose-6-Phosphatase (G6 P-ase) activity was determined using 
method described by Feuer et a[. (1965). To a pre-incubated reaction
mixture at 37°C containing 0.1  M Tris-maleate buffer, pH 6 -S’, f2 .0  ml)
l-Ovvxi HzO (lxio<3>io+iov\)
0.01 M EDTA (0.5 ml) 0.03 M G6 P (0.5 m l),^  \-o ml of),25% microsomal
preparation was added. One ml of aliquot of the reaction mixture was
pipetted at 0, 5, 10, and 15 minutes into acid molybdate mixture (0 .2  ml
70% perchloric acid + 3.0 ml of 1.66% ammonium molybdate + 4.0 ml
mixture of isobutanol: toluene ( 1 : 1 ,v :v ) .  Oyi£ ml aliquot of the upper
organic phase was pipetted into test tubes containing 3.0 ml of 2%
|*v> €tt\<Jwio£ CW 'A O .S vv )j( 0 ¥ O ' 2.c/o
^stannous cnloride. Optical density was read at 725 nm.
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2. Inosine Diphosphatase (IDP-ase) activity was determined 
according to method described by Feuer et al. (1965). To a pre-incuba- 
ted mixture at 37°C of 1.75 ml of 0.05 M Tris-maleate bu ffer, pH
0 -iSv^HiO
0.25 ml of MgCI2 (0.05 M ), 0.25 ml of inosine diphosphate (0-024 M),J^0.1  
ml of 25% microsomal suspension was added to start the reaction. Half 
(0 .5 ) ml of aliquot of the reaction mixture was pipetted at 0 ,5 ,10 , and 
15 minutes into acid molybdate mixture as described for G6P-ase assay. 
Similar procedures were used to develop and record the optical density.
Phosphate determination was carried out according to the method of 
Bartlett (1959).
Protein determination was carried out as according to the method of 
Miller (1959).
Statistical Analysis
Each result represents the means ± S .E .M . of 4 measurements 
obtained from 4 rats. Statistical analysis was carried out by Student's 
t-tes t (Snedecor and Cochrane, 1967) and significance was accepted at P 
<[0.05 level. The percentage of recovery from gas chromatography was 
computed by a rapid method (Fross, 1968).
RESULTS
Body and Liver Weights
Both liver weight and body weight increased in the pregnant rat 
(late pregnancy); however, the relative liver weight (expressed as 
percentage of body weight) remained the same (Table 1 ).
The test compounds, pregnanolone and 16a-hydroxyprogesterone did 
not affect the body weight and liver weight (Table 1 ) .
Liver Phospholipid and Protein Contents
Protein and phospholipid contents of the liver of pregnant animals 
were slightly decreased (Table 1).
The phospholipid content was slightly decreased by pregnanolone 
treatment (Table 1 ), while the protein content remained the same. The 
16a-hydroxyprogesterone treatment did not affect these parameters.
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Microsomal Phospholipid and Protein Contents
The microsomal phospholipid and protein contents were decreased 
significantly in the pregnant rat (Table 2 ) .  The decreases reversed 
gradually after parturition reaching values of the non-pregnant rats at
2-3 weeks postpartum.
The treatments with test compounds had contrasting effect on the 
phospholipid content of the microsomes.
Microsomal Phospholipid Composition
Both PC and PE fractions were altered in the pregnant animals 
(Table 3 ). A shift in the relative proportions of PC:PE was also 
observed. The ratio of PC:PE was decreased from 3.5 in non-pregnant 
rats to 3.1 in pregnant rats.
Analysis of individual phospholipids indicates that 16a-hydroxypro­
gesterone treatment increased both PC and PE fractions whereas 
pregnanolone significantly decreased PC, PE and SM fractions. 
However, 16a-hydroxyprogesterone administration decreased the PC:PE 
ratio to 2 . 6  from control value of 3 .1 . Pregnanolone treatment did not 
affect the ratio (Table 3 ).
The alteration of PC:PE ratios during pregnancy and treatments 
agree with earlier reports by Kardish (1977). The activity of methyl 
transferase, the enzyme responsible for the stepwise methylation of PE to 
PC was assayed in the pregnant animals. As shown in Table 4, the 
methyl transferase activity was decreased during pregnancy.
An alteration in the activity of the microsomal phosphatases was 
observed in the pregnant rats; G6 P-ase was decreased, whereas,
IDP-ase was increased (Table 4 ). The effect of pregnancy resembles
the effect of hepatotoxic compounds such as CCI^. Treatment of rat 
with inducers, does not affect the G6 P-ase activity (Chapter 4 ). The 
effect of pregnanolone treatment on phosphatases resembled that of 
hepatotoxins whereas, the 16a-hydroxyprogesterone administration had 
no effect on the activ ity .
Methyl T ransferase activity was significantly reduced during
pregnancy (Table 4 ). Therefore, the methylation of PE to PC was 
decreased. This in turn affects the PC:PE ratio.
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Drug Metabolizing Enzymes
A reduction in hepatic microsomal drug metabolizing enzyme activity  
was clearly demonstrated in the pregnant rats as compared to 
non-pregnant vo-ts In  vitro  activities of APDM-ase and COH-ase were 
decreased (Table 4 ).
Both test compounds had contrasting effects on the drug  
metabolizing enzyme activities. 16a-ttydroxyprogesterone administration 
induced the activities of APDM-ase and COH-ase, whereas, pregnanolone 
treatment decreased the activities (Table 4 ). The alterations in drug - 
metabolizing activity following the treatments were in accord with their  
inducing and depressing capacity, as reported earlier (Feuer, 1979).
Cytochrome P-450 Electron Transport System
Determinations of cytochrome P-450 mixed-function oxygenase system 
agree with the reduction in drug metabolizing activ ity . Cytochrome 
P-450 and the activity of the NADPH-cytochrome c reductase decreased 
in the pregnant rats (Table 5 ).
Fatty Acid Composition Changes During Pregnancy and Postpartum
Whole L iver. Pregnancy also significantly decreased total fa tty  acid 
content of the liver (Table 6 ) .  Both saturated and unsaturated fa tty  
acids were decreased to the same extent. The ratio of saturated to 
unsaturated fatty acids was not significantly altered, from 40/60 in 
non-pregnant rats to 39/61 in the pregnant group. There were, 
however, significant qualitative changes in fatty  acid composition. 
Among saturated fatty acids, stearic acid was decreased and arachidic 
acid was increased. The content of palmitic acid did not change 
markedly. The fraction of unsaturated fatty acids also varied; 
palmitoleic, oleic, linoleic, eicosatriaenoic, arachidonic, eicosapentaenoic 
and docosapentaenoic acids were decreased; whereas docosahexaenoic 
acid was raised.
Fatty acid changes were reversible after pregnancy (Table 6 ) .  
Some of these changes were prompt and occurred within 1-2 days in the 
early postpartum period, such as palmitoleic and stearic acid; some 
returned gradually including docosapentaenoic acids. Oleic, linoleic,
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eicosatriaenoic, arachidonic, and docosahexaenoic acids reached the 
values of the non-pregnant animals only after 2 to 3 weeks during
weanling. The ratio of saturated/unsaturated fatty acids was 39/61, 1 to 
2 days after parturition, and 40/60 during weanling.
Liver-Phosphatidylcholine
The effect of pregnancy was reflected in the fatty  acid composition 
of individual phospholipids. Total fatty acid content was decreased in 
PC fractions (Table 6 ) .  In  particular, unsaturated fatty  acids bound to 
these lipids were decreased, thus the ratio of saturated to unsaturated 
fatty  acids increased during pregnancy from 42/58 in non-pregnant to 
46/54 in pregnant animals. Significant reduction was seen among
unsaturated fatty acids of PC; such as palmitoleic, oleic, linoleic, 
eicosatrienoic, arachidonic, eicosapentaenoic, docosapentaenoic, and 
docosahexaenoic acids. Palmitic acid was slightly decreased while stearic 
acid showed no change. There were slight changes immediately 
postpartum. Normal fatty  acid levels were observed 2 to 3 weeks later 
during weanling. The reduction of unsaturated fatty acids was 
compensated and the saturated/unsaturated fatty  acid ratio returned to
normal and was 46/54 in early postpartum, and 42/58 2-3 weeks during
weanling. There were slight increases in stearic, arachidonic, 
docosapentaenoic and docosahexaenoic acids at 1 to 2 days postpartum. 
These values returned to normal values during weanling. There was a 
general enhancement of unsaturated fatty  acid contents during weanling.
Liver Phosphatidylethanolamine
Pregnancy was associated with a significant decrease in the fa tty  
acid content and composition of liver PE fractions (Table 6 ) .  Pregnancy 
altered the ratio of saturated/unsaturated fatty  acid to 49/51 from 48/52 
in non-pregnant animals. Apart from the greater decrease of 
unsaturated fractions, all individual fatty acids were significantly  
decreased.
A gradual increase in the fatty  acid content of PE fractions took 
place after parturition. I t  returned to the level of non-pregnant animals 
at 2 to 3 weeks during weanling (Table 6 ) .  The saturated/unsaturated
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fatty acid ratio remained at 48/52, 1 to 2 days postpartum. A moderate 
increase was observed in the levels of palmitic, linoleic, arachidonic and 
docosahexaenoic acids. The total fatty acid content also increased 
gradually after parturition, reaching normal levels 2 to 3 weeks during 
weanling.
Liver Microsomal Preparation
Acyl components of liver microsomes were significantly decreased 
during pregnancy (Table 7 ). An overall, parallel decrease occurred in 
both saturated and unsaturated fatty  acids, although the saturated/un­
saturated fatty  acid ratio slightly changed from 43/57 to 44/56, in 
non-pregnant and pregnant animals, respectively. Both saturated and 
unsaturated fatty acids were decreased while only docosahexaenoic acid 
was increased.
The microsomal fatty acid changes during pregnancy were reversible 
(Table 7) after parturition. However, at 2 to 3 weeks during weanling 
the unsaturated fatty acid components increased; resulting in a 
saturated/unsaturated ratio of 43/57, comparable to the levels obtained in 
the non-pregnant animals.
Microsomal -  Phosphatidylcholine
The fatty acid content of PC fractions was decreased significantly  
during pregnancy (Table 7 ). Unsaturated fatty acid content was 
decreased resulting in an increase of saturated/unsaturated fatty  acid 
ratio to 45/55 during pregnancy as compared to 42/58 in the 
non-pregnant group. The major components involved in this modification 
were palmitic, palmitoleic, stearic, oleic, linoleic, eicosatrienoic, 
arachidonic, docosapentaenoic, and docosahexaenoic acids.
PC fatty acid levels returned to normal levels after pregnancy 
(Table 7 ). The saturated/unsaturated fatty  acid ratios at 1 to 2 days 
postpartum and at 2 to 3 weeks during weanling, were 44/56 and 43/57, 
respectively. Among the individual fatty  acids, palmitic, palmitoleic, 
stearic, linoleic and arachidonic acids showed slight increases, whereas 
oleic, eicosatrienoic, docosapentaenoic, and docosahexaenoic acids were 
unchanged at 1 to 2 days postpartum. All these fa tty  acid
95
concentrations returned to non-pregnant levels within 2 to 3 weeks 
during weanling.
Microsomal -  Phosphatidylethanolamine
Fatty acids in the PC fractions were significantly decreased during  
pregnancy (Table 7 ). Since unsaturated fatty acids were preferentially  
decreased, the saturated/unsaturated fatty acid ratio was increased from 
46/54 to 51/49, in non-pregnant and pregnant rats, respectively. 
Palmitic, palmitoleic, stearic, oleic, linoleic, arachidonic, and 
docosahexaenoic acids decreased in large amounts.
The reversible changes occurred in microsomal PE fractions after 
pregnancy. Saturated/unsaturated fatty  acid ratios steadily decreased to 
48/52 at 1 to 2 days postpartum and returned to the non-pregnant level 
of 46/54 at 2 to 3 weeks during weanling. The intervals at which 
various discrete fatty acids returned to non-pregnant levels showed 
variations. Some increased gradually, such as palmitic, oleic, linoleic, 
and arachidonic acids; some returned to the non-pregnant level slowly 
such as palmitoleic, stearic, docosapentaenoic, and docosahexaenoic 
acids. All fatty  acid components returned to normal levels within 2 to 3 
weeks of the weanling period.
Liver Microsomal Fatty Acid Composition Under Treatments
Whole Microsomal Preparation. 16a-Hydroxy progesterone and 
pregnanolone treatments had contrasting effects on the total fatty  acid 
contents of the microsomal preparation; 16a-Hydroxyprogesterone 
increased the total fatty acid content while pregnanolone decreased it 
(Table 8 ) .  16a-Hydroxyprogesterone treatment mainly affected the 
polyenoic acids and increases in eicosatrienoic, arachidonic, 
eicosapentaenoic and docosahexaenoic acids were observed. The 
saturated components were not altered by the treatment. In  contrast, 
pregnanolone decreased both saturated and unsaturated fatty acids. The 
treatments altered the ratio of saturated to unsaturated fatty acids from 
44/56 in controls to 41/59 with 16a-hydroxyprogesterone and to 45/55 
with pregnanolone treatment.
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Microsomal -  Phosphatidylcholine, 16a-Hydroxyprogesterone 
administration increased the total fatty  acid content of microsomal PC 
fractions (Table 8 ) .  The treatment increased both saturated and 
unsaturated components. Among the saturated fatty  acids; palmitic and 
stearic acids were increased while in the unsaturated fatty  acids, oleic, 
linoleic, arachidonic, eicosapentaenoic and docosahexaenoic acids were 
increased. In  contrast, the administration of pregnanolone decreased 
both saturated and unsaturated components. The treatment did not
J3GYI tO .
affect palmitoleic, eicosat^4enoic and docosahexaenoic acids. The ratio of 
saturated to unsaturated fatty acids was modified to 41/49 with 
16a-hydroxyprogesterone and to 43/57 with pregnanolone treatment from 
42/58 of control value.
Microsomal -  Phosphatidylethanolamine. 16a-Hydroxyprogesterone 
treatment enhanced the total fatty acid content of the microsomal PE 
fraction. Both monoenoic and polyenoic acids were increased by this 
treatment (Table 8 ) .  All the saturated and unsaturated components in 
this fraction were increased significantly except palmitoleic acid. In  
contrast, pregnanolone treatment decreased the total fatty  acid content 
in this fraction. Palmitic and docosahexaenoic acids were not affected by 
the treatment. A contrasting effect was also observed in the ratio of 
saturated to unsaturated fatty  acids. The ratio was modified to 42/58 
with 16a-hydroxyprogesterone treatment and to 54/46 with pregnanolone 
treatment from 47/53 of control value. The ratio changed drastically in 
this fraction.
DISCUSSION
Effect of Pregnancy
VlBody and Liver Weights. During p re ^ n c y  a substantial body 
weight gain not involving the reproductive organs and product of 
conceptions has been established in several species, including man 
(Korula et a [ . , 1982). A large proportion of liver weight increase can 
be accounted for by fractional increases in the content of water, 
phospholipids, protein and RNA (Campbell and Kosterlitz, 1953). S till, 
the major proportion of the weight gain in both rats and mice can be
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attributed to water. Hervey and Hervey (1967) concluded that the 
weight gain during pregnancy was due to positive energy balance, i .e . ,  
an increased food intake. Of the total body weight gain, 31% was fa t, 
43% was lean tissue including its water content and 26% was water 
exclusive of lean tissue. Adipose tissue and lean protein increments 
were apparently uniformly distributed in the animals. Similarities in the 
relative liver weight (expressed as % of the body weight) between 
non-pregnant and pregnant rats reported in Table 1 and also by Dean 
and Stock (1975) support this view.
Microsomal Phosphatases. There was a significant alteration in the 
function of the hepatic endoplasmic reticulum. The activity of G6 P-ase 
was decreased while the activity of IDP-ase was increased (Table 4 ). A 
similar reduction in G6P-ase activity in the pregnant rat has previously 
been reported (Kardish, 1977). This pattern of change (a decrease in 
G6 P-ase and an increase in IDP-ase activity) has also been reported 
following treatments of animals with CCI^ (Feuer et a h , 1967), coumarin 
(Feuer et a L , 1967), ethionine and dimethylnitrosamine (Feuer and
Granda, 1970). On the other hand, inducers of drug-metabolizing 
enzymes, e .g . ,  hexobarbital, phenobarbital and 4-methylcoumarin (Feuer 
and Granda, 1970) have no effect on either of the phosphatases. Based 
on these investigations, Feuer and Granda (1970) have suggested that 
the differential response in the activities of the phosphatases to 
treatments with hepatotoxins might be used as a biochemical marker for 
hepatotoxicity. The effect of pregnancy on these microsomal 
phosphatases resembles that of treatment with hepatotoxins. Further 
studies, as discussed in Chapter 2 and later section, on the microsomal 
drug metabolism and phospholipids, agree with this view of the 
hepatotoxic-like action of pregnancy.
The loss of activity of G6P-ase after incubation of microsomes with 
phospholipase A was evidence that enzyme required phospholipids 
(Kardish, 1977). The increase in the nucleoside diphosphatase has been 
observed following treatment of animals with phospholipase A (Feuer and 
Golberg, 1967). The activity of G6 P-ase m vitro was partially restored 
by adding of phospholipids (Kardish, 1977). The striking parallelism 
between the effect of phospholipase A on the microsomal phosphatases
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suggests that action of pregnancy on microsomal phosphatases (Table 2) 
may be through an effect on the microsomal phospholipids (Table 4 ). The 
alteration of phospholipids affects the organization of the membrane 
phospholipid-protein complex which in turn affects the association of the 
phosphatases with the ER membranes.
Hepatic Drug Metabolism. A decrease in the activity of hepatic 
microsomal drug metabolizing enzymes was clearly demonstrated in this 
study (Table 4) and confirm the earlier reports (Neale and Parke, 1973; 
Dean and Stock, 1975; Kardish, 1977; Turcan et a l . ,  1981). Similar 
decreases have been observed for the nitroreductase (paranitrobenzoic 
acid) activity and azoreductase (neoprontosil) activity in the pregnant 
animals (Yaffe et a l . , 1972; Neale and Parke, 1973). Drug-metabolizing 
activity progressively decreased with maximal depression occurring in 
late pregnancy (days 20- 2 2 ) followed by a rapid reversal of this 
depression immediately upon delivery (Kardish and Feur, 1972).
These results demonstrated that a decrease in the activity of d ru g - 
metabolizing enzymes in the pregnant rats was paralleled by a similar 
decrease in the content of microsomal cytochrome P-450 and cytochrome c 
reductase (Table 5 ). Similar results have been observed by other 
researchers (Guarino et a [ . , 1969; Dean and Stock, 1975). Other
workers have reported no change in the microsomal concentrations of 
cytochrome P-450 while the drug-metabolizing enzyme activity was
reported to be decreased (Schlede and Borowski, 1974; Turcan et a L ,
1981). In  addition, Neal and Parke (1973) observed in the rabbit that
pregnancy did not significantly affect the cytochrome P-450.
More recently, it has been suggested that, during pregnancy, the 
decrease in high spin state of cytochrome P-450 may be responsible for 
decrease in the drug metabolism (Turcan et a [ . , 1981). This decrease 
was greatest for p-nitrobenzoic acid reductase (53% of non-pregnant 
levels) and least for ethylmorphme N-demethylase (74% of non-pregnant 
levels). The rate limiting step for oxygenation of a number of drugs is 
the firs t electron reduction of cytochrome P-450 by NADPH-cytochrome 
P-450 reductase (Schenkman and C inti, 1970). The spin state of the 
hemeprotein is important with respect to the ease of this reduction since 
an increase in the high spin form of cytochrome P-450 is associated with
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a positive shift in the redox potential thus facilitating electron flow from 
reductase to the terminal cytochrome (Sliger et a L , 1979). The
observations by Turcan et aL (1981) may explain a possible mechanism 
for depression of drug metabolizing activity along with a significant 
decrease in the proportion of high spin state of cytochrome P-450 during  
pregnancy.
Since during pregnancy, the formation and circulation of female sex
hormones increase considerably, both progesterone and estrogen were
obvious candidates responsible for this inhibition. Microsomal enzymes
which are involved in the metabolism of drugs are in many ways similar
to those involved in the metabolism of endogenous steroid hormones
(Kuntzman et a L , 1964) and it is believed that drugs and steroids are
metabolized by the same enzyme system. Studies by Tephly and
Mannering (1968) and Wada et a[. (1968) have shown that steroid
hormones such as estradiol, progesterone, testosterone competitively
inhibited microsomal drug metabolism when added jn vitro system.
Consequently, it has been suggested that the high levels of circulating
steroids during pregnancy may be responsible for decreased activity of
drug metabolism by inhibition as competitive substrates. On the other
fitfhand, in vitro kinetic studies on Guarino et a[. (1969) and Turcan et aL 
(1981) have shown no significant difference in the apparent Km values of 
the enzyme activity in the control and pregnant ra t, ruling against an 
endogenous competitive inhibitor. However, it is possible that in the 
intact animal, elevated levels of steroids may competitively inhibit drug 
metabolism in the ER and that failure to observe such m vitro  inhibitions 
may result from loss of the inhibitors during preparation.
Microsomal Phospholipids
Present results (Tables 2 and 3) suggest that the phospholipids are 
essential for the catalytic activity of hepatic microsomal drug-metabolizing 
enzymes and it is well known that the ER undergoes a considerable 
change during pregnancy (Kardish, 1977; Turcan et a L , 1981). The 
decrease in phospholipids is reversible after parturition and reaches the 
non-pregnant levels 2 to 3 weeks during weaning (Table 2 ). The PC:PE 
ratio was altered from 3.5 in non-pregnant rats to 3.1 in the
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pregnant rats. Phospholipids are important in substrate binding 
(Narasimhulu, 1977), electron transfer to cytochrome P-450 (Dupel and 
U llrich, 1976), and maintaining the hemeprotein and NADPH-cytochrome 
P-4 5 0  reductase in a functional complex. The decrease in total 
microsomal phospholipid and the decreased PC:PE ratio as seen during 
pregnancy may, therefore, explain the decrease in cytochrome P-450 
mediated drug metabolism.
The increase in PE fractions during pregnancy may inhibit the 
PC-enhanced hydroxylation of benzphetamine (Strobel et a l . ,  1970). The 
results of the present studies (Tables 2 ,3 ,4  and 5) agree with these 
observations. Table 4 demonstrates a decrease in the incorporation of 
^C -m ethyl group into total microsomal phospholipids in the liver of 
pregnant rats. Detailed analysis of individual phospholipids indicated 
that the decrease in the incorporation of radioactivity resided mainly in 
the PC fraction (Kardish, 1977). This decrease in incorporation of 
radioactivity into PC indicates a decrease in the conversion of PE to PC 
via the methylation pathway. This observation was in accord with the
shift in the ratio of PC to PE (Table 3 ).
Fatty Acid Composition
Available reports compared total liver lipids in non-pregnant and 
pregnant rats (Knopp et a l. ,  1973). These studies were concerned with 
the origin of foetal lipids, placental fatty acid synthesis, and the role of 
maternal adipose tissue and were not addressed to the importance of the 
maternal hepatic metabolism. Furthermore,itdid not relate the concentra­
tion of the various lipid classes and phospholipid synthesis to any aspect 
of liver function.
Present studies show that pregnancy brought about a significant 
decrease in the hepatic phospholipid content which returned progres­
sively to the pre-pregnancy level within 2 to 3 weeks postpartum and 
also the total fatty acid conent of the liver was decreased (Table 6 ).
This represented a selective effect since, several major saturated and
unsaturated components such as stearic, oleic, linoleic, eicosatrienoic, 
arachidonic, and eicosapentaenoic acids were decreased whereas some 
fa tty  acids were increased, such as arachidic and docosahexaenoic acids.
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The fatty acid content of various phospholipids, such as PC and PE 
fractions representing unsaturated acyl components, was decreased in 
the pregnant rat. Thus the sequence of events in the liver during  
pregnancy are related to a gradual loss of phospholipids and selective 
changes in acyl group synthesis and binding. This process was 
reversible with a progressive increase in the formation of phospholipids 
and unsaturated fatty  acids and in their incorporation into phospholipids 
after parturition.
During pregnancy in the ra t, there was a decrease in total 
membrane phospholipids and a shift in phospholipid bases and fatty  acids 
in the hepatic endoplasmic reticulum. These changes were reversible 
and aii lipid components evaluated returned progressively to 
non-pregnant levels within 2 to 3 weeks during weanjing (Table 7 ) .  
Both saturated and unsaturated fatty acids were significantly decreased 
in microsomes and the effect was greatest in the unsaturated acyl 
components. This might indicate a decrease of desaturase activity  
(Sprecher, 1975; Emmelot and van Hoeven, 1975) and it appears to 
follow a selective process in the unsaturated fatty  acid availability since 
oleic, linoleic, arachidonic, eicosapentaenoic, and docosahexaenoic acids 
were significantly decreased. The enzymatic transformation of linoleic to 
arachidonic acid (Steinberg et a h , 1956) is localized exclusively in
microsomes together with the highest arachidonic/linoleic acid ratio (Getz
and Bartley, 1961). These observations suggest that in the pregnant 
rat the metabolic pathways of polyunsaturated fatty  acid biosynthesis 
from various mono and diene adjuncts are shifted to linoleate sequences 
as precursors for docosahexaenoic acid (Sprecher, 1975). The level of 
this fatty acid was significantly elevated in both total liver and 
microsomes (Table 7 ). Since it slightly decreased in microsomal
phosphatidylcholine and phosphatidylethanolamine fractions, this indicates 
that phospholipids containing docosahexaenoic acid are removed preferen­
tially from the membrane, either by decreased synthesis or by accelera­
ted degradation.
The results reported here suggest that during pregnancy the 
linoleate/arachidonate ratio in microsomal phospholipid is decreased,
particularly in phosphatidylcholine fractions. This indicates that
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pregnancy and associated physiological changes modify the sequential 
participation of polyunsaturated fatty  acids in the structure of 
membranes. The reduction of linoleate-arachidonate transformation may 
represent an inhibition of the microsomal elongation-desaturation system 
(Sprecher, 1975). The production of increased amounts of docosahexa­
enoic acid in microsomes may then be associated with a certain 
impairment of this enzyme system with the subsequent stimulation of 
another pathway. Since desaturation is a process involved in the 
flu idity of the phospholipid complexes, the reduced degree of
unsaturation contributed to more solidly packed chains. This process 
has been the eventual influence on membrane osmotic stability (Van 
Deenen and de Gier, 1964), frag ility  (Mason and Lee, 1973), and on the 
relative mobility of structural phospholipids (Trauble and Sackmann, 
1973). Thus the lower enzyme activity of the hepatic microsomes in 
pregnant rats may be related to the diminished availability of arachidonic 
acid and its precursor, linoleic acid (Feuer, 1979). Similar changes 
develop in membrane phospholipids under various conditions, including 
alcohol (Reitz et a [ . , 1973), carbon tetrachloride (Ilyas et a h , 1978a), 
essential fatty acid deficiency (Holman, 1970), and in rapeseed oil
feeding (Dewailly et a l . ,  1978). Thus, their role in the development of 
unexpected toxic-pharmacologic reactions is anticipated. In  this fashion, 
the reduced synthesis of arachidonic acid from available linoleic acid and 
its incorporation into microsomal phospholipids may play a role in
lowering the function of the hepatic endoplasmic reticulum during 
pregnancy. Such a decrease may be associated with conformational 
changes of the membrane, correlating with an absolute decrease of
enzyme activity by means of reduced membrane surface or less active 
sites. These changes may also be associated with a decrease in high 
spin cytochrome P-450 during pregnancy (Turcan et a [ . , 1981). I t  is 
suggested that drug metabolism during pregnancy may be modulated by 
the changes in the microsomal fatty  acids bound to the phospholipid 
bilayer.
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Effect of 16a-Hydroxy progesterone and Pregnanolone on D rug- 
Metabolizing Enzymes
Kardish and Feuer (1972) observed that the ]n vitro  metabolism of 
progesterone was shifted from the hydroxylation to the reductive process 
in the microsomes from pregnant rats. In  addition, they reported the m 
vitro  activity of the progesterone 5a-hydrogenase activity was increased 
whereas progesterone hydroxylase activity was decreased. Excessive 
levels of pregnanolone and pregnanediol in the serum of human subjects 
during pregnancy have been reported (Stoa and Bessesen, 1975). I t  
was hypothesized, therefore, that the inhibition of drug metabolism may 
have resulted from excessive quantities of progesterone produced during  
pregnancy and its metabolism predominantly to reduced derivatives. 
Kardish (1977) reported that the reduced drug metabolism was associated 
with decreased microsomal phospholipid content in the rats treated with 
various reduced progesterone metabolites such as 5a-pregnan-3-20-dione, 
5^?-pregnan-^3,20-dione. While the 16a- and 63-hydroxy progesterone 
derivatives increased the activity of drug-metabolizing enzymes and 
phospholipid content in the ER. I t  was concluded that action of reduced 
derivatives of progesterone on the drug metabolism and phospholipids 
mimicked the effect of hepatotoxins while that of hydroxyprogesterone 
derivative acted as inducers of drug metabolism. The results in Tables 
2 ,3 ,4  and 5 agree with his observations. The present data demonstrates 
a contrasting effect on the phospholipid concentrations in the ER, in 
particular on PC and PE. The pattern of action of pregnanolone
resembles with the action of pregnancy. On the other hand,
16a-hydroxyprogesterone treated animals showed induction of all the 
parameters associated with drug metabolism.
Fatty Acid Composition
The effects of pregnanolone on microsomal phospholipids were 
similar to those found with carbon tetrachloride treatment although of 
lesser magnitude (Ilyas et a [ . , 1978a,b). I t  seems reasonable to
characterize this progesterone derivative as behaving mild hepatotoxin
which reduced unsaturated fatty  acids in liver and microsomal
membranes. An association between drug metabolizing enzyme activity  
and fatty acid composition may appear incidental, a correlation exists 
between the observed differences in fatty  acids and the changes in
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enzyme activity of the endoplasmic reticulum in the liver (Feuer, 1979). 
The inductive action on these membranes is associated with increased 
fatty  acid content and the inhibition is accompanied by a significant 
diminution. Although neither the exact mechanism leading to fatty  acid 
changes nor the stimulus for the increased or decreased synthesis with 
subsequent modification of phospholipid fatty  acid composition are known, 
primary initiation of de novo protein synthesis (Eriksson and Dallner, 
1973), related increase of enzyme activity (Belina et a [ . , 1975) or
hormonal changes (Feuer, 1979) might be responsible for this pattern.
Results in Table 8 agree with the reported data (Colbeau et a L ,
1971). The results show that the microsomal membranes consist of a 
mixture of phospholipids differing in fatty  acid chain length and in the 
chemical nature of the headgroups which respond with structural changes 
to xenobiotics and to steroid metabolites. Fatty acid side chains are 
essential in phospholipids for transfer reactions (Higgins and B arrnett,
1972) and contribute to the structural membrane state depending on the 
degree of saturation. Variations in fatty  acid side chains and
headgroups also influence the occurrence of phase-separation equilibrium  
(Shimschick and McConnell, 1973). Increased levels of polyunsaturated 
fatty  acids lower the transition temperature, and increase membrane
flu idity (Becker et a l . , 1978). Specific drug binding to membrane
phospholipid structures have an influence on the physical state of the 
membranes (Rosenberg et a l . , 1975). Current experiments showed that 
16a-hydroxy progesterone treatment significantly increased mono- and 
poly-unsaturated fatty  acids while, pregnanolone treatment decreased 
these acids. Speculatively, changes in phase equilibria could occur. 
Lowered phase equilibria has been associated with enhanced drug  
metabolizing activ ity , and reduced activity corresponded with raised
equilibria. Thus the regulatory action of steroid hormones on
endoplasmic reticulum function might be manifested in modifications of the 
composition of the lipid moiety of the membrane (Feuer, 1979). These 
membrane modifications might become continuous over the complete 
microsome membrane population with the resulting increase or decrease in 
biotransformation capacity of the endoplasmic reticulum.
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Present experiments have shown that treatment of rats with 
16a-hydroxyprogesterone significantly increased microsomal PC and PE 
content and unsaturated: saturated fatty  acid ratio, mainly manifested in 
relatively greater increases in oleic, linoleic, arachidonic and
docosahexaenoic acids. In  contrast, pregnanolone treatment caused a 
reduction of these fatty  acids. These effects showed a resemblance to 
those brought about by PB and CCI^. The action of
16a-hydroxyprogesterone was similar to PB, indicating mild induction 
effects (Ilyas et a l . , 1978a,b). The relationship between effects on 
drug-metabolizing activ ity , PC, PE and fatty  acid changes, is not clearly 
understood. I t  rather may represent a mere parallelism and cause-effect 
relationship. However, correlation of total hepatic PC and PE-bound 
fatty acids may be congruent with the suggestion that changes in fa tty  
acid side chains influence enzyme activity of the endoplasmic reticulum in 
the liver (Gibson et a L , 1980) .
Drug-induced proliferation of endoplasmic reticulum membranes 
depends upon the concurrent increase of membrane proteins and
phospholipids. These actions, may have, therefore, some physiological
importance (Holtzman et a [ . , 1970). I t  seems that enhanced production 
of microsomal PC and PE is connected with inducer actions, or conditions 
where drug-metabolizing activity is increased. On the other hand, the 
effects of hepatotoxicants are associated with reduced synthesis. Thus 
these changes may have a relevance to the mechanism of drug metabolism 
mainly manifested in hepatic microsomes (Ilyas et a l . ,  1978a,b). Results 
presented here might lead to a promising approach to the elucidation of 
the mechanism of action of cytochrome P-450 dependent enzyme systems.
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CHAPTER H
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THE EFFECTS OF PHENOBARBITAL, AROCLOR-1254 
3-METHYLCHOLANTHRENE AND CARBON TETRACHLORIDE ON 
DRUG-METABOLIZING ENZYMES AND LIPIDS IN THE LIVER OF RATS
INTRODUCTION
The increased activities of the microsomal drug-metabolizing enzymes 
following treatment of animals with a wide variety of drugs, pesticides, 
food additives, polycyclic hydrocarbons, and other xenobiotic compounds 
is now well documented (Conney, 1982; Ioannides et a [ . , 1984).
Classical inducers of microsomal enzymes, such as PB, PCB, and MC 
administered to rats for several days, increased the activities of hepatic 
drug metabolizing enzymes, but generally had no effect on other enzymes 
of the ER, such as G6P-ase, IDP-ase. By contrast hepatotoxic 
compounds such as CCI^, ethionine, and coumarin, which had little effect 
on drug-metabolizing enzymes, markedly decreased microsomal phospha­
tases (Feuer and Granda, 1970). The drugs and foreign compounds 
which induce microsomal enzymes have widely differing pharmacological 
activities, e .g . PB (hypnotic), DDT (pesticide), MC (carcinogen) and 
the only features they would all seem to have in common are that they 
are (a) lipid soluble and hence become localized in the ER of the liver, 
and (b) substrates of, or become bound to, the ER drug-metabolizing 
enzymes. This latter property appears to be an important criterion for 
enzyme induction, at least at translational level. The mixtures of 
chlorinated biphenyls (ArocIor-1254), are potent enzyme inducers, more 
potent than the same dose of PB and at least as effective as DDT 
(L itters t and Van Loon, 1972). I t  appears that Aroclor-1254 possesses 
the enzyme-inducing properties characteristic of both "drug" and 
"polycyclic carcinogens" type of inducing agent (Alvares et a L , 1973). 
Aroclor-1016 (16% chlorine), is a much less potent inducer of hepatic 
microsomal oxidations than Aroclor-1254 (54% chlorine) (Bickers et a L ,
1972).
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I t  is generally accepted that the ability of mammalian liver 
monooxygenase system to metabolize a remarkably wide range of xenobio- 
tics and endogenous substrates results from the participation of multiple 
forms of cytochrome P-450. Cytochrome P-450 has been solubilized, and 
the various isozymes isolated and purified to apparent homogeneity from 
ra t, rabbit, mouse, pig, and human liver pretreated with inducing
agents, or from untreated animals. These isozymes d iffe r in their 
physicochemical properties, immunological characteristics, amino acid 
sequences, substrate specificity, molecular weights, and enzyme kinetics 
(Lu and West, 1980; Kumar and Padmanaban, 1981). A t least four 
distinct forms of this enzyme in rat (Ryan et a L , 1982) and eleven of its 
different forms in rabbit livers have already been identified (Aoyama et 
a h , 1981). Multiple forms of the cytochrome P-450 have also been 
isolated from tissues other than liver, and two major forms (P-450 I and 
I I )  ( >70% tissue total hemeprotein content) have been isolated from 
rabbit-lung microsomes (Wolf et a [ . , 1978). Although both pulmonary 
forms of cytochrome P-450 metabolized benzo(a)pyrene, the products
d iffer; P-450 I I ,  but not I ,  catalyses its metabolism to intermediates 
which bind covalently to DNA (Wolf et a L , 1978, 1979).
The precise mechanism of induction of microsomal enzymes by drugs 
and xenobiotics has been fully elucidated and may involve enhanced
synthesis of new protein enzyme (Conney and Gilman, 1963), or reduced 
degradation or both (Bar-Nun et a L , 1980). Both PB and MC
administered to rats were found to stimulate hepatic RNA-poIymerase 
activity (Gelboin et a l . , 1967; Bar-Nun et a [ . , 1980; Kumar and
Padmanaban, 1981). I t  has been suggested that PB induction may 
result from genomal depression (Orrenius et a l . , 1965), and increased 
transcription (Ruddon and Rainey, 1970). Other workers have 
suggested that PB primarily affects the transcription of messenger RNA 
(Wold and Steele, 1969). As actinomycin D blocks the increase in the 
rate of synthesis of cytochrome P-450 by PB (Bhat and Padmanaban, 
1978), it appears reasonable to suggest that drugs act at the level of 
transcription. I t  has been shown that PB increased the rate of 
synthesis of NADPH2-cytochrome c reductase by membrane bound poly­
ribosomes within 3-4 hours following PB administration, but no increase
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was observed in the synthesis of this enzyme by free polyribosomes 
(Glazer and Sartorelli, 1972). PB greatly enhances the stability of rat 
liver polyribosomes, possibly by lowering ribonuclease activity (Cohen 
and Ruddon, 1971).
The classic inhibitors of drug metabolism, such as SKF 525-A and 
carbon monoxide, also inhibit the microsomal synthesis of cholesterol 
(Kato et a [ . , 1963), and the microsomal hydroxylation of cholesterol and 
steroid hormones (Astrup et a L , 1967). PB, a classic inducer of drug 
metabolism, similarly induces cholesterol biosynthesis (Mitoma et a l . , 
1968), cholesterol breakdown (Wada et a l . ,  1967), hydroxylation of cholic 
acids (Einarsson and Johnasson, 1969), the 3-hydroxylation of cortisol 
(Conney et a l . ,  1967) and the hydroxylation of testosterone (Conney and 
Klutch, 1963). In contrast, MC treatment has little or no effect on the 
steroid hormones (Conney, 1967).
The lipid component of membrane enzymes constitutes an integral 
part of their catalytic activity or regulatory action (Vessey and Zakim, 
1971; Omura, 1980; Harada and Omura, 1981; Vlasuk et a L , 1982). 
Perturbation of membrane lipids brought about by organic solvent, 
detergents, and phospholipase treatment altered enzyme properties, 
suggesting the importance of phospholipids in membrane function (Zakim 
and Vessey, 1975). In  particular, the synthesis of PC from PE and the 
breakdown of LPC were altered by various drugs. Modification by
inducers resulted in activation, whereas hepatotoxins elicited inhibition 
(Feuer et a L , 1972). Furthermore, PB treatment increased the
unsaturation of acyl derivatives of microsomal phospholipids while CCI^ 
treatment decreased unsaturation (Ilyas et a [ . , 1978b).
Many drugs and other foreign compounds bring about proliferation  
of microsomal membranes and increase enzyme activ ity , while other
substances independent of their chemical structure fragment these mem­
branes and inhibit enzyme action (Klaassen and Plaa, 1969; Ilyas et a l . , 
1978b). PB treatment particularly affects the synthesis of PC from PE 
by stepwise methylation (Davison and Wills, 1974b; Acheampong-Mensah 
and Feuer, 1975; Sastry et a [ . , 1981). The increase in microsomal 
phospholipid content by PCB administration is not caused by the
stimulation of synthesis, but rather due to the inhibition of the
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catabolism of membrane phospholipids (Ishidate and Nakazawa, 1976). 
3-Methylcholanthrene administration was shown to depress both turnover 
rate of total phospholipids and the formation of PC in microsomes
(Davison and Wills, 1974b). On the other hand, CCI^ inhibits both
synthesis and turnover rate of microsomal phospholipids (Cooper, 1973).
Since the synthesis of phospholipids is modified by drug  
treatments, it was of interest to determine their action on molecular 
composition of these species in the liver and microsomes. In  view of the 
dependence of mixed function oxidase system on the membrane phospho­
lipids, three inducers (PB, MC, PCB) and a hepatotoxic compound
(C C I4) were employed in this study.
MATERIALS AND METHODS
Animals. Male albino Wistar rats (Woodlyn Farm, Guelph, Ontario) 
weighing 200-220 g were housed in individual cages and maintained on 
laboratory chow (Purina Laboratory Chow, Ralston Purina C o ., St. 
Louis, MO) and water ad libitum. Animal quarters were well aerated, 
and air conditioned rooms were kept at 20 ± 2°C and 50-60% relative 
ambient humidity. Housing, experimental handling, and husbandry of 
animals were within accepted guidelines from the Animals for Research 
Act of Ontario, Canada. All rats were starved overnight to reduce liver 
glycogen before decapitation. There were four animals in each group.
Experimental Compounds. Compound administration was carried out 
with PB, 80 mg/kg body weight, dissolved in 0.85% saline solution, 2.5 
m l/kg, MC and PCB, 80 mg/kg body weight, dissolved in arachis oil, 2.5 
m l/kg. CCI4 was given at 5.2 mmol/kg, dissolved in arachis oil, 2.5 
m l/kg. Four daily i.p . doses of all compounds were injected. None of 
these compounds had any significant effect on food consumption. The 
animals received the last injection of these compounds 18 hours before 
sacrifice. All animals were sacrificed between 8 and 8:30 a.m . to 
minimize any possible difference due to diurnal variations in drug  
metabolism. Control animals received the appropriate vehicle only. No 
significant differences were found between the physiological saline and 
oil control group.
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Purina Laboratory Chow was analysed to confirm the fat content 
which agreed with the given values of 2%. Fatty acid analysis of chow 
diet was also carried out.
All tissue preparations and lipid analysis (phospholipid and fatty  
acids) were carried out as described earlier in Chapter 2. The 
reproducibility and precision of all the analysis were within the 90-95% 
range.
Chemicals. Carbon tetrachloride and sodium phenobarbital were 
purchased from British Drug Houses, L td ., Toronto, Ontario, Canada. 
Aroclor-1254 was donated by the Ministry of Environmental Research 
Laboratories, Toronto, Ontario, Canada. Cholesterol and triglycerides  
were supplied by Lipid Research Laboratories, Toronto, Ontario, 
Canada. 7-Ethoxyresorufin and resorufin were obtained from Pierce 
Chemical C o., Rockford, Illinois, U .S .A . 7-Ethoxycoumarin and 
coumarin were obtained from D r. G. Kakis, Department of Pathology, 
University of Toronto, Toronto, Ontario, Canada. All other chemicals 
were purchased from common commercial sources, and were of reagent 
grade. The sources of other chemicals used in the analysis are given in 
Chapter 2. Arachis oil was of edible quality.
Enzyme Assays
1. 7-Ethoxyresorufin O-deethylase A ctivity (EROD-ase). Assay of 
7-Ethoxyresorufin was carried out according to method described earlier 
(Burke and Mayer, 1974). The general reaction mixture contained 2.0  
ml of 0.1 M Tris bu ffer, pH 7 .8 , 10-50 ul of 25% microsomal suspension 
and 10 ul of ethoxyresorufin [50 uM in 1.25% (w /v ) Tween 80]. A 
baseline of fluorescence was recorded at an excitatory wavelength of 510 
'nm and an emission wavelength of 586 nm with a Luminescence Spectro­
meter Model LS-5 of Perkin-Elmer Corporation, U .S .A . with slit 
arrangement 1 mm (cuvette entrance), 0.5 mm (cuvette exit) and 3 mm 
(photomultiplier tube entrance). A 10 ul aliquot of NADPH (50 mM) was 
stirred into the mixture to start the reaction and the progressive 
increase in fluorescence, as ethoxyresorufin was deethylated to the 
resorufin, was recorded. The reaction was run in air at 37°C. The 
fluorimeter was calibrated with 10 ul of resorufin (0.01 M in ethanol).
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Solution of ethoxyresorufin was stored in the dark and the metabolic 
reaction was performed in a room with dim light.
2. 7-Ethoxycoumarin O-deethylase Activity (EC D-ase). 7-Ethoxycou- 
marin O-deethylase activity was determined by the method of Wiebel and 
Gelboin (1975). A stock solution of 140 mM ethoxycoumarin was 
prepared in dimethyl formamide. An aliquot was added to the microsomal 
suspension (2 .0  ml) to give a final concentration of 70 tjM. The hydroxy  
coumarin was measured fluorimetrically on Luminescence Spectrometer 
Model LS-5 oF of Perkin-Elmer Corporation, U .S .A ., using an excitation 
wavelength of 370 nm and an emission wavelength of 450 nm.
3. Other Enzymes. The activities of APDM-ase, G6P-ase and 
NADPH-cytochrome c reductase were assayed using the methods 
described earlier in Chapters 2 and 3.
Chemical Determinations. DNA and RNA (Schneider, 1957), protein 
(M iller, 1959) and cytochrome P-450 (Omura and Sato, 1964) were 
determined. Phospholipids were extracted using chloroform/methanol 
(2 :1 , v /v )  according to the method of Folch et al. (1957), and were 
separated by thin layer chromatography on silica gel using a solvent 
system composed of chloroform/methanol/water (25:15:2, v /v )  according 
to the method of Skipski et aL (1962). The details of separation and 
extraction procedures are mentioned in Chapter 2. The recovery of 
fatty acids from both the total lipids and phospholipids by gas 
chromatography was consistently 90-95% for samples as compared to the 
known mixtures of fatty  acids. The precision of this method of analysis 
was found to be excellent.
Phosphate content of samples was measured by using the method of 
Bartlett (1959). The recovery of lipid phosphorus from thin layer plates 
was consistently 85-95% for samples both from control and induced 
animals.
Cholesterol Determinations. Cholesterol was determined by using 
the method of Rudel and Morris (1973) as follows: 0.1 ml of microsomal
suspension was mixed with 0.3 ml of 33% KOH and 3 ml of 95% ethanol. 
The tube was then stoppered and placed in a water bath at 60°C for 15 
minutes. A fter cooling, 5 ml of petroleum ether and 3 ml of water was
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added. The tube was then capped and shaken for 60 seconds to extract 
cholesterol. One ml of the petroleum-ether phase was pipetted into 
another tube and solvent evaporated under N2. Subsequently, 2 ml of
0-phthalaldehyde solution (50 mg/100 ml glacial acetic acid) was added, 
followed 10 minutes later by 1 ml of concentrated H2S 0 4. The 
absorbance at 550 nm was determined 10-20 minutes after the addition of
1-^SOt*. A blank and cholesterol were saponified and extracted. The 
triglycerides were estimated by the method of Bucolo and David, 1973).
Statistical Analysis. Statistical tests included Student's t  test 
(Snedecor and Cochrane, 1967). Each result represents the means ± 
S .E .M . of four measurements. The percentage of recovery from gas
chromatography was computed by a rapid method (Fross, 1968). 
Significant differences were accepted at p < 0 .0 5  or p <  0.005.
RESULTS
Liver Weight
The liver of rats treated with PB and PCB showed significant
increases in weight, whereas no change was observed in animals treated 
with MC. CCl^ treatment decreased liver weights (Table 1 ). Expressed 
as percentage of body weight, the PB and PCB treated livers were 
respectively 25% and 30% larger than the controls.
Nucleic Acids and Protein Content
In the whole liver, RNA content was increased by PB, PCB, and
MC treatments. Protein content did not change. Assuming that the
treatment does not significantly affect the degree of liver hyperploidy, 
the DNA content can be used to compare the number of cells per g liver 
of treated and control animals. Induction by PB, PCB, and MC had 
essentially no effect on the amount of DNA/g liver (Table 1 ), so that the 
liver hypertrophy caused by PB and PCB probably results from the 
proliferation of subcellular organelles, particularly of the ER. The 
induction by PB and PCB is fu rther indicated by the increased conent of 
RNA and protein of microsomes. MC increased the RNA content without
TA
BL
E 
1. 
EF
FE
CT
 
OF
 
FO
RE
IG
N 
CO
M
PO
UN
DS
 
ON
 
BO
DY
 
W
EI
G
H
T,
 
LI
VE
R 
W
EI
G
H
T,
 
P
R
O
TE
IN
, 
NU
CL
EI
C 
A
C
ID
S
 
C
H
O
LE
ST
ER
O
L,
 
TR
IG
LY
C
ER
ID
ES
 
AN
D 
PH
O
SP
HO
LI
PI
D 
CO
M
PO
SI
TI
O
N 
OF
 
LI
VE
R 
IN 
TH
E 
MA
LE
 
R
A
TS
*
115
4- 4-
o
o
4- 4- 4— 4-4-4- 4—4—
cn£4=r cnCOCMCN crcn 00toin r—O. . • r — . . . . • • . CMCN
=r© o COCO T— *— o CNo
4141 41 41414141 4141 414141 4141
O O cn £4 tO cn CO toin 00 in
. . . 00 . . • . . . • cn in
COCO£4 CN CNT— i n to toCOin in £4
cn CO T— T— CO
o
4-
COto CO © r—to cn cn to CN T— IN £4. . . CN r— . • . . . . • T— r“
LO o o o CO o © r—COO
414!41 41414141 4141 414141 4141
£4 CO in O to 00 to CO o £4 to 00. ■ • CM£4 . . . • . . • 00 CM
in o £4 CNT*“ CN o to o COto cn £4 CO
CN r— £4 «— CMLD
4-
GQ
o
Q.
00Q.
4- 4- 4- 4- 4- - 4- 4- 4- 4- 4-
£4 C1 £4 cn 00 £4 CN CO in in CO ro cn in. • . T— • . . • • • • r— CN
CO © O O in *— *— r--cn r-
41 41 41 41 41 41 41 41 41 41 41 41 41 41
in in 00 cn IN in cn CN £4 cn CO £4 cn CO• • . CM £4 . . . . . . . 00 CN
to CM in CN r— CM o in CO in in CO CO £4r— to T— CM in t—
CN
0L in *5—
4- 4- LU 4- 4- 4- LU 4~ 4- 4- 4- 4-
to 00 co > in © CO 00 CO cn 5 O r— CN to co• . . hh T— r— • . • • o . • • r— CN£4 o o -1 © £4 o o C/1 CN £4 T~
41 41 41 LU 41 41 41 41 41 41 oQZ
41 41 41 41 41
r— in in o CO CD to £4 00 cn (J <n IN o r— in
• • . “T“ CO £4 . • • . b—t . . . o cn00 !—1in _L. CN t— CM cn in CM 5 to 00 CO £4 CO
o r— in T— CMin
Os_+j
CoU
COCOCM £4 o CN to CM CO © to O 00 to• . • t—■ r- . • • • . • . r— r—
COo o O CO t- O T*“ COT—
414141 41414141 41 41 414141 41
IN
41
O
00 in£4 £4 CN£4 oo cn o CNin in T-« . in r— • . • • . . .. £4 CO
to cn £4 CMr—CMCM to  cn o COoo
CM £4 CN£4
CN
a 
E coi_
CO 
CL CO
T5D
SI
U l 
0 
U) £
4_l 4-> ^
o
.S’.S'.a0  0  
£ 5 cn^ o
> s  ^  °
O •- Cl co _j v-i
cn
cn
E
U l
'ui U)
V)—*T3 7?. 0
2 * a - ? o 5  
o — t-c  O _ 0 0 u>S’0 S’ —  
£ < <  S 3  0 . 5 *£ Z 2 £ W £  l. 
CL 0^ Q  CL U h
cn
05
D ig ,
sv_  __ Ul
'T3 to 0
? a ^ o 2  
? ?  a o
“ a |  S >•
; < § | o ®  c z s z ^ s :  i- 
Q. OC CL O h
c
*0+Jo
Va
lu
es
 
are
 
ex
pr
es
se
d 
as 
m
ea
ns
 
± 
S
.E
.M
. 
of 
fo
ur
 
ra
ts
 
in 
ea
ch
 
gr
ou
p.
 
Va
lu
es
 
di
ffe
r 
si
gn
ifi
ca
nt
ly
 
fro
m 
co
nt
ro
l; 
f 
p<
 
0.
05
; 
tf 
p<
 
0.
00
5.
116
any change in the protein level. In  contrast, CCI4 decreased both RNA 
and protein contents in the microsomes (Table 1 ).
j
Lipid Composition
In the whole liver, PB, PCB, and CCI^ treatments significantly 
increased the triglyceride contents. MC treated animals did not show 
any change. Cholesterol levels remained unchanged. However, in the 
microsomes, cholesterol content was decreased by PB and PCB 
treatments, while triglycerides were increased by PB, PCB, and CCI4 
treatments. Phospholipid contents were increased by both PB and PCB, 
although more profound changes were observed by PCB inductive effect 
than PB. In  contrast, CCIj* decreased phospholipid content, while no 
change was observed by MC treatment (Table 1).
Enzyme Activities
I t  is evident from the results in Table 2 , that the APDM-ase 
activity significantly increased in PB ( HO^ p < 0 .0 0 5 ) ,  PCB (1 4 6 %  
p < 0 .0 0 5 ) and MC ( 43% p <  0.05) treated animals. In  contrast, CCI^ 
treatment reduced the activity (.64% p <  0 .005). The inductive actions 
of PB, PCB, and MC did not affect G6 P-ase activity while CCI^ treatment 
decreased the activ ity . MC profoundly increased EROD-ase activ ity , 
while PCB caused an induction of this enzyme to a lesser extent. 
Similarly, PCB and MC treatments both equally induced ECD-ase activ ity . 
The EROD-ase activity is an apparently more specific and sensitive assay 
for P-448 induction, as observed under these experimental conditions. 
PB and CCI^ did not affect the deethylase activities. PB, PCB and MC 
treatments increased cytochrome P-450 or P-448, while CCIH treatment 
caused a decrease. NADPH cytochrome c reductase activity was 
enhanced by PB and PCB treatments and decreased by CCI^. These 
increases by PB and PCB treatments together with the expected 
increases in liver weights, confirm the maximum induction. On the other 
hand, administration of CCI^ decreased the enzyme activities and 
cytochrome P-450 content, which confirms the inhibition of drug  
metabolism.
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Phospholipid Composition
The results in Table 3 show that PB treatment significantly 
increased the PC {61% ,  p <  0.005) and LPC (5 0 % ,p < 0 .0 5 )  contents
while it reduced the SM content (25*%, p 4  0 .05 ). Similarly, PCB
treatment increased the PC ( £<%, p <  0.005) and LPC ( 5o/i^  p <  0.05) 
and reduced the SM content [5oZ j  p <  0 .05 ). I t  is evident from these 
results that the induction by PB and PCB enhances the total 
phospholipid content of microsomes mainly due to increases in the choline 
containing phospholipids while MC induction increases the PE content. 
SM content is reduced by all the inducing agents employed in this 
study. On the other hand, CCI^ reduced all the individual 
phospholipids except the PS content.
Fatty Acid Composition
Whole Liver
As observed from Table 4, PB treatment significantly reduced the 
total fatty  acid content from control group. Arachidonic acid was 
reduced together with other minor acyl derivatives. PCB treatment
significantly increased palmitic, palmitoleic, oleic, Iinoleic, and 
arachidonic acids. MC treatment did not effect the acyl derivatives. In  
contrast, CCI4 treatment caused a two-fold increase in the contents of 
palmitic, oleic and Iinoleic acids, as well as significantly increased the 
palmitoleic and docosahexaenoic acids.
Total amount of fatty  acids was decreased by PB and increased by
PCB and CCI^ treatments. The ratio of saturated to unsaturated fatty
acids was altered from 40/60 in controls to 42/58 with PB, 39/61 with
PCB and C C ^; and 43/57 with MC treatment.
Liver -  Phosphatidylcholine
The acyl derivatives of liver PC were modified by the inductive 
actions of PB and PCB. PB treatment decreased palmitic acid, while
increased stearic acid content. PCB treatment caused a two-fold
increase in the contents of oleic and Iinoleic acids, while significantly 
increased palmitic, stearic, arachidonic and docosahexaenoic acids.
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The total content of fatty acids was significantly increased by PCB 
treatment and decreased by CCI^ treatment. Neither PB nor MC 
treatments affected the total amounts. The saturated and unsaturated 
fa tty  acid ratio was modified from 43/57 in controls to 40/60 with PB, 
38/62 with PCB and 48/52 with CCI^ treatments. MC treatment showed 
no change in the ratio (Table 4 ).
Liver -  Phosphatidylethanolamine
Total amount of fatty acids was increased by PB and PCB 
treatments while no change was observed by MC and CCI^ treatments in 
the liver PE fractions. The relative amounts of saturated versus 
unsaturated fatty  acids were modified resulting in altered ratios 
(controls, 47/53; PB, 42/58; PCB, 42/58, MC, 46/54; C C ^ , 55/45 
(Table 4 ).
Liver Microsomal Preparation
The administration of test compounds significantly altered the fa tty  
acid composition of the endoplasmic reticulum. As shown in Table 5, PB 
treatment caused a two-fold increase in the contents of stearic, Iinoleic, 
and arachidonic acids while significantly increased palmitic, palmitoleic, 
oleic and docosahexaenoic acids. PCB treatment significantly increased 
palmitic, palmitoleic, stearic, and oleic acids while a three-fold increase 
was observed in Iinoleic and arachidonic acids. MC treatment did not 
affect these acyl derivatives. In  contrast, CCl4 administration reduced 
the total amount. The ratio between saturated and unsaturated fatty  
acids was modified from 43/57 in controls to 46/54 with PB, 37/63 with 
PCB, 44/56 with MC and 49/51 with CCI^ treatments.
Microsomal -  Phosphatidylcholine
In the PC fraction of microsomes, PB administration increased oleic, 
Iinoleic, arachidonic, and docosahexaenoic acid contents. PCB treatment 
increased stearic, oleic, arachidonic and docosahexaenoic acids, while a 
three and two-fold increase was observed in palmitoleic and Iinoleic 
acids, respectively. MC treatment did not show any change. In
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contrast, CCI^ decreased oleic, Iinoleic, arachidonic and docosahexaenoic 
acids.
PB and PCB administration increased the total amount of fatty  
acids. No change was observed by MC and CCI^ treatments. The 
relative amounts of saturated and unsaturated fatty acids were modified 
by these experimental compounds, thus the ratios were altered between 
saturated and unsaturated fatty  acids (control, 43/57; PB, 40/60; 
PCB, 34/66; MC 41/69; CCI^, 51 /49).
Microsomal -  Phosphatidylethanolamine
PB administration increased the contents of palmitoleic, oleic, 
Iinoleic, arachidonic, and docosahexaenoic acids in the PE fraction of 
microsomes. PCB treatment caused a two-fold increase in the contents of 
palmitic, oleic and docosahexaenoic acids, while a three-fold increase was 
observed in palmitoleic and Iinoleic acids. Stearic and arachidonic acids 
also increased significantly. In  contrast, CCI^ treatment decreased the 
contents of palmitoleic, oleic, Iinoleic, arachidonic and docosahexaenoic 
acids, while stearic acid was increased. MC treatment mainly affected 
the acyl derivatives of this fraction by increasing palmitic, palmitoleic, 
stearic, oleic, and docosahexaenoic acids.
Total amount of acyl derivatives was increased by PB and MC 
treatments, while a two-fold increase was observed by PCB administra­
tion. In  contrast, CCI^ treatment decreased the total fatty  acid content. 
The ratios between saturated and unsaturated fatty  acids were modified 
by these experimental compounds, thus resulting in altered ratios 
(control, 46/54; PB, 38/62; PCB, 42/58; MC, 49/51; CCI^, 58 /42).
DISCUSSION
Cell Proliferation
The liver of the rats treated with PB and PCB increased by 25% 
and 30% in weight (as expressed as a percentage of body w e ig h t). In  
the case of PB, each individual hepatocyte appears to increase initially  
in size and only later in the induction process is the total number of 
hepatocytes increased (Ernster and Orrenius, 1965; Koransky and
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Schulte-Hermann, 1970). MC treatment did not cause liver hypertrophy  
(Conney, 1967), while CCI^ decreased the liver weight by 9% (Cooper,
1973). Trans-stilbene oxide has been shown to increase the number of 
hepatocytes without affecting their size (Suzuki et a l . ,  1980). PCB has 
also been reported to increase the number of hepatocytes and 
degeneration of focal areas of the liver (Kimbrough and Linder, 1974).
Hypertrophy of the Endoplasmic Reticulum
A t the same time, PB and PCB treatments cause more than two-fold 
increase in the phospholipid content of the liver endoplasmic reticulum 
(Ernster and Orrenius, 1965; Ishidate and Nakazawa, 1976). I t  has 
been suggested that the increase in total microsomal phospholipids caused 
by PB results from increased phospholipid biosynthesis (Orrenius et a [ . , 
1965) and/or decreased breakdown (Eriksson, 1973); while the increase 
caused by PCB seems to result from inhibition of phospholipid catabolism 
(Ishidate and Nakazawa, 1976). Although no significant increase in the 
total phospholipid content has been observed by MC treatment, an 
increase in PE content was noted. CCI4 treatment caused a 44% decrease 
of phospholipid content in microsomes (Table 1) which was confirmed by 
a reduced composition of various phospholipid constituents (Table 3 ) . 
The present results agree with earlier studies by Sastry et al. (1981).
I t  is tempting to speculate that an increased bilayer area might be 
required to accomodate the increased amounts of microsomal d rug- 
metabolizing enzymes that result from induction. Thus induction of 
these enzymes by PB and PCB should increase the protein content of the 
endoplasmic reticulum by approximately 30-34%. Indeed, induced 
microsomes do contain 26% more protein per g liver than do control 
microsomes (SeidegSrd et a l . , 1977). These values are in approximate 
agreement with the observed 50% increase in the phospholipid content of 
the endoplasmic reticulum (Table 1 ).
Induction of Drug-Metablizing Enzymes
As cytochrome P-450 and P-448 have widely different substrate 
binding sites and show markedly different substrate specificities (Table 
2 ) ,  they may be considered as two distinct enzyme proteins rather than
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isozymes of the same enzyme (Bidelman and Mannering, 1970). Hepatic 
microsomes from MC-pretreated rats incubated with biphenyl (which 
displaces ligand from heme) (Delaforge et a l . , 1982), showed a 25% 
increase in the amount of cytochrome determined as the CO reduced 
complex, although no such effect was observed when microsomes from 
PB-pretreated rats were used. These observations indicate that MC, or 
a metabolite, is associated with the sixth ligand of the heme moiety of 
the hemeprotein. Electron spin state studies have shown that two forms 
of P-448 are formed when rats are treated with MC, one low-spin and 
one high-spin form (Ryan et a L , 1975); addition of MC to the low-spin 
converted it to the high-spin form demonstrating that the latter is a 
complex of the cytochrome with the carcinogen. This association of MC 
with the sixth ligand of the heme could affect the conformation of the 
‘heme-pocket1 and of the substrate-binding site, and thus account for 
the different substrate specifications of cytochrome P-450 and P-448 
(Phillipson et a L , 1982). I t  appears that cytochrome P-450 possesses 
one substrate-binding site of broad specificity which can accomodate a 
diversity of substrates, while cytochrome P-448 possesses a different 
binding site exhibiting narrow specificity (Dus, 1982). The results of 
the present work support this hypothesis (Table 2 ) .  MC and PCB (the  
inducers of P-448) especifically enhance the ethoxyresorufin and 
ethoxycoumarin 0-deethylase activities. However, the sensitivity and 
specificity of ethoxyresorufin 0 -deethylase assay for carcinogens 
reported earlier by Ioannides et aL (1984) agree with the results in 
Table 2 .
Cytochrome P-448 is undoubtedly induced by de novo synthesis 
following treatment of animals with MC and other substrates. 
Furthermore, a cytosolic binding protein for MC and similar inducing 
agents has been identified (Slaga et a L , 1973) and the intracellular 
appearance of an inducer-receptor complex has been shown to correlate 
well with induction of cytochrome P-448 mRNA (Tukey et a L , 1982). 
Induction of cytochrome P-448 appears to depend on this cytosolic 
receptor (Nebert et a [ . , 1981). On the other hand, PB and PCB
treatments lead to increased levels of several other microsomal proteins 
such as NADPH-cytochrome c reductase (Orrenius et a L , 1965) and
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epoxide hydrase (Thomas et a L , 1979), as well as cytosolic enzymes 
such as glutathione-S-transferase (Fleischner et a l. ,  1972) and aldehyde 
dehydrogenase (Dietrich et a L , 1977). Increased levels of translatable 
cytochrome P-450 mRNA in PB-treated rats (Bhat and Padmanaban, 1979) 
up to 100-fold justifies further studies on the induction process related 
to the involvement of transcriptional and/or post-transcriptional 
mechanisms.
Hepatotoxicity
CCI4 administration decreased the APDM-ase and NADPH-cytochrome 
c reductase activities parallel with decreased content of cytochrome 
P-450. G6P-ase activity was decreased as well (Table 2 ). As reported 
earlier (Feuer and Granda, 1970), such a disturbance in microsomal 
phosphatases may serve as a biochemical marker for the early detection 
of liver toxicity. Simultaneous administration by inducing agents such 
as PB abolished the effect of CCI^ on G6 P-ase activ ity . These 
observations suggest a common site of action in the mediation of the 
responses of the hepatic endoplasmic reticulum to treatments with both 
hepatotoxins and inducers of drug-metabolizing enzymes.
Cholesterol Content of the Endoplasmic Reticulum
In agreement with the present findings, Davison and Wills (1974b) 
have reported that induction with PB decreased the proportion of 
cholesterol in the liver microsomal fraction to 73% of the control value. 
I t  is known that smooth microsomes are richer in cholesterol than rough 
microsomes (Colbeau, 1971) and that PB causes proliferation of the
smooth portion of the endoplasmic reticulum (Ernster and Orrenius, 1965; 
Ilyas et a L , 1978b). PCB treatment also significantly decreases 
cholesterol in the microsomes. CCI^ on the other hand, increases the 
microsomal content of cholesterol. Many studies suggest that cholesterol 
interacts with membrane phospholipids and renders the bilayer more 
condensed, rig id , and resistant to temperature changes (Darke et a [ . ,
1972). Cholesterol appears to interact with neutral phospholipids in the
following order of affin ity: SM >  PC >  PE (Demel et a [ . , 1977). This
preferential interaction of cholesterol with SM is very interesting in
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connection with the observation that PB and PCB treatments lower the 
contents of both SM and cholesterol in the endoplasmic reticulum (Tables 
1 and 3 ).
Lipid Peroxidation of the Endoplasmic Reticulum
The lipid peroxidation of liver in jury has been proposed as a 
mechanism responsible for the hepatotoxicity of a variety of chemical 
agents such as CCI^, hydrazine, ethanol, and phosphorus (Recknagel et 
a l . , 1974). Increased peroxidation results in the destruction of
phospholipid-containing intracellular membranes which may lead to 
triglyceride accumulation and cellular necrosis. The results in Table 1 
confirm this finding of triglyceride accumulation in CCI^ treatment. PCB 
and PB treatments also showed similar accumulation of triglycerides. PB 
was shown to increase the diene conjugation absorption of microsomal 
lipids (Hahn et a l . ,  1976) and to increase by 5-fold in malonyldialdehyde 
production. PB and PCB are known to induce NAD PH-cytochrome c 
reductase which is the enzyme required for NADPH-dependent enzymatic 
lipid peroxidating system (Conney, 1967). The mechanisms of 
peroxidation by CCI^ are d ifferent from these inducing agents. Free 
trichloromethyl radicals (*C C I3) produced from CCI^ (Nastainczy et a l . ,
1982) covalently binds to the heme and protein moieties of cytochrome 
P-450 (Fernandez et a L , 1982), thus damages the P-450 mixed function 
oxidases (Table 2 ) .  The early site of injury in CCI^ toxicity is the liver 
endoplasmic reticulum where CC^ is activated by the drug-metabolizing 
enzyme system to the free radical. This free radical, in tu rn , triggers  
peroxidative breakdown of lipids constituting the microsomal membranes, 
accompanying various biochemical and structural alterations such as loss 
of glucose-6 -phosphatase activity (Table 2 ) .
Phospholipid Composition of the Endoplasmic Reticulum
In agreement with the findings of the present work, several authors 
have reported that treatment of animals with PB (Davison and Wills, 
1974b; Ishidate and Nakazawa, 1976; Sastry et a [ . , 1981), PCB
(Ishidate and Nakazawa, 1976) and CCI^ (Cooper, 1973) affect 
phospholipid composition of liver microsomes. The maintenance of the
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characteristic phospholipid composition may be indispensible to the 
performance of various functions of the endoplasmic reticulum. The one 
consistent change in phospholipid composition caused by the inducing 
agents employed in these studies is a decrease in the content of SM; 
this is also the case for trans-stilbene oxide (Suzuki et aJ. ,  1980). 
CCi^ treatment did not affect the content of SM.
MC and PCB administration inhibit the synthesis of choline-con­
taining phospholipids at the site of CDP-choline formation (Davison and 
Wills, 1974b; Ishidate et a l . , 1978). However, PC may also be formed 
through the N-adenosylmethionine dependent methylation of PE. There 
are some reports that this methylation activity is increased in the 
induced state and that the content of PC is controlled by this reaction 
(Sastry et a [ . , 1981). I t  seems likely that the increased activity of the 
methylation pathway can compensate for the decreased synthesis of PC 
via CDP-choline; so that the only net result of diminished CDP-choline 
formation is a decrease in the relative content of SM in PB -. PCB-, and 
MC-induced microsomes. The SM was dec'tea&eJi by So°/to in PCB-induced 
microsomes as compared to control p^oo]=>. (Table 3 ). This suggests that 
inhibition of CDP-choline formation is more profound in PCB-treatment. 
A similar reduction by trans-stilbene oxide has been reported (Suzuki et 
a l. ,  1980).
The administration of hepatotoxins decrease the microsomal 
phospholipids. The incorporation of (M e-1IfC) methionine into PC is 
decreased with the administration of CCI^ and other toxic compounds 
(Cooper, 1973). A decreased activity of methyl transferase by CC^ 
treatment has also been reported (Feuer et a L , 1974).
Fatty Acid Composition of the Endoplasmic Reticulum
The properties of phospholipids are also greatly influenced by the 
nature of fatty-acyl groups they contain. Relative to other subcellular 
fractions, microsomes are rich in essential fatty  acids ( i . e . ,  the total 
contents of Iinoleic acid and polyenoic acids containing 20 or 22 carbon 
atoms). The polyenoic acid content of phospholipids is of special 
interest in several aspects.
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Administration of PB results in a two-fold increase in the content of 
Iinoleic and arachidonic acids in the microsomes. Similarly, the contents 
of these acids increased in the PC and PE fractions of the microsomes. 
All of these increases contributed to a two-fold increase in the total 
content of fatty acids in microsomes (Table 5 ).
A three-fold increase in the content of Iinoleic and arachidonic acids 
was observed in microsomes of PCB-treated animals. In  the PC and PE 
fraction of microsomes, a major increase in these fa tty  acids was 
observed. Palmitoleic acid was increased three-fold in both PC and PE 
fractions. A two-fold increase in the total fatty  acid content in 
microsomes may be attributed due to these changes.
MC treatment only affected the fatty  acids in the PE fractions in 
the microsomes. Palmitic, palmitoleic, stearic, and oleic acids were 
increased in PE which raised the total fatty  acid content of this fraction.
CCI^ treatment consistently decreased the unsaturated acids in total 
microsomes and phospholipid fractions. The total content of fa tty  acids 
was reduced (Table 5 ).
Several discrepancies exist in the literature concerning the effects 
of drugs on the fatty  acid composition of microsomes. Davison and Vi/ills 
(1974b) found that PB progressively increases the Iinoleic acid content of 
microsomal PC and PE, and decreases their contents of oleic, arachi­
donic, and docosahexaenoic acids. They also found that MC treatment 
raised the oleic acid content by 26% and 8% in PC and PE, respectively.
Other researchers have failed to confirm these changes in the fa tty  acid
composition of d ifferent microsomal phospholipids after PB treatment 
(Ariyoshi and Takabatake, 1972; Ilyas et a L , 1978b; Mounie et a [ . ,
1983).
Fatty acid side chains are also essential in phospholipids 
participating in transfer reactions (Glomset, 1962; Higgins and Barnett,
1972). Therefore, changes in phospholipid moieties attached to the
endoplasmic reticulum membranes might also reveal the mechanism 
whereby foreign compounds act. Moreover, fatty acid changes might 
provide an answer to the role of phospholipids in induction or inhibition 
of enzyme activities.
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The fatty  acid composition of microsomes can also be altered by 
giving animals a diet deficient in essential fatty  acids. Kaschnitz (1970) 
reported that such a diet caused a 43% decrease in the drug-hydroxyla- 
ting activity of microsomes and a 27% decrease in the content of 
cytochrome P-450. A marked decrease in the microsomal content of 
arachidonic acid was also observed and concluded to be at least partly  
responsible for the changes in enzyme activ ity . Moreover, compositional 
changes in the fatty  acids of microsomal phospholipids have also been 
shown to occur as a result of dietary changes during induction which 
modified the activity and substrate selectivity of the microsomal enzyme 
system (Mounie et a [ . , 1983).
In  these findings, a decrease in the saturated/unsaturated
ratio in the microsomes was observed due to major affects on the 
unsaturation of acyl-derivative of PC fractions. On the other hand, MC 
affected saturated acyl components in the PE fractions only. These 
findings agree with earlier suggestion by Becker et aL (1978) that 
induction of cytochrome P-^50 by MC may require membrane proliferation  
with saturated fatty acids. Other observations, e .g . ,  that the fa tty  
acid composition of microsomal phospholipids does not change after 
injection of arachis oil (Davison and Wills, 1974a) and that essential fa tty  
acids are preferentially esterified to position 2 of phosphoglycerides, also 
suggest that arachidonic acid may be essential to the function of ER 
membranes.
There is considerable evidence that the specific fa tty  acid 
structures of phospholipids are produced by re-arrangement of the acyl 
group subsequent to the de novo synthesis of the molecule (Lands and 
Merkl, 1963). In  particular, arachidonic acid is known to be introduced 
into phospholipids by deacylation-reacylation mechanism (Treshella and 
Collins, 1973). However, treatment of PB had no effect on the specific 
activities of monoacyl-phosphoglyceride acyltransferase and of acyl-CoA  
hydrolase (Elligson et a L , 1970). I t  was concluded that the changes in 
fatty acid composition caused by this drug probably result from changes 
in the availability of precursors for acyl-CoA synthesis.
The function of the polyunsaturated fatty  acids in phospholipids is 
not known with certainty, although they are related to the physical
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properties of molecules with double bonds. In  phospholipids, the 
unsaturated fatty  acids are esterified in position 2 of the glycerol 
skeleton. This particular position appears to be essential in enzyme 
reactions when fatty  acid is transferred to other molecules (Glomset,
1962; Higgins and Barnett, 1972). Polyunsaturated chains also take 
part in the association of substrates to enzymatically active sites 
depending on the membrane flu id ity . The inductive actions of PB, PCB, \
and MC, as well as the inhibitory action of CCI^ on phospholipids and 
corresponding changes in the microsomal drug-metabolizing enzymes, 
indicate that the integrity and function of the endoplasmic reticulum in 
the liver is highly dependent on lipid entities. Naturally-occurring PC 
forms highly fluid lipid regions whereas SM induces high rig id ity within 
membrane lipid bilayers (Shinitzky and In b ar, 1976).
Membrane Fluidity and Biological A ctiv ity
Three of the most important determinants of membrane flu id ity  are 
the molar ratio of cholesterol: phospholipid, the degree of unsaturation 
of the acyl chains in the membrane phospholipids, and the molar ratio of 
SM and PC (Borochov et a l . , 1977). The close connection between 
membrane lipids and drug action is well documented (Feuer e t a [ . , 1974; 
Sanderman J r . ,  1978). Recent evidence indicates that fatty  acid 
deficiency modifies the flu idity of the microsomal membrane and 
apparently the co-operativity of the enzyme activity (Castuma and 
Brenner, 1983). The contrasting effect of CCI^ on these three 
determinants may cause an appreciable increase in the membrane 
microviscosity. With the MC-inductive action in the endoplasmic 
reticulum, there was no significant change in cholesterol: phospholipid 
ratio or unsaturation in the membrane phospholipids, but SM was 
decreased bg 2.5% . . Increased flu id ity or decreased microviscosity may 
affect more subtle features of the drug metabolism such as cytochrome 
b5, NADH-cytochrome b5 reductase, epoxide hydratase, UDP-glucuronsyl 
transferase etc. The initiation of the action of foreign compounds may 
intrinsically be associated with a change in the synthesis and disposition 
of the structural elements integrating the lipid moiety within the 
endoplasmic reticulum.
CHAPTER
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DISCUSSION AND CONCLUSIONS 
FUNCTIONS OF LIPIDS IN THE ENDOPLASMIC RETICULUM
Investigations on lipid modei membranes have been found very  
useful for the understanding of structure and function of biological 
membranes in general (Stier et a [ . , 1976; Ruckpaul et a L , 1982;
Stubbs and Smith, 1984). The hepatic endoplasmic reticulum in ra t, like 
other cellular membranes, contains considerable amount of lipids, 
especially phospholipids with high proportions of unsaturated fa tty  acids 
(De Pierre and Dallner, 1975; Rowe and Wills, 1976; Hammer and Wills,
1979). The lipid component of the endoplasmic reticulum is associated 
with different functions of the membrane (Lands et a [ . , 1982; Hill et 
a L , 1983). Among the various classes of phospholipids, the
phosphatidylcholine fraction is an essential component of the hepatic 
microsomal mixed function oxidase system (Strobel et a L , 1970).
Phosphatidylcholine is required for full enzymic activity in the 
reconstituted solubilized component enzymes (Lu et a L , 1974; Iyanagi et 
a [ . , 1978). Non-ionic detergents, such as Triton X -1 0 0 , can replace 
phosphatidylcholine in the reconstituted mixed function oxidase system
(Lu et a [ . , 1974), which suggests that phosphatidylcholine has
physicochemical role in coupling of the cytochrome P-450 with its 
reductase (De Pierre and Dallner, 1975; Stier et a [ . , 1976). The data 
from this study demonstrates that aminopyrine N-demethylase and 
coumarin 3-hydroxylase activities are directly related to the phospholipid 
content of the microsomes (Table 3 in Chapter 2 ). The S-adenosyl-L- 
methionine: microsomal-phosphatidylethanolamine methyl transferase
activity gradually increases during development and decreases during  
pregnancy parallel to aminopyrine N-demethylase and coumarin 
3-hydroxylase activities in the current study (Table 1 in Chapter 2 and 
Table 4 in Chapter 3 ). This may suggest that phosphatidylcholine is 
necessary for optimal activity of mixed function oxidase system m vivo  
as well.
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I t  has been repeatedly shown that the lipid composition of the 
endoplasmic reticulum membrane is easily modified by physiological and 
non-physiological factors (Lippiello et a L , 1979; Brenner et a l . , 1981) 
and it undergoes circadian changes (Actis et a [ . , 1973). Considering 
that the endoplasmic reticulum represents a lipid-protein macromolecule, 
one of the most important problems is to understand and explain the 
intimate mechanism of function of this membrane dependent on lipid- 
protein interactions. These relationships may evoke conformational 
changes in the enzymic activity involved, thereby altering the kinetic 
properties of the membrane enzymes. The present study demonstrates 
that changes in phospholipid fatty  acids are intricately involved with the 
enzymic activities in the hepatic endoplasmic reticulum of ra t. I t  seems 
that distinctive species of phospholipids containing Iinoleic acid in the 
3 -position are necessary for liver mixed function oxidase activity  
(Davison and Wills, 1974a). In  this study the Iinoleic acid content 
fluctuates under different conditions and correlates with an increased or 
decreased ratio of saturated to unsaturated fatty  acids in phosphatidyl­
choline and phosphatidylethanolamine fractions of the endoplasmic 
reticulum (Table 5 in Chapter 2 , Tables 7 and 8 in Chapter 3 and Table 
5 in Chapter 4 ). Furthermore, this change also corresponds with 
changes in the aminopyrine N-demethylase and coumarin 3-hydroxylase  
activities (Table 1 in Chapter 2 , Table 4 in Chapter 3 and Table 2 in 
Chapter 4 ). Among the polyunsaturated fatty acids, eicosatrienoic, 
arachidonic and docosahexaenoic acids are altered during pregnancy and 
development of ra t. The results in the present work generally agree with 
the previously reported studies relating fatty  acid composition of 
phospholipids with drug-metabolizing enzyme in the ER (Actis et a [ . , 
1973; Davison and Wills, 1974a; Lambert and Wills, 1977; Becker et 
a l . , 1978; Hammer and Wills, 1979; Holloway and Garfield, 1981;
Castuma and Brenner, 1983).
Dietary lipids also affect cytochrome P-450 concentrations and the 
rate of oxidative drug metabolism in rat liver; these were lowest on a 
fa t-free  diet, higher on a diet containing 10% lard (saturated and 
monounsaturated fatty  acids, with 6% Iinoleic acid), and highest on a diet 
containing 10% corn oil (50% Iinoleic acid) (Rowe and Wills, 1976). I t
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seems that diet containing corn oil incorporates Iinoleic acid and 
arachidonic acid into liver microsomal phospholipids (Norred and Wade, 
1972; Century, 1973), with corresponding increases in mixed function 
oxidase (Norred and Wade, 1973). Thus dietary Iinoleic acid is 
important in maintaining the normal levels of hepatic microsomal enzyme 
activities. In  the present study purina rat chow diet was fed to rats 
containing oleate (32% of the total fatty  acids) and linoleate (10% of the 
total fatty  acids) as major dietary source which may not effect drastically  
the linoleate concentration in the endoplasmic reticulum (Faas and 
C arter, 1982). Therefore, the alterations in Iinoleic acid content may be 
related to modifications in the physical properties of the endoplasmic 
reticulum membrane under different conditions, i b - 3  Polyunsaturated 
fa tty  acids may have a similar effect, for diets containing 10% herring oil 
(mostly C20:5 and C22:6 fatty acids) result in incorporation of large 
amounts of these polyunsaturated fatty acids into the endoplasmic 
reticulum and subsequently increase mixed function oxidase activ ity . 
Accordingly, from the observation of the present work, it may be 
suggested that particular concentrations of both mono- and 
poly-unsaturated fatty acids in the hepatic endoplasmic reticulum are 
necessary for optimal activity of the drug-metabolizing enzymes (Table 5 
in Chapter 2 , Tables 7 and 8 in Chapter 3 and Table 5 in Chapter 4 ).
A sex difference in the phospholipid content of liver microsomes 
between male and female rat has been reported (Belina £  a l . ,  1975). As 
seen here (Table 5 in Chapter 2) a sex difference also exists in the 
fa tty  acid contents between male and female rat at 2-3 weeks of age in 
the endoplasmic reticulum. This observation is consistent with the lower 
level of oxidative methylation and hydroxylation in female rat (Table 1 in 
Chapter 2 , Table 4 in Chapter 3 and Table 2 in Chapter 4 ). In  the 
microsomal phospholipids, the sex difference is obvious in phosphatidyl- 
ethanolamine fraction only. The phosphatidylethanolamine fraction in 
female rat has relatively higher contents of stearic and arachidonic acids 
and lower content of palmitic acid than male rat (Table 5 in Chapter 2) 
at 2-3 weeks of age. Apparently, the total content of fatty  acids in 
phosphatidylcholine and phosphatidylethanolamine is about 70% and 50%, 
respectively, more in male than female rat (Table 5 in Chapter 4 versus
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FIGURE 12
A) Hypothetical model of cytochrome P-450 rotamers (open circles) and 
cytochrome P-450 reductase in the plane of membrane
B) Hypothetical model of two rotamers of cytochrome P-450 being 
immersed into the membrane to a different depth due to a different 
conformation
haemflavine
(Note that contact transfer of electrons from reductase is impeded in the 
case of ellipsoidal shape of cytochrome P-450).
(Taken from Greinert et a l . ,  1982).
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Tables 7 and 8 In Chapter 3 ). However, this sex difference jpev&t&te 
at 6-8  weeks of age in the endoplasmic reticulum.
The ratio of saturated to unsaturated fatty  acids is an important 
factor that determines flu id ity  or microviscosity of rat liver microsomes 
which in turn can influence the interaction between components of the 
drug-metabolizing enzymes (Castuma and Brenner, 1983). Recently, a 
model has been proposed in which cytochrome P-450 forms disc-shaped 
rotomers immersed in the bilayer membrane to a depth which is varied by 
substrate-induced and redox state-dependent conformational changes 
(Figure 12A) (C reinert et a l . , 1982). I t  is proposed that a uniaxial 
rotation of cytochrome P-450 about the normal to the membrane is 
corelated with the microviscosity of the membrane. Vertical mobility of 
proteins in biological membranes, influenced by temperature changes, has 
recently been demonstrated by studies of X -ray  low-angle scattering 
(Funk et a h , 1982). Alteration of protein-lipid interaction induced by a 
change in protein conformation may trigger the shift (Imai et a [ . , 1977). 
A vertical motion could, hypothetically, be the mechanism by which 
mixed function oxygenation is regulated. The key point is the contact 
for transfer of electrons between cytochrome P-450 reductase or 
cytochrome b5 and cytochrome P-450 which necessitates a local encounter 
of their prosthetic groups. For their proper alignment, mobility of 
proteins in the plane of the membrane and normal to the membrane is 
proposed (Figure 12B). Optical alignment to NADPH cytochrome P-450 
reductase may be achieved by the downward movement induced by 
substrate binding, and result in an increased electron-transfer rate. An 
upward shift, bringing cytochrome P-450 closer to cytochrome b5, would 
promote transfer of the second electron. However, none of these models 
or studies reveal the significance of the binding of an immobilized 
fraction of cytochrome P-450 which may be as large as 54%. The 
inductive actions of xenobiotics may indeed, regulate the mixed-function 
oxidases through this proposed rotation and mobility; speculativeiy, the 
decreased ratio of saturated to unsaturated fatty acids in the hepjtic 
endoplasmic reticulum may facilitate the contact between cytochrome P-450 
and its reductase for transfer of electron. On the other hand,
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increased ratio of saturated to unsaturated fatty acids may restrict this 
mobility and rotation, thereby affecting the drug metabolism.
THE EFFECT OF DEVELOPMENT ON LIPIDS IN THE ENDOPLASMIC 
RETICULUM
The endoplasmic reticulum is not only the site of various 
hydroxylation reactions, but it is also the main organelle for the 
synthesis of cellular structural components, especially, phospholipids and 
fa tty  acids.
Several studies on the ontogenesis of hepatic drug-metabolizing 
enzymes suggest that prior to b irth , the activity is either negligible or 
low in most species and that rapid development occurs during the firs t 
few weeks of the postnatal period (Basu et a L , 1971; McLeod et a L , 
1972; Bell and Ecobichon, 1975). This development is related to the 
increase formation of smooth endoplasmic reticulum membranes as 
assessed biochemically or by quantitative electron microscopy (De La 
Iglesia et a L , 1976). The enzyme activity of these membranes is
dependent upon the presence of phospholipids, and in particular, the 
degree of adequate function correlated with acyl side chains of these 
molecules (Gallenkamp, 1977).
Present investigations indicate that the development of drug-metabo­
lizing enzymes is connected with the increased synthesis of microsomal 
phospholipids (Tables 1 and 2 in Chapter 2 ) .  The increase in phospho­
lipid content is gradual during the weanling period and approaches the 
adult level in both sexes by 6 to 8 weeks of age. This correlates with 
the amount of membrane surface area of the endoplasmic reticulum 
membrane accumulating within the hepatocyte (Dhami et a l . , 1979).
Similarly, a gradual increase in the ratio of phospholipids to aminopyrine 
N-demethylase activity was also observed with increase in age (Tables 3 
in Chapter 2 ) .  Furthermore, acyl side chains are also increased in 
parallel fashion during development. Relatively greater amounts of 
unsaturated fatty acids are incorporated into the endoplasmic reticulum 
membranes with a subsequent shift to lower ratios of saturated to 
unsaturated fatty acids. Individual fatty  acids involved in this trend
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are palmitic and stearic with decreased concentrations. In  contrast, 
Iinoleic, arachidonic, docosapentaenoic and docosahexaenoic acids are 
progressively increased in the total phospholipid complement and 
particularly , in the phosphatidylcholine fraction (Table 5 in Chapter 2 ) .  
Phospholipids play an important role in the efficient functions of the 
endoplasmic reticulum membranes and in the physical state of the lipids, 
and may modulate the activities of drug-metabolizing enzymes during  
development (Lee et a l . ,  1973; Dockter and Magnuson, 1975).
A significant increase in the activity of hepatic drug-metabolizing 
enzymes occurs promptly after b irth (Table 1 in Chapter 2 ) .  The 
present results agree with previously published data (Ecobichon et a L , 
1978). I t  appears from this work that during the course of these events 
there are prerequisites for the normal development of enzyme activ ity . 
These include: (a) increased synthesis of arachidonic and docosahexa­
enoic acids from Iinoleic and linolenic acid, and possibly from other 
precursors (Sprecher, 1975), and (b) the enhanced incorporation of 
these unsaturated fatty  acids into phospholipids. In  these processes the 
synthesis of phosphatidylcholine fractions containing polyunsaturated acyl 
chains, especially Iinoleic acid at the 3-position, seems to be essential. 
Thus the presence of unsaturated fatty acids in phospholipids may not 
only enhance the flu idity of membranes but constitutes an initial step in 
the ontogenesis of the biochemical function of the hepatic endoplasmic 
reticulum.
Until now only in rats and mice marked sex differences in drug 
disposition have been observed. In  rats after weanling and beginning of 
sexual maturation, males exhibit distinctly higher activities than females, 
in mice the opposite holds true. Therefore, postnatal age courses after 
sexual maturation must be investigated separately for both sexes in these 
species. In rats, this sexual differentiation was found to be due to a 
neonatal androgen-induced imprinting where the hypotha­
lamic-hypophyseal axis plays an obligatory role (Einarsson et a [ ., 1973; 
Gustafsson, 1974; Levin and Ryan, 1975; Chung, 1977).
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THE EFFECT OF PREGNANCY ON LIPIDS OF THE ENDOPLASMIC 
RETICULUM
Many studies demonstrate that a disturbance of the normal 
endocrine equilibrium may influence the pattern of an animal to drug 
treatment (Kardish, 1977; Feuer, 1979). This may be applied to 
changes evolved during the course of pregnancy which imposes an 
altered response to drugs or xenobiotics. Several reports suggest a 
decreased drug metabolism during pregnancy in experimental animals 
(Neale and Parke, 1973; Dean and Stock, 1975; Devereus and Fouts, 
1975; Feuer and Kardish, 1975; Guenther and Mannering, 1977; Dhami 
et a l . , 1979; Turcan et a L , 1981) as well as in pregnant women 
(Schlede and Borowski, 1974) which contrasts with an accompanying 
hypertrophy and hyperplasia of hepatocytes (Campbell et a l . ,  1977). On 
the other hand, some studies failed to demonstrate any significant 
inhibition of drug-metabolizing enzyme activity in the pregnant rat 
(Vaisman et a L , 1976) as well as in pregnant women (Davis et a L ,
1973). Investigations from this study show a decreased drug metabolism 
during pregnancy in the rat (Table 4 in Chapter 3) and provide a more 
detailed approach into the nature and cause of impairment that 
pregnancy exerts on the lipids of the hepatic endoplasmic reticulum.
During pregnancy there is a reduction in the membrane phospho­
lipid content and a shift in composition of phospholipid bases and 
associated fatty  acids (Tables 2 and 3 in Chapter 3 ). Changes in the 
amount of phospholipids and fatty  acid chains are progressive and return  
to normal levels postpartum (Table 7 in Chapter 3 ). The alteration of 
the endoplasmic reticulum membrane environment may represent one of 
the major factors involved in the reduction of microsomal drug-metabo­
lizing enzyme activity during pregnancy. Previous report suggests that 
these modifications may be correlated with hormonal factors (Figure 13) 
(Feuer, 1979).
The significant changes occurring in fatty acid concentrations of 
hepatic microsomal phospholipids shown in this study may reflect the 
effect of pregnancy. The (reduced! phosphatidylcholine and 
phosphatidylethanolamine contents represents the partial replacement of 
the existing membranes in the hepatocytes of the pregnant rat with 
membranes containing more hydrophobic groups (Tephly and Mannering, 
1968; Chaplin and Mannering, 1970).
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During pregnancy, the effect may be attributable to the decreased 
activity of S-adenosyl-L-methionine: microsomal phosphatidylethanolamine 
methyl transferase (Feuer et a l . ,  1977; Feuer, 1979). The modifications 
of palmitic, palmitoleic, stearic, oleic, Iinoleic, arachidonic, 
docosapentaenoic and docosahexaenoic acid chains probably cause an 
alteration, in the physical properties of the membrane. Particularly, 
decreased concentrations of Iinoleic and CO-3 polyunsaturated fatty  acids 
affect the membrane flu id ity  and thereby modulate the drug-metabolizing 
enzyme activity during pregnancy.
THE EFFECT OF MICROSOMAL ENZYMES INDUCERS AND HEPATOTOXIC  
CHEMICALS ON LIPIDS OF THE ENDOPLASMIC RETICULUM
Many compounds of widely diverse chemical structures induce the 
mixed function oxidase system in the liver and other tissues, with 
accompanying proliferation of the endoplasmic reticulum and cellular 
hypertrophy (Conney, 1967; Davison and Wills, 1974b; Parke, 1975; 
Suzuki et a [ . , 1980; Mounie et a L , 1983). Since many of the drugs 
used today are inducing agents, enzyme induction may have important 
clinical implications (Ioannides, 1980). Induction of the mixed function 
oxidase is associated with increased biosynthesis of the hemeprotein 
cytochrome P-450 and cytochrome c reductase (Table 2 in Chapter 4 ) ,  
which requires the synthesis of new protein, but not of heme, since the 
heme pool can usually meet the increased requirement (Ioannides and 
Parke, 1976). Furthermore, the pronounced effects on enzyme activities 
and lipids of the endoplasmic reticulum with Aroclor-1254 treatment 
confirm the earlier suggestion of Ioannides and Parke (1975) that the 
most potent inducers are substrates whose rates of metabolism are slow, 
so that they remain associated with the enzyme for long time periods.
I t  has been demonstrated that the phosphatidylcholine content in rat 
liver endoplasmic reticulum membranes increases significantly after 
phenobarbital treatment for several days (Cooper and Feuer, 1972; 
Davison and Wills, 1974a), and it has also been suggested that this 
increase is mainly due to the stimulation of phosphatidylcholine synthesis 
through transmethylation from phosphatidylethanolamine, since the
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activity of phosphatidylethanolamine N-methyl{increases at an earlier time 
after the injection of phenobarbital in the male rat (Young et a L , 1971; 
Davison and Wilis, 1974b; Ishidate et a [ . , 1978; Sastry et a L , 1981). 
Furthermore, the rate of the incorporation of [ 32P] orthophosphate into 
the phospholipids, especially into phosphatidylcholine, was markedly 
stimulated 12 hours after a single dose of phenobarbital (80 mg/kg body 
weight) (Ishidate and Nakazawa, 1976). The observations from the 
present study (Table 3 in Chapter 4) confirm earlier suggestions that 
the increase in microsomal phospholipid content is probably attributable, 
in part, to an actual increase in phosphatidylcholine synthesis and/or 
decreased turnover rate of phospholipids (Davison and Wills, 1974b).
An increase of microsomal phospholipid content is observed in the 
endoplasmic reticulum of rats pretreated with Aroclor-1254 (Table 3 in 
Chapter 4 ). However, Ishidate and Nakazawa (1976) found that the rate 
of incorporation of [ 32P] orthophosphate into microsomal phospholipids is 
decreased by the administration of Aroclor-1254 and this decrease is 
greatest in phosphatidylcholine and lowest in phosphatidylethanolamine. 
The decrease in the specific activity of phosphatidylcholine caused by 
Aroclor-1254 administration was also recognized in the incorporation of 
[M e-ltfC] choline. I t  was suggested that the increase of microsomal 
content of phospholipids, particularly phosphatidylcholine, is not due to 
the stimulation of the synthesis but is due entirely to a decrease in 
catabolism, thus differing from the effect of phenobarbital.
In  the present study the 3-methylcholanthrene treatment did not 
alter the phospholipid content in the hepatic endoplasmic reticulum  
(Table 3 in Chapter 4 ), however a significant increase in phosphatidyl­
ethanolamine fraction is observed. Davison and Wills (1974b) reported 
little change in phosphatidylethanolamine N-methyl transferase activ ity  in 
the endoplasmic reticulum at 12 hours after 3-methylcholanthrene injection 
to male rats. The enzyme activities for phospholipid methylation are low 
in several types of cells and tissues. Therefore, doubts have been 
expressed regarding the functional significance of phospholipid 
methylation (Vance and K ru ijfi, 1980). However, smail changes in 
phospholipid methylation are necessary to bring about physiologically 
relevant alterations in phosphatidylcholine synthesis (Axelrod and H irata ,
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1980). During induction with 3-methylcholanthrene, alterations in 
phospholipid methylation is possibly the primary cause of the decrease in 
membrane viscosity (Sastry et a L , 1981) and may decrease the turnover 
rate of the phospholipids in the endoplasmic reticulum.
Carbon tetracholoride treatment decreases the phospholipid content 
in the endoplasmic reticulum membrane (Table 5 in Chapter 4 ). All 
individual phospholipid fractions decrease except for phosphatidylserine. 
These results agree with earlier studies by Cooper (1973).
Phospholipids comprise the majority of the total lipids of the liver 
endoplasmic reticulum (Victoria and Barber, 1969) and changes in fa tty  
acid composition in the present study under different treatments (Table 
5 in Chapter 4) must be occurring mainly in the phospholipids of the 
membrane. The de novo fatty  acid synthesis is catalysed by two enzyme 
systems which function sequentially: acetyl CoA carboxylase and fatty
acid synthetase; and mainly long-chain saturated fatty  acids are 
produced by these enzymes (Pande and Mean, 1968). Moreover, 
acyltransferase plays a role in the control of fatty acid composition of 
the endoplasmic reticulum (Elligson et a L , 1970). In  addition, in the 
synthesis of mono- and poly-unsaturated fatty  acids, desaturation and 
chain elongation are supplementary processes (Sprecher, 1975). 
Therefore, phenobarbital, Aroclor-1254, 3-methylcholanthrene and carbon 
tetrachloride may influence these enzyme systems; resulting in changes 
of unsaturated and polyunsaturated fatty synthesis and their subsequent 
incorporation in the endoplasmic reticulum membrane.
A comparison of the levels of induced enzyme activities (Table 2 in 
Chapter 4) in the hepatic endoplasmic reticulum having altered fa tty  acid 
composition, with those membranes having normal fa tty , acid composition, 
gives an indication of typical concentrations of fa tty  acids required for 
maximal enzyme activ ity . The rats treated with phenobarbital and 
Aroclor-1254 showed marked incorporation of both saturated and 
unsaturated fatty acids in the endoplasmic reticulum membrane and 
freduce) the ratio of saturated to unsaturated fatty acids (Table 5 in 
Chapter 4 ). 3-Methylcholanthrene treatment did not affect the fa tty  acid 
content in the endoplasmic reticulum membrane. In  rat liver microsomes, 
monooxygenases induction by phenobarbital and 3-methylcholanthrene are
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associated with increases in membrane oieic acid and linoleic acid, 
respectively (Davison and Wilis, 1974a; Becker et a L , 1978). I t  may be 
suggested from the results of this study (Tables 2 and 5 in Chapter 4) 
that the induction of cytochrome P-450 and P-448 dependent enzymes are 
associated in the membrane with different fatty acids. I t  is also 
proposed that cytochromes P-450 and P-448 may be located in different 
patches of non-uniformly distributed membrane lipid (De Pierre and 
Dallner, 1975; Daiiner and De Pierre, 1982), or may be on different 
sides of the endoplasmic reticulum membrane with an asymmetric lipid 
distribution (Nillson and Daiiner, 1977).
The inductive actions of phenobarbital and Aroclor-1254 in this 
study were found to influence the microviscosity of the endoplasmic 
reticulum membrane: (a) cholesterol/phospholipid ratio (Shimitzky and
In b ar, 1976) and (b) unsaturation of the fatty  acid chains of 
phospholipids, especially linoleic, arachidonic and docosahexaenoic acids 
(Lentz et a L , 1976). I t  has been proposed that alterations in
phospholipid methylation are possibly the primary causes for decrease in 
microviscosity of liver microsomes of rats treated with 3-methylcholan­
threne (Sastry et a L , 1981). However, sphingomyelin content was
significantly decreased in the liver microsomes by the inductive actions 
of phenobarbital, Aroclor-1254 and 3-methylcholanthrene (Table 3 in 
Chapter 4 ). For the newly induced cytochrome P-450 and NADPH-cyto- 
chrome c reductase (by phenobarbital, Aroclor-1254 and 3-methylcholan­
threne) to be effective (Table 2 in Chapter 4 ) , these enzymes must be 
inserted into the endoplasmic reticulum membrane in the optimal 
stereochemical relationship. Microviscosity or flu id ity  of the endoplasmic 
reticulum membrane may play an important role in bringing these 
enzymes into proper position to facilitate the effective topography of 
cytochrome P-450 and NADPH-cytochrome c reductase in the phospholipid 
matrix.
A number of studies on the mechanism of hepatotoxicity of carbon 
tetrachoioride emphasize the importance of the endoplasmic reticulum as 
an early site of liver in jury. According to current hypothesis, carbon 
tetrachloride is firs t activated by the drug-metabolizing enzymes of the 
endoplasmic reticulum to the reactive radical (*C C I3) ,  which then 
triggers peroxidative breakdown of lipids constituting the endoplasmic
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reticulum (Tables 3 and 5 in Chapter 4 ). This is accompanied by 
various biochemical and structural alterations, including cytochrome 
P-450, NADPH-cytochrome c reductase, aminopyrine N-demethylase and 
glucose-6-phosphatase activities (Table 2 in Chapter 4 ). The results of 
this study are consistent with earlier reports (Recknagel, 1967; Glende 
et a L , 1976; Benedetti et a L , 1977a,b; Masuda, 1981), showing that 
triglycerides and cholesterol accumulate in the endoplasmic reticulum  
membrane (Table 1 in Chapter 4) and thereby induces a fa tty  liver. 
Evidence has been reported demonstrating that the hepatic in jury  
produced by carbon tetrachloride proceeds through involvement of the 
peroxidation of subcellular lipids (Recknagel et a l . ,  1974). The reported 
evidence for a marked lipoperoxidation process involving phosphatidyl­
ethanolamine could be correlated with the carbon tetrachloride-induced  
loss of microsomal glucose-6-phosphatase (Table 3 in Chapter 4 ), since it 
has been demonstrated (Duttera et a l. ,  1968) that phosphatidylethano­
lamine is required for this enzymic activ ity . Thus, an important aspect 
of carbon tetrachloride hepatotoxicity is the inhibition of the 
monooxygenase activity accompanying the breakdown of polyunsaturated 
fatty  acids of microsomal phospholipids (Tables 3 and 5 in Chapter 4 ).
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APPENDIX TABLE A
FATTY ACID COMPOSITION OF WHOLE LIVER DURING DEVELOPMENT
IN THE MALE RATS*
Foetus 1-2  Days 2-3 Weeks 6-8  Weeks
Fatty  ^ ^ ________      _^_______
Acid ug/g i  ug/g i  ug/g i~ ug/g \
14:0 120 + 6 1.5 140 + 5+ 1 .6 190 + 2 + 1 .6 350 + 7 + 2 .8
15:0 60 + 9 0 .8 70 + 3 0 .8 80 + 2 0.7 160 + 6 + 1 .2
16:0 1770 + 29 23.5 2140 + 19+ 25.2 2330 + 41 19.0 2390 + 22 18.2
16:1 110 + 5 1.5 110 + 4 1.3 170 + 5 + 1.4 210 + 6 + 1 .6
18:0 890 + 23 11.9 880 + 25 10.4 2190 + 48 ++17.8 2210 + 35 16.9
18:1 1750 + 18 23.3 1840 i 26+ 21.7 1750 + 42 14.3 1580 + 25 + 12.1
18:2 1000 + 4 13.4 1120 + 31 13.2 2100 + 49 ++17.1 2560 + 17 + 19.5
20 :0 50 + 1 0 .6 60 ± 1 0 .6 70 + 2 + 0 .6 80 + 2 0 .6
20:1 40 + 1 0.5 40 ± 1 0.5 60 + 2 + 0.5 50 + 1 + 0.4
20:2 50 + 3 0.7 60 + 1+ 0.7 60 + 1 0.5 100 + 2 + 0 .8
20:3 100 + 9 1.3 100 + 5 1.2 150 + 6 ++ 1 .2 110 + 1 ++ 0.9
20:4 640 + 23 8.5 850 i 38+ 10.1 1470 + 55 ++12 .0 1840 + 25 ++14.0
20:5 70 + 1 1 .0 90 ± 2 1 .0 140 + 6 + 1 .2 160 + 5 + 1.1
22:3 50 + 4 0.7 80 ± 2 1 .0 120 + 3 + 1 .0 130 + 1 1 .0
22:5 140 + 11 1.9 170 + 4 2 . 0 340 + 5 ++ 2 . 8 320 + 4 2.4
22 :6 600 + 7 7.9 650 i 6+ 7.6 930 + 29 ++ 7.5 750 + 5 ++ 5.9
24:0 60 + 7 0.9 90 + 2+ 1 .0 100 + 3 + 0.9 110 + 4 0 . 8
Sat. 2950 + 23 39 3370 23f 40 4970 + 90 + 41 5300 + 41 + 40
Unsat. 4670 + 41 61 5060 + 57f 60 7280 + 110 ++59 7820 + 43 + 60
Total 7620 + 61 8430 + 35f 12250 + 190 + 13120 + 51 +
Values are expressed as means ± S .E .M . of four foetuses or litters or rats 
in each group.
Values differ significantly from preceding age group; + p 4.0.05; f t  p < 0 .0 0 5 .  
(Sat./unsat. indicate saturated and unsaturated fatty acids; ug/g indicates 
micrograms/g liver; % indicates percentage of total fraction).
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APPENDIX TABLE B
FATTY ACID COMPOSITION OF WHOLE LIVER DURING 
DEVELOPMENT IN THE FEMALE RATS*
AGE
Fatty 1-2  Days 2-3 Weeks 6-8  Weeks
Acid _______ ________ _______________ ______ __________
u g /g  i  u g /g  i  u g /g  %~
14:0 140 + 6 1.6 190 + 6 t  1 .6 220 ± 5 t 1 .6
15:0 70 + 2 0.9 80 + 3 0.6 130 + 1 t 0.9
16:0 2130 + 29 25.6 2230 + 24 t  18.1 2250 + 39 16.2
16:1 130 + 2 1.5 170 + 14 t  1.4 190 + 17 1.4
18:0 920 + 25 11 .0 2300 + 143 f t 18.6 2270 + 51 19.9
18:1 1640 + 26 22.1 1630 + 41 13.2 1660 + 25 11.9
18:2 1150 + 30 13.8 2100 + 51 f t 17.1 2720 + 56 f t 19.5
20 :0 50 + 1 0 .6 70 + 6 f  0 .6 100 + 3 t 0.7
20:1 40 + 2 0.5 70 + 2 f  0 .6 50 + 3 t 0.4
20:2 60 + 22 0.7 60 + 3 0.5 110 + 7 t 0 .8
20:3 120 + 4 1.4 160 + 5 f  1.2 120 + 4 t 0.9
20:4 660 + 18 7.9 1640 + 64 f t1 3 .3 1960 + 19 f t 14.1
20:5 100 + 3 1.2 160 + 11 f  1.3 170 + 5 1 .2
22:3 90 + 3 1 .0 120 + 6 f  0.9 120 + 15 0.9
22:5 170 + 7 2 .0 340 + 11 f f  2 .8 340 + 17 2.4
22:6 400 + 10 7.5 850 + 55 f f  6.9 880 + 15 6.3
24:0 70 + 3 0.9 120 + 4 f f  0.9 100 + 5 0.7
Sat. 3370 + 13 41 4990 + 147 f  40 5590 + 71 40
Unsat. 4960 + 39 59 7430 + 150 ff60 8340 + 48 t 60
Total 8340 + 46 12420 + 293 f t 13930 + 73 t
Values are expressed as means ± S .E .M . of four litters or rats in each group. 
Values differ significantly from preceding age group; f  p^.0.05; f f  p < 0 .0 0 5 .  
(Sat./unsat. indicate saturated and unsaturated fatty acids; u g /g  
indicates micrograms/g liver; % indicate percentage of total fractions).
174
APPENDIX TABLE C
FATTY ACID COMPOSITION OF LIVER PHOSPHATIDYLCHOLINE FRACTIONS
FROM THE DEVELOPING RATS*
Male Female
Fatty Age: 1-2  Days 2-3 Weeks 1-2  Days 2-3 Weeks
Acid ___ _ ______  ______ ______  _____ _______ ______________
u g /g  u g /g  i ”~ u g /g  W~ u g /g  i~
14:0 3 + 1 0 .2 3 + 1 0.2 2 + 1 0 .2 3 + 1 0 . 2
15:0 4 + 1 0.4 5 + I t 0.3 4 + 1 0.4 5 + I t  1 .2
16:0 250 + 3 23.6 400 + 2f t 23.4 250 + 5 24.5 370 + 7 tt2 1 .2
16:1 20 + 1 2 .0 30 + I f f 1.7 20 + 1 2 . 0 30 + 1t t  1 .8
18:0 250 + 6 23.0 350 + 3 ft 20 .8 240 + 4 23.0 420 + 5 t t2 4 .1
18:1 120 + 4 1 1 .0 180 + 5tt 10.7 90 + 2 9.1 180 + 5ff10 .4
18:2 140 + 4 13.3 270 + 6t t 15.8 120 + 3 11.7 250 + 8tt14.2
20:1 3 + 1 0.5 7 + If 0.4 5 + 1 0.5 7 + 1t 0.4
20:2 4 + 1 0.4 3 + 1 0 .2 4 + 1 0.5 3 + 1 0 . 2
20:3 9 + 1 0.9 10 + 1 0.7 9 + 1 0.9 10 + 1 0.7
20:4 120 + 2 11 .6 240 + 3 ft 14.3 120 + 4 11.7 270 + 5 f f 15.2
20:5 40 + 1 3.4 40 + 1 2 .6 40 + 1 3.6 40 + 1 2 . 6
22:5 10 + 1 1.1 10 + 1 0 .8 10 + 1 1 .2 10 + 1 0.9
22 :6 90 + 1 8.5 130 + 2f t 7.9 110 + 2 10 .6 130 + 2+ 7.7
Sat. 510 + 8 47 760 + 2f 45 510 + 8 49 800 + 9f 46
Unsat. 560 + 8 53 940 + 13f 55 540 + 8 51 950 + 12f 54
Total 1070 + 12 1700 + 13 t f 1050 + 11 1750 + 6f t
Values are expressed as means ± S .E .M . of four litters or rats in 
each group.
Values differ significantly from preceding age group; f  p £ 0 .0 5 ,  f f  p <  0.005. 
(Sat./unsat. indicate saturated and unsaturated fatty acids; u g / g  indicates 
micrograms/g liver; % indicates percentage of total fraction).
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APPENDIX TABLE D
FATTY ACID COMPOSITION OF LIVER PHOSPHATIDYLETHANOLAMINE 
FRACTIONS FROM THE DEVELOPING RATS*
Fatty
Acid
Male Female
Age: 1-2 Days 2--3 Weeks 1-2  Days 2 -3 Weeks
u g /g % u g /g 6.•o u g /g o"o u g /g 0.•s
16:0 150 + 4 25.8 210 + 1 f t  24.0 170 ± 6 25.3 200 + 4t 21.9
16:1 4 + 1 0 .8 10 + 1 f t  1 .0 5 ± 1 0.9 10 + i f f 1 .0
18:0 150 + 4 26.0 210 + 4 f t 24.7 170 ± 6 25.4 240 + 7ft 27.3
18:1 70 + 1 11.4 110 + 2 t f 12.9 70 ± 1 10 .8 110 + 2f t 12 .6
18:2 50 + 1 7.9 90 + 1 f t 10.1 60 ± 2 9.1 90 + 1f t 9.8
20:3 3 + 1 0 .6 4 + 1 t  0.5 3 ± 1 0 .6 4 + i t 0.5
20:4 90 + 6 15.8 150 + 5 f f 16.9 100 ± 5 15.8 150 + 2f f 17.5
22:3 5 + 1 0.9 7 + 1 t  0.9 6 ± 1 0.9 10 + i t 0 . 8
22:6 60 + 3 10 .6 80 + 1 t  9.0 70 ± 2 11 .2 80 + I t 8 . 6
Sat. 300 + 9 52 420 + 5 f t  49 330 ± 13 51 440 ± 9ff 49
Unsat. 280 + 8 48 440 + 5 f f  51 320 ± 7 49 460 + 1f t 51
Total 580 ± 18 870 + 9 f f 650 ± 20 900 + 8t t
Values are expressed as means ± S .E .M . of four litters or rats in 
each group;
Values differ significantly from preceding age group; f  p 4  0 .05, t f  p < 0 .0 05 .  
(Sat./unsat. indicate saturated and unsaturated fatty acids ug/g indicates 
micrograms/g liver; % indicates percentage of total fraction).
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APPENDIX TABLE E
FATTY ACID COMPOSITION OF LIVER MICROSOMAL PREPARATION DURING
DEVELOPMENT IN THE MALE RATS*
Age
Fatty Foetus 1-2  Days 2-3 Weeks 6 -8  Weeks
Acid ______   j________  _______ ________ ________________
u g /g  V  u g /g  W u g /g  u g /g  i~
14:0 70 + 1 2.52 100 + 4 t 2.64 120 + 3+ 2.54 180 + 7++ 3.58
15:0 40 + 1 1.42 40 + 4 1.19 80 + 1+ 1.57 100 + 4++ 1.94
16:0 610 + 16 22.01 690 + 10+ 18.32 880 + 17++17.75 810 + 17 + 16.01
16:1 50 + 3 1.76 80 + 3+f 2.04 100 + 3+ 2.09 100 + 6 1.93
18:0 570 + 16 20 .66 780 + 15+t 20.85 990 + 22++19.90 1000 + 7 19.75
18:1 310 + 17 11.13 450 + 15+t 11.88 540 + 6++10.92 570 + 5 + 11 .22
18:2 350 + 11 12.47 580 + 9+t 15.45 680 + 14++13.57 700 + 9 13.90
20:0 20 + 1 0.73 20 + 1 0.61 40 + 2+ 0.72 30 + 2 + 0.69
20:1 20 + 1 0.74 20 + 1 0.58 30 + 2+ 0.69 40 + 1 + 0.72
20:2 20 + 1 0.91 30 + 1 ++ 0.89 40 + 2 ++ 0.80 40 + 2 0.76
20:3 70 + 2 2.72 60 + 2 + ■ 1.48 70 + 2+ 1.46 80 + 3 + 1.55
20:4 230 + 11 8.25 330 + 9++ 8.81 690 + 6++13.82 640 + 18 + 12.73
20:5 80 + 3 2.99 70 + 2 + 1.78 100 + 3++ 2.10 110 + 6 2.18
22:3 30 + 2 1.21 40 + 1 + 1.21 60 + 2 ++ 1.16 50 + 2 + 0.99
22:5 80 + 4 2 .8 6 120 + 6 ++ 3.11 160 + 5++ 3.21 180 + 3 + 3.60
22:6 180 ± 10 6.58 300 + 5++ 8.09 330 + 3++ 6.61 370 + 9 + 7.34
24:0 30 ± 3 1.04 40 + 2 1.05 50 + 2 ++ 1.08 50 + 2 1.07
Sat. 1340 ± 28 48 1680 + 22 f t  45 2170 + 37+144 2180 + 27 43
Unsat. 1430 ± 46 52 2070 + 13 + f 55 2810 + 12ff56 2890 + 36 57
Total 2770 ± 32 3750 + 29 4980 + 36 1*1* 5070 + 27
Values are expressed as means ± S .E .M . of four foetuses or litters or rats in 
each group.
Values differ significantly from preceding age group; f  p < 0 .0 5 ,  + f  p < 0 .0 0 5 .  
(Sat./unsat. indicate saturated and unsaturated fatty acids; u g / g  indicates 
micrograms/g liver; % indicates percentage of total fraction).
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APPENDIX TABLE F
FATTY ACID COMPOSITION OF LIVER MICROSOMAL PREPARATION
DURING DEVELOPMENT IN THE FEMALE RATS*
Age
Fatty Foetus 1-2  Days 2-3 Weeks 6-8  Weeks
Acid _____     . _______ __________ _________________
ug/g  u g /g  i~ u g /g  % u g /g  %
14:0 50 + 3 2.36 70 + I t 2.41 90 + 2 t 2.58 200 + 13+ 3.97
15:0 20 + 1 1.08 40 + 2+ 1.42 40 + 2 t 1.10 100 + 7 t 2.11
16:0 440 ± 11 22.19 620 + 2 0 f t 21.86 740 + 1 7 t t 20.64 920 + 2 Of t 18.46
16:1 30 ± 1 1.76 40 + 2f 1.58 70 + i t t 1.96 100 + 6 t 1.98
18:0 400 + 4 20.32 560 + 1 5 f t 19.76 640 + 8 f t 17.92 860 + 2 O f f 17.22
18:1 220 + 1 11.25 320 + 10 f t 11.39 450 + 4 t f 12.80 540 + 2 3 t f 10.95
18:2 280 + 6 13.97 330 + 6 t 11.84 590 + 7 f t 16.68 660 ± 30 13.36
20:0 10 Hr 0 0.73 20 + I t ' 0.71 20 + 1 0.59 20 ± 1 0.49
20:1 10 Hh 1 0.76 20 i I t - 0.71 20 + 1 0.54 30 ± 2 t 0.56
20:2 20 i 1 0.96 20 + 2 0.86 30 + I t 0.94 50 + 2 t 1.10
20:3 40 i 4 2.24 80 + 4 f t 2.71 50 + 2 f t 1.46 80 + 4 f t 1.55
20:4 180 + 9 9.09 280 + 1 8 f f 9.85 300 + 6 8.51 680 + 311 13.66
20:5 50 i 4 2.72 80 + 2 t 2.78 60 + 3 t 1.77 100 + 7 t 2.13
22:3 10 + 1 0.54 30 + 1t 0.95 30 + 2 1.05 60 + 2 t 1.12
22:5 40 + 2 2.10 70 + 3 t t 2.50 90 + 3 t 2.64 170 + 1 2 f f 3.51
22:6 140 + 2 7.01 220 + 9 f t 7 .64 270 + 5 t 7.63 330 + 21 6.64
24:0 20 + 1 0.91 30 + 2 f 1.06 40 + I t 1.14 60 + 3 f 1 .19
Sat. 940 + 10 48 1340 + 2 0 f f  47 1570 + 20 44 2170 + 3 9 t 43
Unsat. 1040 + 10 52 1240 + 2 0 f f  53 2000 + 10f 56 2810 ±1 12 f 57
Total 1980 ± 20 2840 + 6 0 f f 3570 + 2 0 f 4980 ±14 9 f t
Values are expressed as means± S .E .M . of four foetuses or litters or rats in 
each group.
Values differ significantly from preceding age group; + p /L 0 .0 5 , f f  p < 0 .0 5 .  
(Sat./unsat. indicate saturated and unsaturated fatty acids; u g /g  indicates 
micrograms/g liver; % indicates percentage of total fraction).
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APPENDIX TABLE G
FATTY ACID COMPOSITION OF LIVER MICROSOMAL PHOSPHATIDYLCHOLINE
FRACTIONS FROM THE DEVELOPING RATS*
Fatty
Acid
Female Male
Age: 1-2 Days 2--3 Weeks 1-2 Days 2-3 Weeks
u /g ot> ug /g 0"o u g /g % u g /g %
14:0 0 .6 + 0.1 0 .2 1 + 0.1  + 0.3 6 + 0.1 0.2 1 + 0.1  + 0.3
15:0 0.5 + 0.1 0 .2 1 + 0.1 + 0 .2 5 ± 0.1 0 .2 1 + 0 . 2+ 0 .2
16:0 66 + 1.7 23.4 114 + 3.3++ 23.2 64 ± 3.0 23.3 98 + 2.3++ 19.6
16:1 5 + 0.1 2 .0 8 + 0 . 2++ 1 .6 5 ± 0 .2 2.1 8 + 0 . 2++ 1 .6
18:0 65 + 3.0 23.1 103 + 3.8+ + 20.9 65 ± 2 . 8 23.7 120 + 2.7++ 24.0
18:1 20 + 0.5 7.5 43 + 1 . 0++ 8.9 22 ± 1.5 8 .2 42 + 1 . 6 ++ 8.4
18:2 30 + 1 .5 11 .2 59 + 1 . 8++ 1 2 .0 33 ± 0 .8 1 2 .0 60 + 1.3++ 1 2 .0
20:1 1 + 0.3 0.4 2 + 0 . 6+ 0.4 1 ± 0.1 0.4 1 + 0 .6 0.3
20:2 1 + 0.1 0.3 1 ± 1.5 0.3 1 ± 0.1 0.3 1 + 0.1 0.3
20:3 3 + 0.3 1 .0 3 ± 1.3 0.7 2 ± 0.1 1 .0 3 + 0.1 + 0.7
20:4 36 + 1.5 12.9 86 ± 1.4++ 17.5 31 ± 1.3 11.5 91 + 1 . 2 ++ 18.2
20:5 10 + 0.4 3.5 13 ± 0.3+ 2.7 10 ± 0 .2 3.8 13 + 0 . 6  + 2 . 6
22:5 4 + 0.5 1.4 4 ± 0.1 0 .8 3 ± 0 .2 1.4 4 + 0.1  + 0.9
22:6 35 + 1.3 12.7 52 ± 0.7 f t 10.5 32 ± 0 . 6 11 .8 54 + 1 . 0 + 10 .8
Sat. 130 + 4.6 47 220 ± 6 . 8 t f 45 130 ± 7.4 47 220 + 4.5++ 44
Unsat. 150 + 2.5 53 270 ± 2 . 1 f t 55 140 ± 1.3 53 280 + 3.2++ 56
Total 280 + 6.9 490 ± 5 .8  f f 270 ± 6.7 500 + 7.6++
Values are expressed as means± S .E .M . of four litters or rats in each group. 
Values differ significantly from preceding age group; + p < 0 .0 5 ,  t f  p ^ 0 .0 0 5 .  
(Sat./unsat. indicate saturated and unsaturated fatty acids; u g / g  indicates 
micrograms/g liver; % indicates percentage of total fraction).
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APPENDIX TABLE H
FATTY ACID COMPOSITION OF LIVER MICROSOMAL PHOSPHATIDYLETHANO- 
LAMINE FRACTION FROM THE DEVELOPING RATS*
Fatty
Acid
Male Female
Age: 1-2 Days 2--3 Weeks 1-2 Days 2-3 Weeks
u g /g % u g /g  % u g /g % u g /g  %
16:0 42 ± 1 .2 23.3 63 ± 0.4++25.6 49 + 2 . 0 26.1 56 ± 1.0+ 21.7
16:1 2 ± 0.1 1.1 3 ± 0 . 1+ 1.1 2 + 0.1 1 .0 3 ± 0 . 1+ 1.1
18:0 50 ± 2.3 28.2 61 ± 1.3+ 24.9 49 + 2 . 0 26.2 74 ± 1.2+ 28.9
18:1 23 ± 0.9 13.0 31 ± 0.1+ 12.7 23 + 0.3 12.4 28 ± 0 . 1+ 10 .0
18:2 15 ± 0.4 8 .6 25 ± 0 . 6++10 .0 16 + 0.9 8.7 21 ± 0.6+ 8.3
20:3 1 ± 0.1 0.4 1 ± 0.1 0.5 2 + 0.1 0.4 1 ± 0.1+ 0.5
20:4 29 ± 1.1 16.6 39 ± 0.7++15.7 30 + 1.4 16.2 50 ± 0.8++19.4
22:5 1 ± 0.1 0.7 2 ± 0.1++ 0.7 1 + 0.1 0 .8 2 ± 0 . 1++ 0 . 8
22:6 14 ± 0.5 8.1 22 ± 1.2++ 8.9 15 + 0 .6 8.1 21 ± 1.2+ 8.4
Sat. 93 ± 3.1 52 124 ± 1.6+ 50 98 + 4.1 52 180 + 1.0+ 51
Unsat. 87 ± 1.9 48 122 ± 1.5++50 90 + 1 .0 48 126 + 1.1+ 49
Total 180 ± 4.1 250 ± 2.5++ 190 + 4.2 260 + 0.9+
Values are expressed as means ± S .E .M . of four litters or rats in each group. 
Values differ significantly from preceding age group; f  p^ .0 .05, f t  p < 0 .0 05 .  
(Sat./unsat. indicate saturated and unsaturated fatty acids; ug/g indicates 
micrograms/g liver; % indicates percentage of total fraction).
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